Share your experience by using thehashtag #jenscongress on: /JENS.CONGRESS /jens_congress @JENS_Congress /groups/8519337/profile HOW TO DOWNLOAD THE CONGRESS APP 1. Connect to the Wi-Fi network: Convention Center password: venezia2017 2. Enter your store: 3. Search and download the “MCA EVENTS” app You can now interact with speakers using Q&A on MCA app. Ask questions to the speakers directly via app and engage the discussion at the end of the sessions. 22 33 ORGANISING INSTITUTIONS Dear Colleagues, Dear Friends, The European Society for Paediatric Research (ESPR), the European Society for Neo- european foundation for the care of newborn infants natology (ESN), the Union of European Neonatal and Perinatal Societies (UENPS) and www.efcni.org the European Foundation for the Care of Newborn Infants (EFCNI) have combined The European Foundation for the Care of Newborn Infants (EFCNI) is the first pan-European organisation their efforts for the 2nd Congress of joint European Neonatal Societies (jENS 2017). The and network to represent the interests of preterm and newborn infants and their families. congress promises yet again to be a unique event in the field of neonatology. It gathers together parents, healthcare experts from different disciplines, and scientists with the common goal of improving long-term health of preterm and newborn children. Our vision and activities are to ensu- re the best start in life for every baby with best possible treatments and care. The congress will highlight best scientific research and clinical care programmes avai- lable nowadays. You will also have access to sessions where world-leading experts will cover a wide range of topics in neonatology, ranging from state-of-the-art basic and clinical research to patient-centred care and clinical guidelines. A panel of more than 130 leading international experts who have personally contri- buted to the state of the art will review cutting-edge developments in the areas of neonatal care and research, which are particularly active today. Networking and interactivity between renowned expert’s participants, Key Opinion www.espr.info Leaders, industry and the Organising Societies - will be the keywords of this congress. The European Society for Paediatric Research (ESPR) aims to promote paediatric research and post-gra- Innovative and interactive tools such as specially designed apps, jENS TV, interacti- duate training in Europe. The Society aims to encourage collaboration between the various specialized fields of paediatrics, with the goal of maintaining paediatrics as a unified, scientifically orientated discipli- ve e-posters, interactive communications between speakers and the audience and ne. It has involved into a dynamic and vibrant society which takes up wider societal responsabilities and much more will make this congress a truly pioneering experience. has a succesful Journal in “Pediatric Research”. Within ESPR, the European Society of Neonatology (ESN) is responsible for education and training in Neonatology in Europe. In the past year a transition from ESN to The 2nd edition of the congress comes to the most famous Italian city. Venice, with a new Board of Neonatology (EBN) was realised to improve the representation of all European countries in its combining spectacular buildings, incredible charm, and a true touch of romance the neonatal educational activities of ESPR. was ranked the most beautiful city in the world. It certainly deserves a visit and will without a doubt become one of the congress locations that live on in memory. The Organising Societies and Scientific Committee of jENS warmly welcome all par- ticipants in this 2nd edition and thanks all presenters and supporters for their great commitment. We wish you fruitful discussions with leading experts in the field of neonatology and are convinced that together, we will make the 2nd jENS an unfor- gettable experience. www.uenps.eu Enjoy the Congress! The mission of UENPS is to improve healthcare in the neonatal and perinatal medicine in the European countries. Main goals of UENPS are to improve quality in perinatal and neonatal care by integrating, coor- dinating and adding national and scientific societies’ efforts, to promote the knowledge of the perinatal indicators and to develop recommendations, guidelines, training of the healthcare providers and any Professor Luc Zimmermann Professor Manuel Sanchez Luna other tool to achieve the best healthcare for every newborn and surveillance of neonatal rights wherever President ESPR President UENPS they are born. SUPPORTED BY Doctor Morten Breindahl Silke Mader President ESN Chairwoman EFCNI 44 55 EXECUTIVE COMMITTEE SCIENTIFIC COMMITTEE MANON BENDERS VIRGILIO P. CARNIELLI PIERRE GRESSENS Congress President Chair Past Scientific President LUC ZIMMERMANN MANUEL President of ESPR SÁNCHEZ-LUNA President of UENPS AGNES PETRA HÜPPI NEIL MARLOW VAN DEN HOOGEN SILKE MADER MORTEN BREINDAHL Chairwoman of the President of the European Executive Board and Society for Neonatology Co-Founder of EFCNI (ESN) european foundation for the care of newborn infants OLA D. SAUGSTAD UMBERTO SIMEONI 66 77 DARSENA VENEZIA ROMA FIRENZE CAPRI COMO NAPOLI ROOM ROOM ROOM ROOM ROOM ROOM ROOM GOUND FLOOR GOUND FLOOR GOUND FLOOR GOUND FLOOR PALAZZO DEL CINEMA PALAZZO DEL CINEMA GOUND FLOOR 09:00 09:00 ESN COURSE 1 NEONATAL INFECTIONS 12:00 12:00 17:30 17:30 09:00 - 17:30 ESN COURSE 1 | CAPRI ROOM (PALAZZO DEL CINEMA) NEONATAL INFECTIONS 09:00 - 09:15 Introduction/welcome Sinno Simons (The Netherlands) 09:15 - 10:15 Basics of infectious diseases in neonatology René Kornelisse (The Netherlands) 10:15 - 11:00 Early onset sepsis NICE guideline Mark Turner (United Kingdom) 11:00 - 11:30 COFFEE BREAK 11:30 - 12:30 Adequate antibiotic dosing/TDM Karel Allegaert (Belgium) 12:30 - 13:00 Time for questions 13:00 - 14:00 LUNCH BREAK 14:00 - 15:00 Infection prevention Agnes van den Hoogen (The Netherlands) 15:00 - 15:45 Emerging resistance patterns of microbial pathogens and how these relate to the choice of antibiotics Christoph Bührer (Germany) 15:45 - 16:00 COFFEE BREAK 16:00 - 17:00 Heart rate variability and physiologic monitoring of neonatal sepsis / probiotics in necrotizing enterocolitis Irwin Reiss (The Netherlands) 17:00 - 17:30 Discussion 30th October, 2017 99 DARSENA VENEZIA ROMA FIRENZE CAPRI COMO NAPOLI ROOM ROOM ROOM ROOM ROOM ROOM ROOM GOUND FLOOR GOUND FLOOR GOUND FLOOR GOUND FLOOR PALAZZO DEL CINEMA PALAZZO DEL CINEMA GOUND FLOOR 09:00 09:00 PRE- PRE- PRE- ESN PRE- CONGRESS CONGRESS CONGRESS COURSE 2 CONGRESS COURSE 2 COURSE 3 COURSE 4 COURSE 1 MULTIMODAL UNMET NEEDS: CONTROVERSY IN NEONATAL VENTILATORY NEURO-IMAGING IMPROVING PHARMACOLOGY HAEMODYNAMICS SUPPORT- AND NEURO- THE QUALITY OF MATCHING MONITORING IN NEONATAL CARE PHYSIOLOGY? NEONATES - APPROACHES AND STRATEGIES 13:00 13:00 14:00 14:00 PRE- CONGRESS COURSE 5 NEONATAL GASTROENTEROLOGY, SURGERY AND NUTRITION 17:00 17:00 17:30 17:30 PLENARY SESSION 1 OPENING CEREMONY 18:30 18:30 Join our Symposium Strategies and modern 09:00 – 17:00 PRE-CONGRESS COURSE 1 technologies of continuous noninvasive VENTILATORY SUPPORT- MATCHING blood gas monitoring PHYSIOLOGY? | COMO ROOM (PALAZZO DEL CINEMA) Mosaici 2, November 1st, 12.30 pm – 1.30 pm Industry Supported session - please see page 125 09:00 – 11:00 New insights in pathophysiology of neonatal lung disease Robin Steinhorn (United States) jENS 2017 Congress of joint European Neonatal Societies 11:00 – 11:30 COFFEE BREAK October 31st – November 4th 11:30 – 13:00 News in NIV 1: Understanding the controversy of HFNC early in life Anna Lavizzari (Italy) Intraoperative use of transcutaneous CO2 measuring in paediatric and neonatal 13:00 – 14:00 LUNCH BREAK anaesthesia Michael Brackhahn 14:00 – 15:30 News in NIV 2: nasal HFOV Consultant Anaesthetist Daniele De Luca (France) Department of Anaesthesia, PICU and Emergency Auf der Bult, Kinder- und Jugendkrankenhaus 15:30 – 17:00 News in NIV 3: Synchronised NIPPV Hannover Camilla Gizzi (Italy) Validation of novel combined transcutaneous sensor – virtually drift free tcPO2 sensing technology Irwin Reiss Professor of Neonatology, Department of Paediatrics Head Division of Neonatology Erasmus MC Rotterdam Visit SenTec booth No 17 and inform yourselves about the OxiVenTTM Sensor – a new generation of transcutaneous monitoring of ventilation and oxygenation. 10 10 31st October, 2017 11 11 09:00 - 17:00 PRE-CONGRESS COURSE 2 | VENEZIA ROOM 09:00 - 17:00 PRE-CONGRESS COURSE 3 | ROMA ROOM MULTIMODAL NEURO-IMAGING AND UNMET NEEDS: IMPROVING THE NEURO-MONITORING IN NEONATES QUALITY OF NEONATAL CARE - APPROACHES AND STRATEGIES 09:00 - 09:45 The early development of brain white matter Jessica Dubois (France) 09:00 - 11:00 Meeting the patients needs Jos Latour (United Kingdom) 09:45 - 10:15 Quality assurance of MR images: why is it important and what does an MR physicist do anyway? 11:00 - 11:30 COFFEE BREAK Zoltan Nagy (Hungary) 10:15 - 11:00 How to measure brain prefusion in the newborn 11:30 - 13:00 Parent-infant closeness - developmentally supportive Steven Miller (Canada) environment Liisa Lehtonen (Finland) 11:00 - 11:30 COFFEE BREAK 13:00 - 14:00 LUNCH BREAK 11:30 - 12:15 How to diagnose cerebral venous thrombosis in the newborn Luca Ramenghi (Italy) 14:00 - 16:00 Treatment of pain in the NICU – Do we treat our patients with respect of their needs? 12:15 - 13:00 fMRI in the newborn-what do we learn? Marsha Campbell-Yeo (Canada) Petra Hüppi (Switzerland) 16:00 - 17:00 Becoming parent of a preterm baby - what does that mean… 13:00 - 14:00 LUNCH BREAK in Sweden 14:00 - 15:00 Connectomics and development Karl Rombo (Sweden) Martijn Van De Heuvel (The Netherlands) in Romania 15:00 - 16:00 Strength and pitfalls of (a)EEG Diana Gamulescu (Romania) Laura Weeke (The Netherlands) 16:00 - 17:00 How to detect seizures in the newborn Geraldine Boylan (Ireland) 12 12 31st October, 2017 31st October, 2017 13 13 09:00 - 17:00 ESN COURSE 2 | CAPRI ROOM (PALAZZO DEL CINEMA) 09:00 - 13:00 PRE-CONGRESS COURSE 4 | FIRENZE ROOM NEONATAL HAEMODYNAMICS CONTROVERSY IN PHARMACOLOGY Industry Supported session - please see page 125 09:00 - 09:30 Introduction: what would you like to learn? 09:00 - 09:10 Welcome and introduction Sinno Simons (The Netherlands) Willem de Boode (The Netherlands) 09:30 - 10:15 Basics in neonatal pharmacology: 09:10 - 09:50 Cardiovascular physiology what the clinician needs to know! Shahab Noori (United States) Karel Allegaert (Belgium) 09:50 - 10:30 Advanced haemodynamic monitoring 10:15 - 11:00 PK-PD modeling: what is it, and how can we use it? Willem de Boode (The Netherlands) Catherijne Knibbe (The Netherlands) 10:30 - 11:00 COFFEE BREAK 11:00 - 11:30 COFFEE BREAK 11:00 - 11:40 Echocardiography on the NICU 11:30 - 12:15 Pharmacology in neonatal research: anything new? Afif El-Khuffash (Ireland) Sinno Simons (The Netherlands) 11:40 - 12:20 Advanced echocardiographic technologies 12:15 - 13:00 Inotropes in newborn care: an update Eirik Nestaas (Norway) Eugene Dempsey (Ireland) 12:20 - 13:00 Assessment and management of the PDA 13:00 - 14:00 LUNCH BREAK Patrick McNamara (Canada) 13:00 - 13:40 LUNCH 14:00 – 17:00 PRE-CONGRESS COURSE 5 | FIRENZE ROOM 13:40 - 14:20 Assessment and management of PPHN NEONATAL GASTROENTEROLOGY, Nim Subhedar (United Kingdom) SURGERY AND NUTRITION 14:20 - 15:00 Assessment and management of shock Colm Breatnach (Ireland) 14:00 – 15:00 Feeding strategies and the risk of NEC: an overview Jon Dorling (United Kingdom) 15:00 - 15:40 Longterm outcome of circulatory failure Mayka Bravo (Spain) 15:00 – 16:00 Nutritional assessment in surgical neonates Mark Johnson (United Kingdom) 15:40 - 16:00 COFFEE BREAK 16:00 – 17:00 Nutritional management of an infant with ileostomy: practical aspects 16:00 - 16:40 Case histories faculty Alexandre Lapillonne (France) 16:40 - 17:00 Plenary discussion, summary and close Willem de Boode (The Netherlands) 14 14 31st October, 2017 31st October, 2017 15 15 DARSENA VENEZIA ROMA FIRENZE SORRENTO LECCE NAPOLI VERONA ROOM ROOM ROOM ROOM ROOM ROOM ROOM ROOM (Mosaici 1) (Mosaici 2) GROUND FLOOR GROUND FLOOR GROUND FLOOR GROUND FLOOR THIRD FLOOR THIRD FLOOR GROUND FLOOR SECOND FLOOR 08:00 08:00 POSTER WALK 09:00 09:00 Parallel Parallel Parallel Parallel Parallel Parallel Session 1 Session 2 Session 3 Session 4 Session 5 Session 6 (BRAIN 1) (RESUSCITATION) (EFCNI 1) What can we (NUTRITION 1) (CIRCULATION 1) Neurodevelopmental New techniques for Pain reduction - does learn from Nutrition and the Brain Who owns the outcome and optimising newborn a partnership with Neonatal Networks placental blood? congenital heart resuscitation parents reduce pain in disease newborns? 11:00 11:00 COFFEE BREAK 11:30 11:30 PLENARY SESSION 2 Regenerative Medicine 12:30 12:30 LUNCHEON LUNCHEON SYMPOSIUM SYMPOSIUM Early Optimal Strategies and modern LUNCH BREAK Nutrition in the NICU technologies of con- tinuous noninvasive blood gas monitoring 13:30 13:30 POSTER POSTER POSTER ROUND TABLE POSTER SATELLITE POSTER SESSION 1 SESSION 2 SESSION 3 Interactive clinical ses- SESSION 4 SYMPOSIUM SESSION 5 sion: are babies with Respiratory Syncytial LUNG 1 NICU + PARENTS CARDIOLOGY + serious hypoxemic GI + NEC + Virus: Should We NUTRITION 1 conditions still being Identify Paediatric MICROCIRCULATION 1 missed? BILIRUBIN Patients at Risk for Severe Disease? 15:00 15:00 Parallel Parallel Parallel Parallel Parallel Parallel Session 7 Session 8 Session 9 Session 10 Session 11 Session 12 (PULMONOLOGY 1) (BRAIN 2) (CIRCULATION 2) (PHARMA 1) (NUTRITION 2) (EFCNI 2) Pulmonary Monitoring for infants What should we moni- Challenges in Controversies in Family centred deve- symposium at risk tor? Global neonatal drug neonatal nutrition lopmental supportive development care – evidence or haemodynamics (systemic blood flow) philosophy? 17:00 17:00 PHARMACOLOGY COFFEE BREAK SECTION MEETING 17:30 17:30 PLENARY SESSION 3 Bengt Robertson award 18:30 18:30 BRAIN SECTION MEETING 08:00 - 09:00 POSTER WALK | GROUND FLOOR Epidemiology & Networks Chairs: Niels Bjerregaard Matthiesen (Denmark) Cathrine Carlsen Bach (Denmark) ID 004 AN EVALUATION OF DOCTORS AND MEDICAL STUDENTS KNOWLEDGE OF PAEDIATRIC VACCINATIONS IN PAKISTAN N. Nadeem (United Kingdom) PLENARY SESSION 1 | DARSENA ROOM 17:30 - 18:30 ID 005 AN EVALUATION OF DOCTORS AND MEDICAL STUDENTS ATTITUDES AND BELIEFS OF PAEDIATRIC VACCINATIONS IN PAKISTAN OPENING CEREMONY N. Nadeem (United Kingdom) Chairs: Luc Zimmermann (The Netherlands); ID 115 MORTALITY; MORBIDITY AND SHORT-TERM RETINOPATHY OF Silke Mader (Germany); Manuel Sanchez Luna (Spain); PREMATURITY OUTCOMES IN EXTREME PRETERM NEONATES: A Morten Breindahl (Sweden) 5 YEAR STUDY H. Jarvis; M. Sdobnikovs; J. William; F. Dean; P. Satodia (United Kingdom) 17:30 - 17:50 Roundtable – The next step to fulfill the unmet needs in neonatology ID 138 NEONATAL MORTALITY AND MORBIDITY IN FIVE PROVINCIAL HOSPITALS IN THE PEOPLE’S DEMOCRATIC REPUBLIC OF LAOS AFTER Moderator: Michael Kary (Germany); Silke Mader (Germany); IMPLEMENTATION OF A TEACHING PROGRAM FOR NEONATAL CARE Discussants: Luc Zimmermann (The Netherlands); S. Schmidt 1; B. Saysanasongkham 2; T. Hoehn 1 (1. Germany; 2. Laos) Manuel Sanchez Luna (Spain); Morten Breindahl (Sweden); ID 212 DOWN’S SYNDROME – PREVALENCE AND PRENATAL DIAGNOSIS IN Agnes van den Hoogen (The Netherlands) LATVIA I. Zile; I. Gavare; I. Grinfelde; I. Malniece; Z. Baltane; A. Maurina (Latvia) 17:50 - 18:10 Extreme Everest: lessons learnt from high altitude Daniel Martin (United Kingdom) ID 294 THE CHANGING OF LATE FETAL DEATH IN LATVIA BETWEEN 2000 AND 2014 18:10 - 18:30 Learning from our mistakes I. Zile; I. Ebela; V. Folkmanis; I. Rumba-Rozenfelde (Latvia) Martin Elliott (United Kingdom) ID 312 HOW “BABY FRIENDLY” CAN A “BABY-FRIENDLY HOSPITAL” BE? – EXPERIENCE IN A ROMANIAN NEONATAL CLINIC M. Simon; R. Sánta; Zs. Gáll; L. Suciu; R. Marian; M. Rusneac; C. Gliga; M. Cucerea (Romania) ID 369 THE EFFECTIVENESS OF PRENATAL ULTRASOUND DIAGNOSIS IN RECOGNITION OF MUSCULOSCELETAL MALFORMATIONS A. Beke; Z.S. Tidrenczel; F.R. Eros (Hungary) ID 409 PREVALENCE OF LATE PRETERM INFANTS IN THE UNIVERSITY HOSPITAL OF THE SOUTH REGION OF BRAZIL: INCREASED NEONATAL MORBIDITY RISK COMPARED WITH TERM INFANTS P.J.H. Nader; S.S. Nader; L. Acosta; A. Sangalli (Brazil) ID 434 THE INFLUENCE OF TWO DIFFERENT FAT EMULSIONS USED FOR PARENTERAL NUTRITION ON THE INCIDENCE OF SELECTED COMPLICATIONS OF PREMATURITY Z. Owsiańska; G. Matusiak; K. Mielnik; T. Szczapa; J. Gadzinowski (Poland) 16 16 31st October, 2017 1st November, 2017 17 17 ID 440 RIGHT PLACE - RIGHT TIME ? PLACE OF BIRTH AND TRANSFERS OF ID 289 NEONATAL MORBIDITY OF EXTREME PRETERM INFANTS EXTREME PRETERM NEONATES WITHIN TWO ADJACENT NEONATAL BEFORE AND AFTER THE INTRODUCTION OF A DONOR HUMAN OPERATIONAL DELIVERY NETWORKS MILK BANK AT THE PERINATAL CENTER GROßHADERN D. Vieten; M. Sutcliffe; S.V. Rasiah; A. Philpott (United Kingdom) V. Lieftüchter; M. Kujawa; A. Schuze; A.W. Flemmer; S. Herber-Jonat (Germany) ID 490 PHENOTYPIC SPECTRUM OF GOLDENHAR SYNDROME: A DESCRIPTIVE STUDY ID 320 OPTICAL PROPERTIES OF EARLY STOOL FROM PRETERM INFANTS: N. Kasdallah; M.T. Lamouchi; M. Sallemi; W. Barbaria; Kasraoui; IMPORTANT TO CONSIDER FOR ABDOMINAL OXIMETRY BASED ON H. Ben Salem; H. Kbaier; S. Blibech; M. Douagi (Tunisia) NEAR-INFRARED SPECTROSCOPY H. Isler; D. Schenk; J. Bernhard; F. Scholkmann; S. Kleiser; D. Ostojic; ID 521 RETURN TO WORK TRAINING REQUIREMENTS FOR NEONATAL NURSES: D. Bassler; M. Wolf; T. Karen (Switzerland) A NETWORK SURVEY C. Hiatt; R. Blake; J. Furness; K. Dewitt; N. Shankle; V. McFadden; P. Nath; ID 407 REFERENCE VALUES OF ZONULIN IN TERM NEONATES P. Satodia (United Kingdom) A. Tarko; A. Suchojad; A. Jarosz-Lesz; M. Majcherczyk; M. Michalec; I. Maruniak-Chudek (Poland) ID 560 TRENDS IN MAJOR MORBIDITY RATES AT THE LIMIT OF VIABILITY IN THE LAST DECADE ID 472 DETERMINANTS OF THE NEED FOR TREATMENT IN PREMATURE INFANTS S. Zeballos Sarrato; A. Rodriguez Sánchez de la Blanca; S. Villar Castro; WITH SUSPECTED NECROTISING ENTEROCOLITIS C. Ramos Navarro; G. Zeballos Sarrato; M. Sánchez Luna (Spain) N. Bussmann; A. El-Khuffash; D. Corcoran (Ireland) ID 830 PAEDIATRIC HEAD TRAUMA IN THE EMERGENCY DEPARTMENT ID 589 NEWBORNS WITH ULTRASOUND FINDING OF GAS IN HEPATIC PORTAL E. Ryan; T. Bolger; I. Okafor; M. Barrett; E.J. Molloy (Ireland) VENOUS SYSTEM: ANALYSIS OF RISK FACTORS; CLINICAL AND LABORATORY FINDINGS AND DEVELOPMENT OF ALLERGY J. Lozar Krivec; A. Nyasha Zimani; N. Zupančič; D. Paro-Panjan (Slovenia) Ethics ID 621 NEONATAL FECAL BIOMARKERS OF NECROTIZING ENTEROCOLITIS Chairs: Charles C. Roehr (United Kingdom) I. Tofé; M.V. Rodriguez-Benitez; C. Hernandez-Chirlaque; M. Gil-Campos; M.D. Ruiz-Gonzalez; A. Martinez (Spain) ID 657 INGEBORG SYLLM-RAPOPORT (1912-2017) – AN EXEMPLARY LIFE FOR CHILDREN AND PAEDIATRICS ID 664 THE PRETERM INFANT GASTRIC EMPTYING RATE IS DEPENDENT ON THE H. Sallmon 1; R.R. Wauer 1; C.C. Roehr 1;2 FEED VOLUME AND NOT POSTNATAL AGE (1. Germany; 2. United Kingdom) C.H. Ferreira 1; F.E. Martinez 1; G.C. Crott 1; J. Belik 2 (1. Brazil; 2. Canada) ID 675 NECROTIZING ENTEROCOLITIS IN A NEONATAL INTENSIVE CARE UNIT M. Branco; I. Falcão; T. Lopes; E. Proença; A. Almeida; C. Carvalho; L. Pinho Neonatal GI Physiology & NEC (Portugal) Chairs: Jon Dorling (United Kingdom) ID 678 SPONTANEOUS INTESTINAL PERFORATION: A DIAGNOSTIC ID 204 CORRELATION BETWEEN CALPROTECTIN LEVELS IN MECONIUM AND CHALLENGE IN THE NEWBORN VITAMIN D STATUS IN CORD BLOOD: ASSOCIATION WITH INTESTINAL M. Branco; T. Lopes; I. Falcão; L. Pinho; C. Enes; A. Almeida; C. Carvalho; DISTRESS DURING NEONATAL PERIOD E. Proença (Portugal) S.H. Park; W.H. Kim; Y.M. Lee (Korea) ID 806 NECROTIZING ENTEROCOLITIS: WHAT ASPECTS IN 2017? ID 244 COMPARISON OF FECAL CALPROTECTIN LEVELS ACCORDING TO H. Ben Salem; I. Kasraoui; M.T. Lamouchi; E.D. Bouaicha; N. Kasdallah; FEEDING KINDS IN VERY PRETERM INFANTS S. Blibech; M. Doagi (Tunisia) J.H. Park; N.H. Lee; S.Y. Shin; C.S. Kim; S.L. Lee; W.M. Lee (Korea) 18 18 1st November, 2017 1st November, 2017 19 19 ID 853 MATERNAL RISK FACTORS FOR NEC IN PREMATURES INFANTS WITH GA ID 148 TRANSPORT OF HIGH-RISK NEONATES WITH RESPIRATORY UNDER 28 WEEKS FAILURE: A SINGLE CENTER COHORT ANALYSIS BASED ON THE L. Olariu; G. Olariu; L. Olariu; S. Olariu (Romania) TRANSPORT RISK INDEX OF PHYSIOLOGIC STABILITY VERSION II (TRIPS-II) M. Klemme 1; A. Staffler 2; K. M. Förster 1; A. Schulze 1; S. Herber-Jonat 1; J. Kappeler 1; A. W. Flemmer 1 Neonatal Pulmonology, Neonatal Respiratory (1. Germany; 2. Italy) Support, Resuscitation Chairs: Kajsa Bohlin (Sweden); Daniele De Luca (France) ID 193 FACTORS ASSOCIATED WITH EXTUBATION FAILURE IN VERY LOW BIRTH WEIGHT INFANTS ID 031 TIMING OF KEY EVENTS IN NEONATAL RESUSCITATION A. Menshykova; D. Dobryanskyy (Ukraine) A. Heathcote; J. Jones; P; Clarke (United Kigdom) ID 197 A COST IMPROVEMENT PROJECT: REVIEW OF THE USE OF INHALED ID 051 COMPARING NON-INVASIVE VENTILATION METHODS IN NITRIC OXIDE (INO) IN A NEONATAL INTENSIVE CARE RESPIRATORY SUPPORT OF PRETRM NEONATES WITH RESPIRATORY B. Zanetti; R. Roy (United Kingdom) DISEASS A. Shah Farhat; A. Mohammadzadeh; G. Ali Mamuri; R. Saeidi; ID 200 IMPROVED SURVIVAL AND DECREASED INCIDENCE OF S. Noorizadeh (Iran) BRONCOPULMONARY DYPLASIA IN INFANTS LESS THAN 27 WEEKS GESTATION AFTER A RESPIRATORY CARE BUNDLE ID 062 NEONATAL NON-INVASIVE RESPIRATORY SUPPORT APPROACH: J. Soliz; A. Soliz (United States) A TWO COUNTRIES COMPARISON I. Bresesti 1; S. Zivanovic 2; G. Lista 1; C.C. Roehr 2,3 ID 233 LUNG FUNCTION AND IGE RESPONSE ARE REDUCED IN 9 TO 10 YEARS (1. Italy; 2. United Kingdom; 3. Germany) OLD ASTHMATIC CHILDREN WITH PRETERM BIRTH L.C. Fang; J.Y. Wang; S.D. Shyur; S.H. Chu; Y.H. Kao; W.T. Lei (Taiwan) ID 064 PREDICTORS OF EARLY CPAP FAILURE IN VERY LOW BIRTH WEIGHT PRE TERM INFANTS ID 249 PRETERM BIRTH REDUCES ATOPIC SENSITIZATION IN PRESCHOOL W.A. Gonçalves-Ferri; F.P. Martins-Celini; G.H. Seribeli; E. Sacramento; CHILDREN WITH ALLERGIC DISEASE C. Calixto; M. Bertoldi; D.C. Aragon (Brazil) J.Y. Wang; L.C. Fang (Taiwan) ID 069 LENGTH OF MECHANICAL VENTILATION AND CLINICAL FEATURES AT ID 261 LOSS OF SURFACTEN® DURING BOLUS ADMINISTRATION USING A BIRTH IN PREMATURE INFANTS FEEDING CATHETER A.M. Nakato; R.P.G.V.C. Silva; N. Rosario Filho (Brazil) K. Fujioka; J. Kuroda; K. Yamana; M. Ashina; T. Ikuta; S. Fukushima; S. Ohyama; S. Okubo; K. Iijima; I. Morioka (Japan) ID 071 MATERNAL MUTATIONS OF FOXF1 CAUSE ALVEOLAR CAPILLARY DYSPLASIA DESPITE NOT BEING IMPRINTED ID 278 EXPRESSION OF THE HYALURONAN RECEPTOR RHAMM IN M. Alsina; A. Monteagudo-Sánchez; L. Rodriguez Guerineau; BRONCHIOLAR EPITHELIUM OF NEONATES NEGATIVELY CORRELATES C. Rovira Zurriaga; D. Monk; J. Moreno Hernando (Spain) WITH AIR CONTENT IN THE LUNG L. Markasz 1; G. Sedin 1; R. C. Savani 2; R. Sindelar 1 ID 073 CONGENITAL LOBAR EMPHYSEMA MISDIAGNOSED AS (1. Sweden; 2. United States) PNEUMOTHORAX I. Bakalli; E. Kola; R. LLuka; E. Celaj; D. Sala; I. Gjeta; S. Sallabanda (Albania) ID 298 BIPAP REDUCES EXTUBATION FAILURE IN THE FIRST WEEK COMPARED TO CPAP IN NEONATES < 30 WK OF GA WITHOUT INCREASED RISK OF ID 137 A CLINICAL CASE OF A CHILD WITH CCHS IN THE EARLY NEONATAL PNEUMOTHORAX PERIOD L. Capasso; A.C. Borrelli; M.A. Caiazzo; C. Parrella; R. Albachiara; R. Maslarska; M. Kalaydzhieva; S. Deneva; V. Konstantinova; S. Kontilska; F. Raimondi (Italy) I. Ilieva; J. Ivanova; V. Ivanova; E. Kerinova; R. Georgieva; T. Todorov (Bulgaria) 20 20 1st November, 2017 1st November, 2017 21 21 ID 326 THE EFFECT OF SUSTAINED LUNG INFLATION ON EARLY RESPIRATORY ID 395 INHALED NITRIC OXIDE AND PRETERMS: DOOM; GLOOM OUTCOMES IN TERM INFANTS OR RIGHT? 11 YEARS’ EXPERIENCE AT TERTIARY CENTRE M. Cetinkaya; D. Kilic; S. Yılmaz Semerci; B. Cebeci; O. Saglam (Turkey) E. Syrimi; H. Warwick; P. Satodia; P. Nath (United Kingdom) ID 332 PROLONGED AIR RETRIEVAL OF A NEWBORN INFANT WITH TOTAL ID 405 CURRENT PRACTICE OF NEUTRALLY ADJUSTED VENTILATOR ASSIST IN ANOMALOUS PULMONARY VENOUS DRAINAGE THE NEONATAL INTENSIVE CARE UNIT: A TAIWAN SURVEY R. Pal; B. Carter; K. McDonald; J. Tan; D. Wagh; J. Davis (Australia) C.E. Chiang; Y.L. Chen; L.Y. Tsai; Y.H. Chien; S.C. Mu; K.Y. Chao (Taiwan) ID 340 PERINATAL FACTORS ASSOCIATED TO THE FAILURE OF EARLY NASAL ID 439 THE EFFECT OF HYDROCHLOROTHIAZIDE WITH SPIRONOLACTONE CONTINUOUS POSITIVE PRESSURE IN VERY LOW BIRTH WEIGHT TREATMENT ON BRONCHOPULMONARY DYSPLASIA DEVELOPMENT IN INFANTS VERY-LOW-BIRTH-WEIGHT INFANTS T.S. Souza; A.A.Vieira; C. Morcelli-Tovar (Brazil) M. Buyuktiryaki; E. Alyamac Dizdar; N. Uras; N. Okur; O. Ertekin; S.S. Oguz (Turkey) ID 357 IMPACT OF THE USE OF HIGH POSITIVE END EXPIRATORY PRESSURE ON EXTUBATION OF PREMATURE INFANTS WITH SEVERE ID 443 NONINVASIVE RESPIRATORY SUPPORT VIA NASAL CANNULA IN BRONCHOPULMONARY DYSPLASIA PREMATURE INFANTS: IS IT REALLY SAFE? W. Assad Gonçalves-Ferri; F. Pereira Martins-Celini; D. Cristina Troiano; M. Buyuktiryaki; N. Okur; G. Kadioglu Simsek; H.G.Kanmaz; F.E. Canpolat D. Casale Aragon (Brazil) (Turkey) ID 361 THE USE OF DEXAMETHASONE IN PRETERM INFANTS FOR LUNG ID 453 BOCHDALEK HERNIA WITH INTRATHORACIC KIDNEY ASSOCIATED DISEASE IN A TERTIARY NICU WITH AORTIC COARCTATION B. Skenderi Mustafa; H. Ismaili; F. Kajtazi; G. Hazbahta; F. Krasniqi (Kosovo) K.M. Sun; H. Gowda (United Kingdom) ID 462 THE LARYNGEAL MASK AIRWAY AND ITS USE IN NEONATAL ID 366 CONSULTANT PRESENCE AT DELIVERY: A RETROSPECTIVE AUDIT OF RESUSCITATION - A CRITICAL REVIEW OF WHERE WE ARE IN 2017 DEMOGRAPHICS AND OUTCOMES IN A TERTIARY UK CENTRE S.C. Bansal 1; S. Caoci 2; D. Trevisanuto 2; C.C. Roehr 1; E.M. Dempsey 3 L. Mahoney; T. Hunt; H. Rabe; P. Amess; N. Aiton; N. Bhat; R. Bomont; (1. United Kingdom; 2. Italy; 3. Ireland) N. Drenchev; C. Garland; C. Lawn; B. Reulecke; R. Watkins; R. Fernandez (United Kingdom) ID 467 RETROSPECTIVE AUDIT OF POSTNATAL OUTCOME OF ANTENATALLY DIAGNOSED RENAL PELVIS DILATATION ID 379 COMPARISON BETWEEN OUTCOMES OF MINIMALLY INVASIVE S. Vora; N. Kavalloor; T.L. Yap; PC Khoo; V. Rajadurai (Singapore) TECHNIQUE AND INTUBATION SURFACTANT EXTUBATION IN PRETERM INFANTS LESS THAN 1500 GRAMS IN A DEVELOPING COUNTRY ID 511 OUTCOMES OF POSTNATAL DEXAMETHASONE USE IN EXTREME W.A. Gonçalves-Ferri; P. Paiva; L. Scalioni; E. Sacramento; C. Calixto; PRETERM NEONATES IN A TERTIARY NEONATAL UNIT A.C. Hallak; D.C. Aragon (Brazil) A. Holt; L. Osborne; P. Satodia (United Kingdom) ID 381 PREMATURE INFANTS WITH VERY LOW WEIGHT WITH APNEA HAVE ID 516 VALIDATION OF A TRANSCUTANEOUS TCPO2/TCPCO2 SENSOR WITH POOR RESULTS DESPITE TREATMENT AN OPTICAL OXYGEN MEASUREMENT IN PRETERM NEONATES A.B. Gonçalves; M.M. Lourenço; L. Scacioli; E. Sacramento; C. Calixto; W. van Weteringen; T.G. Goos; T. van Essen; N.H. Gangaram-Panday; D.C. Aragon; W.A. Gonçalves-Ferri (Brazil) R.C.J. de Jonge; I.K.M. Reiss (The Netherlands) ID 388 EARLY HIGH FREQUENCY VENTILATION – A PROMISE OF PROTECTIVE ID 524 SUCCESSFUL VENTILATION VIA ACCIDENTAL OESOPHAGEAL VENTILATION? INTUBATION IN A CASE OF FLOYD TYPE III/FARO TYPE B TRACHEAL W.A. Gonçalves-Ferri; M. Bertoldi; A.B. Gonçalves; E. Sacramento; AGENESIS IN A DISCORDANT MONOZYGOTIC TWIN C. Calixto; D.C. Aragon (Brazil) M. Noureldein; A. Olariu; J. Egyepong (United Kingdom) 22 22 1st November, 2017 1st November, 2017 23 23 ID 528 WHAT IS THE IDEAL TARGET PRETERM POPULATION THAT MIGHT ID 660 PERI-OPERATIVE MANAGEMENT OF NEONATES WITH BENEFIT FROM THE EXPENSIVE PALIVIZUMAB PROPHYLAXIS? OESOPHAGEAL ATRESIA IN LOW- INCOME COUNTRIES: S. Tsilika; D. Batra (United Kingdom) EXPERIENCE OF TUNISIA F.Z.Chioukh; K. Ben Ameur; T. Khemis; A. Ksia; A. Ben Salem; H. Ben Hamida; ID 538 INCIDENCE AND OUTCOME OF PNEUMOTHORACES IN A TERTIARY K. Monastiri (Tunisia) NEONATAL INTENSIVE CARE UNIT R.C. Ramaswamy; M.K. Brom; S.V. Rasiah (United Kingdom) ID 662 LESS INVASIVE SURFACTANT ADMINISTRATION IN PRETERM INFANTS. REVIEW AFTER 4 YEARS OF IMPLEMENTATION ID 546 CLINICAL IMPACT OF THE RESPIRATORY SYNCYTIAL VIRUS INFECTION C. Ramos-Navarro; S. Zeballos-Sarrato; N. Gonzalez-Pacheco; IN INFANTS WITH A HISTORY OF PREMATURITY BETWEEN 32-34 WEEKS A. Rodriguez- De la Blanca; M. Arriaga-Redondo; S. Villar-Castro; N. Ramos; C.M. Martín; G. Uclés; R.C Raynero; I. Pérez; I. Pescador-Chamorro; N. Navarro-Patiño (Spain) M. González-Valcárcel; M.D Sánchez-Redondo; A. Pantoja; J. Cobas; A. Escobar; A. Martínez (Spain) ID 693 VERY LOW BIRTH WEIGHT PRETERM BABY PRESENT HIGH INCIDENCE OF RETINOPATHY OF PREMATURITY AND BRONCHOPULMONARY ID 554 LATE PRETERM INFANTS: WHAT IS THEIR REAL RESPIRATORY DYSPLASIA DESPITE DRUG TREATMENT MORBIDITY? A.B. Gonçalves; M.M. Lourenço; L. Scacioli; A. Borges; A.C. Hallak; A.M. Gil Fenoy; F.J. Pacheco Sánchez La Fuente; P. Miranda Romera; M. Bertoldi; D. Testoni; G.H. Seribelli; B.B. Lima; E. Sacramento; C. Calixto; L. Serrano López; E. Martín Álvarez; J.A. Hurtado Suazo (Spain) D.C. Aragon; W.A. Gonçalves-Ferri (Brazil) ID 565 REVIEW OF OUTCOMES IN PRETERM NEONATES FOLLOWING ID 697 AN UNUSUAL CAUSE OF RESPIRATORY DISTRESS IN NEONATES: CHANGE OF VENTILATORY PRACTICE TO VOLUME-TARGETED CONGENITAL PULMONARY LYMPHANGIECTASIS (TWO CASE VENTILATION IN A NEONATAL INTENSIVE CARE UNIT REPORTS) I. Fernando; H. McDermott; A. Singh; S. Rasiah (United Kingdom) S. Nouri Merchaoui; N. Mahdhaoui; H. Ayache; M. Bellalah; I. Kacem; H. Barbouche; A. Ghith; M.T.Yacoubi; J. Methlouthi; H. Seboui (Tunisia) ID 569 THYROID STATUS MONITORING DURING FIRST YEAR OF LIFE IN INFANTS WITH CONGENITAL HYPOTHYROIDISM DETECTED BY ID 711 APGAR SCORE OF 5 MINUTES LESS THAN 5 IS NOT RELATED TO POOR NEWBORN SCREENING OUTCOMES IN VERY LOW BIRTH WEIGHT PRETERM INFANTS N. Zdraveska; V. Anastasovska; A. Kostovski Mirjana Kocova (Macedonia) W.A. Gonçalves-Ferri; P. Paiva; A. Borges; E. Sacramento; C. Calixto; D.C. Aragon (Brazil) ID 601 DIURETICS FOR EVOLVING CHRONIC LUNG DISEASE OF PREMATURITY: WHO ARE WE TREATING? ID 714 ETIOLOGICAL AND PATHOLOGICAL CORRELATIONS IN PERSISTENT A.K. Linklater; R. Cuzzilla; S.E. Jacobs (Australia) PULMONARY HYPERTENSION OF THE NEWBORN M.L. Ognean; R. Dumitra; O. Boantă; C. Zgârcea; E. Olariu; S. Kovacs (Romania) ID 629 CAN TcCO2 MONITORIZATION IN THE DELIVERY ROOM BE HELPFUL FOR DIFFERENTIATING TERM NEWBORNS IN NEED OF HOSPITALIZATION FOR RESPIRATORY MORBIDITIES? ID 717 BRONCHOPULMONARY DYSPLASIA - ARE THERE NEW RISK FACTORS I. Mungan Akin; E. Bocu; M. Uygun; S. Sevuk Ozumut; D. Buyukkayhan; IN VERY PRETERM INFANTS? M.L. Ognean; O. Boantă; E. Olariu; S. Kovacs; C. Zgârcea; R. Dumitra; S. Arslanoglu; F. Ovali (Turkey) D. Andreicuţ (Romania) ID 635 MANAGEMENT OF PNEUMOTHORAX IN NEWBORNS: NEONATAL INTENSIVE CARE UNIT EXPERIENCE IN TUNISIA ID 729 OUTCOMES OF PRETERM INFANTS LESS THAN 26 WEEKS GESTATION AT K. Ben Ameur; T. Khemis; A. Ben Salem; H. Ben Hamida; F.Z. Chioukh; BIRTH WHO RECEIVED CHEST COMPRESSION OR ADRENALINE DURING K. Monastiri (Tunisia) RESUSCITATION AT BIRTH H. Shing; H. Gowda (United Kingdom) ID 642 MALIGNANT PERTUSSIS. IS IT TIME FOR EXCHANGE TRANSFUSSION? R. Roldán; M. Huescar; M.G. Espinosa; A. Morales; E. Salguero (Spain) 24 24 1st November, 2017 1st November, 2017 25 25 ID 741 LUNG ULTRASOUND (LUS) TO ASSESS PERSISTENT PULMONARY ID 804 NEONATAL CHYLOTHORAX: 20 YEARS EXPERIENCE IN A HYPERTENSION OF THE NEWBORN (PPHN) ETIOLOGY TERTIARY NEONATAL UNIT B. del Rey Hurtado de Mendoza; J. Moreno Hernando; H. Sharp; C. Kortsalioudaki; M. Sellwood; G. Kendall (United Kingdom) J. Sánchez-de-Toledo; J. Rodríguez-Fanjul (Spain) ID 832 PREDICTIVE AND RISK FACTORS FOR EARLY NON-INVASIVE ID 745 NEURALLY ADJUSTED VENTILATION IN PATIENTS WITH CONGENITAL RESPIRATORY SUPPORT FAILURE IN A COHORT OF PRETERM INFANTS: DIAPHRAGMATIC HERNIA A RETROSPECTIVE STUDY A.M. Sanchez-Torres; H. Peinado; R. Madero; M.D. Elorza (Spain) I. Bresesti; F. Viaroli; F. Castoldi; F. Scopesi; B. Roviglione; L. Ramenghi; F. Cerritelli; G. Lista (Italy) ID 746 NON-INVASIVE NEURALLY ADJUSTED VENTILATION (NIV-NAVA) IN THE NEWBORN ID 854 HOW SAFE IS NASAL CANNULAE OXYGEN THERAPY DURING H. Peinado; H. Sánchez-Torres; R. Madero; M.D. Elorza (Spain) NEONATAL TRANSPORT? A. Brunton; J. O’Shea; A. Jackson (United Kingdom) ID 748 THE NON INVASIVE RESPIRATORY SUPPORT FAILURES IN PRETERM INFANTS. RISK FACTORS AND OUTCOMES ID 855 THE INCIDENCE OF RESPIRATORY MORBIDITY IN LATE PRETERM INFANT C. Ramos-Navarro; I. Marsinyach Ross; G. Zeballos-Sarrato; G. Olariu; S. Olariu; M. Tunescu (Romania) P. Chimenti-Camacho; A. Perez-Perez; R. Gregorio-Hernández; M. Sánchez-Luna (Spain) ID 860 MATERNAL SMOKING IN PREGNANCY INCREASES THE DURATION OF HOME OXYGEN THERAPY IN INFANTS WITH BRONCHOPULMONARY ID 749 SELECTIVE LUNG VENTILATION: A THERAPEUTIC STRATEGY FOR DYSPLASIA ACQUIRED LUNG COLLAPSE IN A TERM INFANT A. Prayle; A. Davies; A. Silverman; S. Spencer; M. Hurley; J. Bhatt H. Gowda; S. Bhayat (Spain) (United Kingdom) ID 759 INCIDENCE OF RESPIRATORY MORBIDITY IN LATE PRETERM AND TERM ID 862 CONTROLLED VENTILATION WITH A LARYNGEAL MASK AIRWAY FOR INFANTS IN RESPECT TO DELIVERY MODE 48 HOURS IN A NEWBORN WITH TRACHEAL AGENESIS J. Gromann; T. Burkhardt; R. Arlettaz; S. Wellmann (Switzerland) R.H. Mupanemunda; R.F. Danha (United Kingdom) ID 788 RISK FACTORS ASSOCIATED TO SURVIVAL FREE ID 863 ASSESSMENT OF A NEONATAL INTUBATION SCORING INSTRUMENT: BRONCHOPULMONARY DYSPLASIA ACCORDING TO GESTATIONAL A PROSPECTIVE OBSERVATIONAL STUDY AGE R. Bouwmeester; M. Binkhorst; N. Yamada; R. Geurtzen; A. van Heijst; C. Ramos-Navarro; G. Zeballos-Sarrato; E. Sanz-Lopez; L. Halamek; M. Hogeveen (United States) E. Maderuelo-Rodriguez; N. Gonzalez-Pacheco; M. Sánchez-Gómez de Orgaz; M. Sánchez-Luna (Spain) Perinatal Pharmacology and Anethesia ID 792 OUTCOME OF INFANTS BORN AFTER MID-TRIMESTER RUPTURE OF Chairs: Sinno Simons (The Netherlands) MEMBRANES T. Hurley 1; J. Miletin 1, 2; A. Martin 1; C. Fitzpatrick 1; J. Semberova 1, 2 (1. Ireland; 2. Czech Republic) ID 027 UNDERSTANDING THE RELATIONSHIP BETWEEN DOPAMINE CONCENTRATION AND BLOOD PRESSURE IN NEONATES: INCUBATORS ID 793 NEURALLY ADJUSTED MECHANICAL VENTILATION (MV-NAVA) IN THE VERSUS COT NEWBORN K. Kirupakaran; H. Rabe; B. Patel (United Kingdom) A.M. Sánchez Torres; H. Peinado; R. Madero; M.D. Elorza (Spain) ID 104 EFFECT OF CHRONIC EXPOSURE OF LOSARTAN IN MOUSE PRENATAL ALCOHOL EXPOSURE (PAE) MODEL ID 803 CHYLOTHORAX: CASE SERIES OF 20 YEARS A. Takyi (United Kingdom) M. Rosário; A. Reis e Melo; S. Pissarra; G. Rocha; H. Guimarães (Portugal) 26 26 1st November, 2017 1st November, 2017 27 27 ID 187 EFFECT OF POSTNATAL CORTICOSTEROID ON BROWN ADIPOSE TISSUE 09:00 – 11:00 PARALLEL SESSION 1 (BRAIN 1)|DARSENA ROOM THERMOGENESIS IN NEONATAL RAT Y-S. Chang; C.H. Lin; Y.S. Tsai (Taiwan) NEURODEVELOPMENTAL OUTCOME AND CONGENITAL HEART DISEASE ID 492 VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION Chairs: Bea Latal (Switzerland); IMPAIRS ACETYLCHOLINE-INDUCED CONTRACTION IN NEONATAL Nathalie Claessens (The Netherlands) PORCINE CORONARY ARTERIES L. Provitera 1; G. Cavallaro 1; G. Raffaeli 1; I. Amodeo 1; S. Gulden 1; 09:00 – 09:20 Brain health in neonates with CHD: timing is everything G. Zuanetti 1; V. Gentilino 2; F. Macchini 2; E. Villamor 1; F. Mosca 1 Steven Miller (Canada) (1. Italy; 2. The Netherlands) 09:20 – 09:40 Neurodevelopmental outcome and congenital heart ID 875 POINT-OF-CARE ANALYSIS OF BETA-HYDROXYBUTYRATE disease CONCENTRATIONS IN BABIES IS A USEFUL ALTERNATIVE TO Bea Latal (Switzerland) LABORATORY TESTING D.L. Harris; P.J. Weston; J.E. Harding (New Zealand) 09:40 – 10:10 Neonatal surgery and brain injury Petra Lemmers (The Netherlands) 10:10 – 10:25 Cognitive stability in children with congenital heart disease N. Naef; C. Schaefer; V. Rousson; R. Liamlahi; S. Polentarutti; I. Beck; V. Bernet, D. Hitendu; W. Knirsch; B. Latal (Switzerland) 10:25 – 10:40 Congenital heart defects and academic performance in a nationwide cohort of 458,318 Danish children N.B. Matthiesen; S.H. Larsen; T.B. Henriksen; C.C. Bach; J.R. Østergaard; V. Hjortdal (Denmark) 10:40 – 10:55 Early postoperative amplitude-integrated electroence phalography: biomarker of new brain injury in neonates with congenital heart disease N.H.P. Claessens; L. Noorlag; L. Weeke; M. Toet; J.M.P.J. Breur; M.J.N.L. Benders; F. Groenendaal; N.J.G. Jansen; L.S. de Vries (The Netherlands) 09.00 – 11.00 PARALLEL SESSION 2 (RESUSCITATION) |VENEZIA ROOM Chairs: Hans Fuchs (Germany); Claus Klingenberg (Norway) 09:00 - 09:20 New techniques for optimising newborn resuscitation Peter Davis (Australia) 09:20 - 09:40 Unravelling the physiology of haemodynamic transition at birth Stuart Hooper (Australia) 09:40 - 09:55 Delayed cord clamping during resuscitation - a randomized trial O. Andersson; A. KC; N. Rana; U. Ewald; M. Målqvist (Sweden) 28 28 1st November, 2017 1st November, 2017 29 29 09:55 - 10:10 Sustained versus standard inflations during neonatal 10:45 - 11:00 Valid pain assessment in extreme prematures: resuscitation to reduce mortality and improve respiratory a long way to go? outcomes: a systematic review and meta-analysis N. Meesters; S.H.P. Simons; J. van Rosmalen; L. Holsti; M. Bruschettini 1; C.P.F. O’Donnell 2; P.G. Davis 3; C.J. Morley 4; Irwin Reiss; M. van Dijk L. Moja 4; M.G. Calevo 4; S. Zappettini 4 (1. Sweden; 2. Ireland; 3. Australia; 4. Italy) 10:10 - 10:25 nCPAP pressure at initiation: is higher pressure better? 09.00 – 11.00 PARALLEL SESSION 4 |FIRENZE ROOM S. Bhisikar; S. Goel; S. Manerkar; J. Mondkar (India) WHAT CAN WE LEARN FROM NEONATAL NETWORKS 10:25 - 10:40 Bradyprem study: is heart rate the most vital of all vital signs during preterm resuscitation? Chairs: Neena Modi (United Kingdom); Dominique Haumont (Belgium) V. Kapadia 1; J. Oei 2; O.D. Saugstad 3; Y. Rabi 4; N. Finer 1; I. Wright 2; W. Tarnow-Mordi 2; W. Rich 1; D. Rook 5; J. Smyth 2; K. Lui 2; S. Brown 1; M. Vento Torres 6 09:00 – 09:10 eNewborn, the journey thus far (1. United States; 2. Australia; 3. Norway; 4. Canada; Dominique Haumont (Belgium) 5. The Netherlands; 6. Spain) 09:10 – 09:20 Population data sharing: the UK experience 10:40 - 10:55 Predicting developmental outcomes in extremely low Neena Modi (United Kingdom) birth weight infants: a statistical learning approach C. Keogh; B. Arthurs; S. Atikah; P. Carr; N. Grayson; E. Horgan; 09:20 – 09:50 Big data opportunities for European Neonatology E. Moran; S. O’Regan; E.J. Molloy (Ireland) Mark Turner (United Kingdom); Lisa Lehtonen (Finland); Ola D. Saugstad (Norway); Maximo Vento Torres (Spain); Charles C. Roehr (United Kingdom) 09.00 – 11.00 PARALLEL SESSION 3 (EFCNI 1) |ROMA ROOM 09:40 - 09:51 Predicting bleeding risk in thrombocytopenic preterm PAIN REDUCTION – DOES A PARTNERSHIP WITH neonates: the MONET study S.F. Fustolo-Gunnink; K. Fijnvandraat; I.M. Ree; C. Caram-Deelder; PARENTS REDUCE PAIN IN NEWBORNS? P. Andriessen; E.J. d’Haens; C.V. Hulzebos; W. Onland; A.A. Kroon; Chairs: Mats Eriksson (Sweden); D.C. Vijlbrief; H. Putter; E. Lopriore; J.G. van der Bom (Netherlands) Agnes van den Hoogen (The Netherlands) 09:51 - 10:02 A pilot study: implementing a structured amplitude 09:00 - 09:30 The power of parents to reduce newborn pain integrated electroencephalography (AEEG) education Marsha Campbell-Yeo (Canada) programme in an irish neonatal intensive care unit (NICU) setting 09:30 - 10:00 Facilitators and barriers for parents’ involvement in pain A. Jenkinson; M. Boyle; D. Sweetman (Ireland) management Anna Axelin (Finland) 10:02 - 10:13 Fetal heart defects and disrupted cerebral growth: a cohort study in 63,371 fetuses 10:00 - 10:30 Working with parents to build better pain management M.H. Lauridsen; O.B. Petersen; E.M. Vestergaard; N. Uldbjerg; for newborn infants T.B. Henriksen; J.R. Østergaard; N.B. Matthiesen; V.E. Hjortdal Mats Eriksson (Sweden) (Denmark) 10:30 - 10:45 A user centered design approach to evaluate a alidated 10:13 - 10:24 Characterisation and burden of 1-year chronic respiratory infant pain measure e- learning module morbidity among extremely preterm infants: a retrospective B. Stevens; S. Gibbins; M. Campbell-Yeo; C. McNair; J. Yamada; claims analysis K. Dionne; Sarah Dinsdale; C. Johnston; A. Taddio (Canada) M. Mowitz; A. Mangili; L. von Krusenstiern; R. Ayyagari; W. Gao; J. Wang; J. Zhao; S. Sarda (United States) 30 30 1st November, 2017 1st November, 2017 31 31 10:24 - 10:35 STOP (Septum Trauma Occurrence Prevention) in babies 10:40 - 10:55 The maternal-fetal gradient of free and esterified on nasal CPAP-A quality improvement project phytoste rols at the time of delivery in humans R. Mc Coy; K. Singh; V. Kairamkonda (United Kingdom) A. Correani; S. Visentin; E. Cosmi; E. Ponchia; S. D’Aronco; M. Simonato; L. Vedovelli; P. Cogo; V.P. Carnielli (Italy) 10:35 - 10:46 Predictive value of early EEG for seizures during hypothermia in neonates with hypoxic ischemic encephalopathy M.C. Cornet; A. Pasupuleti; A. Fang; H.C. Glass; M.R. Cilio 09.00 – 11.00 PARALLEL SESSION 6 (CIRCULATION 1) |LECCE ROOM (United States) WHO OWNS THE PLACENTAL BLOOD? Chairs: Eirik Nestaas (Norway); Colm Breatnach (Ireland) 09:00 - 09:25 The case for the term infant 09.00 – 11.00 PARALLEL SESSION 5 (NUTRITION 1) |SORRENTO ROOM Ola Andersson (Sweden) NUTRITION AND THE BRAIN Chairs: Colin Morgan (United Kingdom); Elsa Kermorvant (France) 09:25 - 09:50 The case for the preterm infant Heike Rabe (United Kingdom) 09:00 - 09:20 Neuroimaging, a new tool for investigating the effects of early diet on cognitive and brain development 09:50 - 10:15 Harvesting placental blood: what is it for? Helle Pfeiffer (Norway) Anders Fasth (Sweden) 09:20 - 09:40 Improving neurological outcomes of preterm infant: update 10:15 - 10:30 Delayed cord clamping in preterm infants with suspected on the role of early nutrition intrauterine growth restriction Sissel Moltu (Norway) J. Mercer; M. Wang; J. Padbury (United States) 09:40 - 09:55 Early parenteral use of a lipid emulsion containing fish oil 10:30 - 10:45 The effects of delayed cord clamping on 12-months brain results in improved longitudinal growth in extremely preterm myelin content: a randomized controlled trial infants – a randomized controlled trial D. Erickson-Owens; J. Mercer; S. Deoni 3; A. Parker 2; J. Collins 2; S. Najm; C. Löfqvist; G. Hellgren; E. Engström; A.K. Nilsson; J. Padbury (United States) M.X. Andersson; K. Sävman; A. Hellström (Sweden) 10:45 - 11:00 The use of speckle tracking echocardiography to assess 09:55 - 10:10 Growth and body composition up to 4 months of age in myocardial performance in monochorionic diamniotic twins preterm infants and term controls (PeaPod study) with and without twin to twin transfusion syndrome A. Chmielewska; A. Farooqi; M. Domellöf; I. Ohlund (Sweden) C.R. Breatnach; A.T. James; F. Malone; N. McCallion; O. Franklin; A. EL-Khuffash (Ireland) 10:10 - 10:25 Personalised prediction of weight changes in the first week of life S. Kasser; M. Wilbaux; J. Gromann; I. Mancino; T. Coscia; O. Lapaire; 11:00 - 11:30 COFFEE BREAK J.N. van den Anker; M. Pfister; S. Wellmann (Switzerland) 10:25 - 10:40 Z-score differences based on cross-sectional growth charts do not reflect weight gain in preterm infants: an adjusted Z-score for longitudinal assessment of growth N. Rochow 1; E. Landau-Crangle 1; A. Alkhoraidly 2; A. Bhatia 1; G. Fusch 1; P. Muppidi 1; W. Göpel 3; C. Fusch 1, 3 (1. Canada; 2. Saudi Arabia; 3. Germany) 32 32 1st November, 2017 1st November, 2017 33 33 10:00 - 13:00 Respiratory Support in Neonates: How to ventilate term 12:30 - 13:30 Strategies and modern technologies of and preterm infants – Insights into new possibilities and countinuous noninvasive blood gas neonatal ventilation strategies |MILANO ROOM monitoring |LECCE ROOM Industry Supported session - please see page 125 Industry Supported session - please see page 125 10:10 - 10:30 Invasive closed loop ventilation (Lunch will be provided) Andreas W. Flemmer (Germany) 12:30 - 13:00 Intraoperative use of transcutaneous CO2 measuring in 10:30 - 11:00 Basic principles of high frequency ventilation (HFOV) Roland Hentschel (Germany) paediatric and neonatal anaesthesia Michael Brackhahn (Germany) 11:00 - 11:15 New possibilities in non-invasive closed loop ventilation Andreas W. Flemmer (Germany) 13:00 - 13:30 Validation of novel combined transcutaneous sensor - virtually drift free tcPO2 sensing technology 11:00 - 11:15 New insights into HFOV Irwin Reiss (The Netherlands) Roland Hentschel (Germany) 11:40 - 13:20 Hands on closed loop ventilation / HFOV in two groups Andreas W. Flemmer (Germany); Roland Henschel (Germany) 13:30 - 15:00 Interactive Clinical Session: Are Babies with Serious Hypoxemic Conditions Still Being Missed? 11:30 - 12:30 PLENARY SESSION 2 |DARSENA ROOM |FIRENZE ROOM REGENERATIVE MEDICINE Industry Supported session - please see page 125 Chairs: Pierre Gressens (France); Petra Hüppi (Switzerland) Interactive session with audience participation 11:30 - 12:00 Stem cell therapy for neonatal disorders; Chair: Augusto Sola (United States) Prospects and challenges Won Soon Park (South Korea) Early detection of neonatal sepsis and other hypoxemic conditions 12:00 - 12:30 Stem cells for neonatal disorders Andrew Ewer (United Kingdom) Paolo De Coppi (United Kingdom) Recent recommendations from European and Spanish societies for pulse oximetry screening for critical congenital 12:30 - 13:30 LUNCH BREAK heart defects Maximo Vento Torres (Spain) 12:30 - 13:30 Early optimal nutrition in the NICU The controversies in screening for critical congenital heart A meet-the-expert event |SORRENTO ROOM defects Industry Supported session - please see page 125 Thorsten Orlikowsky (Germany) (Lunch will be provided) Chair: Mary Brown-Hise (United States); Boubou Hallberg (Sweden) Perfusion index: can it be a predictive monitoring tool in neonatal illnesses? 12:30 - 12:35 Welcome & conference objectives Augusto Sola (United States) Mary Brown-Hise (United States) 12:35 - 13:15 Early optimal nutrition in the NICU Boubou Hallberg (Sweden) 13:15 - 13:25 Q&A 13:25 - 13:30 Concluding remarks Mary Brown-Hise (United States) 34 34 1st November, 2017 1st November, 2017 35 35 13:30 - 15:00 POSTER SESSION 1 (LUNG 1) |DARSENA ROOM 14:00 - 14:05 Effects of surfactant replacement therapy with porcine vs. bovine preparations on cerebral Chairs: Mats Blennow (Sweden); Anna Lavizzari (Sweden) oxygenation and bioelectric activity of preterm infants T. Szczapa; L. Karpinski; H. Szczapa-Krenz; B. Witoslaw; 13:30 - 13:35 Less invasive administration (LISA) not only A. Adamczak; J. Moczko; I. Miechowicz; P. Niedbalski; improves mortality and morbidity but also J. Gadzinowski1; J. Mazela (Poland) neurodevelopmental outcome of preterm infants K. Klebermass-Schrehof; A. Grill; M. Hayde; N. Haiden; A. Flunt; 14:05 - 14:10 Nasal high-flow therapy (NHFT) as primary respiratory R. Fuiko; S. Brandstetter; A. Berger (Austria) support for preterm infants without use of nasal continuous positive airways pressure (NCPAP) 13:35 - 13:40 Surfactant administration and non-invasive ventilation in S. Zivanovic 1; A. Scrivens 1; R. Panza 2; P. Reynolds 1; K. Ives 1; surfactant deficiency newborn piglets N. Laforgia 2; C.C. Roehr 1 C. Rey-Santano 1; V. Mielgo 1; M. Gomez-Solaetxe 1; F. Ricci 2; (1. United Kingdom; 2. Italy) F. Bianco 2; F. Salomone 2; B. Loureiro 1; J. López-de-Heredia 1 (1. Spain; 2. Italy) 14:10 - 14:15 Risk factors associated with CPAP failure in very low birth weight infants 13:40 - 13:45 Characterization of poractant alfa and budesonide D. Dobryanskyy; O. Borysiuk; L. Sekretar; S.Yaremchuk; extemporaneous combination for safe and effective S. Vereshchak; Z. Salabay (Ukraine) intratracheal administration F. Salomone; F. Ricci; C. Catozzi; F. Ravanetti; F. D’Aló; 14:15 - 14:20 Weaning premature infants from nasal continuous positive N. Machidani; E. Sgarbi; V. Di Lallo; F. Saccani; M. Pertile; airway pressure – current practice in Germany A. Cacchioli; P. Puccini; S. Catinella; G. Villetti; M. Civelli; F. Amadei; A. Kidszun; C. Arnold; J. Winter; C. Whybra-Trümpler; G. Aquino; F.F. Stellari; B. Pioselli (Italy) E. Mildenberger (Germany) 13:45 - 13:50 The effect of minimally invasive surfactant therapy on 14:20 - 14:25 Non-invasive high frequency oscillatory ventilation in diaphragmatic activity preterm infants: a randomised controlled crossover trial C.G. de Waal; G.J. Hutten; F.H.C. de Jongh; A.H.L.C. van Kaam D. Klotz; H. Schneider; S. Schumann; B. Mayer ; H. Fuchs (Germany) (The Netherlands) 14:25 - 14:30 Nasal high flow support during neonatal retrieval in Victoria, 13:50 - 13:55 Evaluation of surfactant dose administered in clinical Australia practice for the treatment of respiratory distress syndrome V. Abraham; C. Roberts; B. Manley; L. Owen; M. Stewart; P. Davis (RDS): retrospective observational study. Surprais study (Australia) H. Boix; D. Elorza; S. Rite; L. Arruza; C. Fernández; I. Serrano; I. Baquedano; A. Sanchez; E. Ferreira; V. Martinez ; P. Fernandez; 14:30 - 14:35 The Comparison of heated humidified high-flow nasal R. Gonzalez (Spain) cannula versus nasal continuous positive airway pressure for respiratory support in NICU 13:55 - 14:00 Respiratory distress syndrome: genetic polymorphism of K. Y. Chao; C. E. Chiang; Y. L. Chen; L.Y. Tsai; Y. H. Chien; S. C. Mu; genes encoding surfactant protein B and xenobiotic (Taiwan) biotransformation enzymes G. Shishko; M. Artsiusheuskaya; A. Sukharava; E. Mikhalenka; 14:35 - 14:40 Which nasal CPAP system to use in preterm newborns with K. Hamolko; I. Valentsiukevich; A. Kilchevski (Belarus) respiratory distress syndrome E. Jazexhiu–Postoli; E. Vevecka; E. Petrela; D. Bujari; E. Rapushi (Albania) 36 36 1st November, 2017 1st November, 2017 37 37 14:40 - 14:45 Nasal trauma in preterm infants receiving binasal 13:50 - 13:55 Is breast milk odor appropriate to manage pain non-invasive respiratory support: a systematic review in preterm neonates? D. Imbulana; B. Manley; P. Davis; L. Owen (Australia) G. De Clifford-Faugère; A. Lavallée; M. Aita (Canada) 13:55 - 14:00 Kangaroo families - the meaning of sound environment for 14:45 - 14:50 High frequency oscillatory ventilation combined with volume the development of prematurely born infants guarantee using very low tidal volumes to prevent lung K. Kostilainen 1; K. Mikkola 1; E. Partanen 1; S. Pakarinen 1; damage in immature newborns M. Huotilainen 1, 2; V. Fellman 1 N. González-Pacheco; A. Rodríguez-Sánchez de la Blanca; (1. Finland; 2. Sweden) C. Ramos-Navarro; M. Velilla-Aparicio; I. Marsinyach-Ross; I. Pescador-Chamorro; M. Sánchez-Luna (Spain) 14:00 - 14:05 Parents´ experiences of active participation during the ward round in a neonatal intensive care unit 14:50 - 14:55 Continuous positive airway pressure is not well transmitted L. Börjesson; T. Stendahl (Sweden) during less invasive surfactant administration: a physiologic study 14:05 - 14:10 The role of paediatric physio-/occupational therapists in G. Jourdain 1; M. De Tersant 1; V. Dell’Orto 1; G. Conti 2; parental empowerment at the NICU D. De Luca 1 M.J.C. Eijsermans; M.J. Jongmans; C.H. Verhage; F. Jenken; (1. France; 2. Italy) J. van der Net; M.J.N.L. Benders; A. van den Hoogen (The Netherlands) 14:55 - 15:00 The impact of lung ultrasound in the reduction of radiation exposure in NICU 14:10 - 14:15 Pathways to emotional closeness in neonatal units – C. Barone; L. Balestriere; A. Faiella; G. Montesano; B. Orsini; a cross-national qualitative study I. Perrotta; D. Riccardi; V. Roseto; I. Rotta; F. Toro; M. Napolitano R. Flacking 1; G. Thomson 2; A. Axelin 3 (1. Sweden; 2. United Kingdom; 3. Finland) 13:30 – 15:00 POSTER SESSION 2 (NICU + PARENTS) |VENEZIA ROOM 14:15 - 14:20 Employing a nutrition nurse in neonatal intensive care unit improved nutrition and growth outcomes in preterm Chairs: Agnes van den Hoogen (The Netherlands); neonates Jos Latour (United Kingdom) O. Aydemir; A. Calik Saglik; Z Sekili; N. Tekin (Turkey) 13:30 - 13:35 Clinical decision support systems for neonatal care - 14:20 - 14:25 Name bands in preterm infants - what is the nation doing? an updated Cochrane systematic review A. Doerr; A. Glover; F. Emery (United Kingdom) K. Tan 1; P. Dear 2; S. Newell 2 (1. Australia; 2. United Kingdom) 14:25 - 14:30 Reducing unnecessary blood sampling in neonatal unit - a quality improvement initiative 13:35 - 13:40 Skin-to-skin contact in extremely preterm newborns H. McDermott; A. Smith; P. Nath (United Kingdom) H. Pavlyshyn; I. Sarapuk; O. Klishch (Ukraine) 14:30 - 14:35 NIoSIM: Northern Ireland simulation and human factor 13:40 - 13:45 Prospective surveillance of risk factors for Intracranial training hemorrhage in preterm infants decreases the rate of R. Little; C. Anderson; M. O’Dowd; R.Tubman (Ireland) intracranial hemorrhage and improves neurodevelopmental outcome at the age of 24 months 14:35 - 14:40 Current parent feedback response rates and feedback L. Schiefele 1; F. Reister 1; J. Essers 1; B. Mayer 1; M. Schmid 2; methods in neonatal transport service across the UK H. Hummler 1, 5 P. Bhat; D. Winderbank-Scott; C. Garland; L. Watts; C. Leach; (1. Germany; 2. Switzerland; 3. Qatar) A. Frame; G. Bullimore; C. Lawn (United Kingdom) 13:45 - 13:50 Thermoregulation and physiological stabilization by skin-to-skincontact at birth in preterm infants A. Linnér; B. Sundberg; B. Westrup; B. Skiold (Sweden) 38 38 1st November, 2017 1st November, 2017 39 39 14:40 - 14:45 Satisfaction level of parents of NICU services provided and 13:50 - 13:55 Hemodynamic changes related to ductus closure connection with their educational attainment in preterms E. Papamichael; E. Polycarpou; M. Talias (Cyprus) A. Rodríguez Sánchez de la Blanca; N.González Pacheco; C. Ramos Navarro; M. Arriada Redondo; N. Navarro Patiño; E. Sanz López; M. Sánchez Luna (Spain) 14:45 - 14:50 Delivering evidence-based information at the point of care A. Dunlop; L. Osborne; P. Satodia (United Kingdom) 13:55 - 14:00 A clinical scoring system as a diagnostic tool for hemodynamically significant patent ductus arteriosus in 14:50 - 14:55 Increased breast milk use reduced severity of necrotizing preterm infants enterocolitis in a quality improvement project in a Chinese N. Okur; H.G. Kanmaz; M. Buyuktiryaki; G. Kadioglu Simsek; NICU F.E. Canpolat; N. Uras; S.S. Oğuz (Turkey) Q. Zhou 1; S.K. Lee 2; X.J. Hu 1; S.J. Lee 1; S.Y.Jiang 1; Y. Cao 1 (1. China; 2. Canada) 14:00 - 14:05 New ibuprofen dosage regimen for patent ductus arteriosus following simulations based on pharmacokinetic- 14:55 - 15:00 Online parent satisfaction survey is representative despite pharmacodynamic evidence low response R. Flint 1; R. ter Heine 1; E. Spaans 1; D. Burger 1; J. de Klerk 1; K. Allegaert 2; C. Knibbe 1; S.H.P. Simons 1 J. de Boer; M. van Dijk (The Netherlands) (1. The Netherlands; 2. Belgium) 14:05 - 14:10 Association between size of patent ductus arteriosus and 13:30 – 15:00 POSTER SESSION 3 |ROMA ROOM co-morbidities S. Bellis; Y. Singh (United Kingdom) (CARDIOLOGY + MICROCIRCULATION 1) Chairs: Afif El-Khuffash (Ireland); Eirik Nestaas (Norway) 14:10 - 14:15 Myocardial deformation and rotational mechanics in infants with down syndrome in the early neonatal period 13:30 - 13:35 Ibuprofen and indomethacin differentially regulate VEGF C.R. Breatnach 1; A. Smith 1; P.T. Levy 2; N. McCallion 1; and its receptors in ductus arteriosus endothelial cells O. Franklin 1; A. EL-Khuffash 1 H. Sallmon; S. Akanbi; S.C. Weber; A. Gratopp; C. Rheinländer; (1. Ireland; 2. United States) P. Koehne (Germany) 14:15 - 14:20 Left and right myocardial performance assessment in infants 13:35 - 13:40 Effectiveness of indomethacin, ibuprofen and paracetamol born to mothers with gestational hypertension for patent ductus arteriosus (PDA) in preterm infants: C.R. Breatnach; C. Monteith; L. McSweeney; E.C. Tully; F.D. Malone; a network meta-analysis E. Kent; A. Doherty; O. Franklin; A. EL-Khuffash (Ireland) S. Mitra; I.D. Florez; M.E. Tamayo; Y. Zhang; B. Sadeghirad; A.M. Zea; L. Mbuagbaw; T. Vanniyasingam; L. Thabane (Canada) 14:20 - 14:25 Left ventricular function in preterm neonates assessment of LV rotational mechanics from 32 weeks post-menstrual age 13:40 - 13:45 Evaluation of the relationship patent ductus arteriosus and to one year the platelet mass index in preterm infants G. Lehman; M.D. Patel; P.T. Levy; S. Choudhry; T.J. Sekarski; M. Kara; İ. Caner; K.Ş. Tekgündüz; İ. Polat; H. Keskin (Turkey) A. Hamvas; G.K. Singh (United States) 13:45 - 13:50 Treatment for patent ductus arteriosus in preterm infants - 14:25 - 14:30 Predictions of cardiorespiratory morbidity after discharge less is more? from the NICU in the extreme preterm infant without chronic T. Hundscheid; W. de Boode (The Netherlands) lung disease P.T. Levy; M.D. Patel; S. Choudhry; A.A. Sanchez; M. Wallendorff; G. Hongjie; M.R. Holland; B. Warner; J. Kemp; T. Ferkol; A. Hamvas; G.K. Singh (United States) 40 40 1st November, 2017 1st November, 2017 41 41 14:30 - 14:35 Neonatalogist-performed echography in neonatology: 13:45 - 13:50 Outcomes of extremely low birth weight babies a Tunisian experience receiving surgical treatment for necrotising F.Z. Chioukh; K. Ben Ameur; T. Khemis; H. Ajmi; A. Ben Salem; enterocolitis S. Hamdi; H. Ben Hamida; K. Monastiri (Tunisia) J. Ashton; C. Charlesworth; P. Yajamanyam (United Kingdom) 14:35 - 14:40 Non-invasive cardiac output monitoring by electrical 13:50 - 13:55 Early biochemical markers associated with development of cardiometry in hemodynamically stable neonate infants necrotizing enterocolitis J. Shin; E.H. Lee; B.M. Choi (Korea) K.W. Olsson; R. Sindelar (Sweden) 14:40 - 14:45 Comparison of two techniques of superior vena cava 13:55 - 14:00 Effect of antibiotic prophylaxis during removal of a central measurement in preterm neonates with birth weight less than venous catheter on development of the neonatal intestinal 1250g microbiota J. Semberova 1, 2; Z. Stranak 2; J. Miletin 1, 2 E. d’Haens; R. Zwittink; C. Belzer; M. Hemels; R. van Lingen; (1. Ireland; 2. Czech Republic) I. Renes; J. Knol; D. van Zoeren-Grobben (The Netherlands) 14:45 - 14:50 Gut and cerebral oxygenation from birth to six weeks of life 14:00 - 14:05 Stooling pattern and gastric residuals are not useful tools for in preterm infants: what is normal? early diagnosis of necrotising enterocolitis in preterm infants C.N. Howarth; T. Leung; J. Banerjee; J. Morris; N. Aladangady S. Carlsson; M. Domellöf; A. Elfvin 3 (Sweden) (United Kingdom) 14:05 - 14:10 Is near infrared spectroscopy a reliable technique to 14:50 - 14:55 Precision assessment of a novel cerebral tissue oximeter and measure gut perfusion in preterm infants? effects of fluctuations in systemic and cerebral physiological J. Banerjee; T.S. Leung; N. Aladangady (United Kingdom) parameters S. Kleiser; D. Ostojic; N. Nasseri; H. Isler; H.U. Bucher; D. Bassler; 14:10 - 14:15 Prediction of major bleeding in extremely low birth weight M. Wolf; F. Scholkmann; T. Karen (Switzerland) infants (<1000g) by sequential coagulation monitoring M. Thanhaeuser; C. Binder; M. Kornsteiner-Krenn; U. Derhaschnig; B. Jilma; A. Repa; A. Berger; N. Haiden (Austria) 13:30 – 15:00 POSTER SESSION 4 (GI + NEC + BILIRUBIN) 14:15 - 14:20 Investigation of the relationship between umbilical cord |SORRENTO ROOM blood IRF level and perinatal events Chairs: Jon Dorling (United Kingdom); Elsa Kermovant (France) Z.E. Erdem Dursun; N. Guzoglu; D. Aliefendioglu (Turkey) 13:30 - 13:35 The open abdomen: a challenge for neonatologists and 14:20 - 14:25 Relationship between plasma levels of bilirubin and oxidant/ neonatal surgeons. The Karolinska’s experience antioxidant status in the early neonatal period in preterm M. Bartocci; E. Palleri; A. Svenningsson; T. Wester (Sweden) infants G.I. Zoutkamp 1; K. Suzuki 2; C.H.P. van den Akker 1 13:35 - 13:40 Anogenital stimulation in rats does not increase gastric (1. The Netherlands; 2. Japan) emptying C.H. Faleiros Ferreira 1; J. Belik 2 14:25 - 14:30 The coagulation screen as a biomarker of neonatal (1. Brazil; 2. Canada) encephalopathy outcomes D. Sweetman; J. Murphy; E.J. Molloy (Ireland) 13:40 - 13:45 Routine probiotics for preterm neonates: experience in a tertiary Australian neonatal unit sive care 14:30 - 14:35 A preterm model of hyperbilirubinemia-induced cerebellar G. Deshpande; V. Shingde; L. Downe; J. Xiao; M. Taber (Australia) dysfunction C.F. Bearer; M. He; J.F. Watchko; J.M. Simard; N. Tang (United States) 42 42 1st November, 2017 1st November, 2017 43 43 14:35 - 14:40 Comparisons between transcutaneous bilirubinometry, 13:50 - 13:55 Elevated essential amino acid levels in very point-of-care whole blood bilirubin and total plasma bilirubin preterm infants on total parenteral nutrition measurement in neonates L. Burgess; M. Turner; B. Flanagan; C. Morgan K. Palmkvist Kaijser; C. Backman Johansson; K. Hemse Nojd; (United Kingdom) C. Bemgard; K. Kjellson; G. Marchini (Sweden) 13:55 - 14:00 Effect of enteral iron supplementation on health outcomes in 14:40 - 14:45 Physiologic free bilirubin redistributes L1 cell adhesion preterm and low birth weight infants: a systematic review molecule (L1) in lipid rafts E. McCarthy; M. Kiely (Ireland) N. Tang; M. He; J.F. Watchko; C.F. Bearer (United States) 14:00 - 14:05 Improved nutrition for extremely preterm infants - 14:45 - 14:50 Reticulocyte haemoglobin content as an early a population based observational study index of iron deficiency in neonatal period V. Westin; S. Klevebro; M. Domellöf; M. Vanpée; B. Hallberg; P. Karagianni; E. Chatzitoliou; V. Antari; M. Lithoxopoulou; E. Stoltz Sjöström (Sweden) G. Mitsiakos; C. Tsakalidis; A. Kioumi; V. Soubasi (Greece) 14:05 - 14:10 Nutrient intake in the first two weeks of life predicts brain 14:50 - 14:55 Effect of probiotic supplementation on breast milk jaundice macro- and microstructural growth in preterm neonates N. Koksal; O. Bagcı; H. Ozkan; I. Varal; P. Dogan (Turkey) J. Schneider 1, 2; L. Beauport 2; E. Duerden 1; T. Guo 1; J. Foong 1; M. Bickle Graz 2; P. Hagmann 2; M. Chakravarty 1; P. Hüppi 2; 14:55 - 15:00 An audit of use of emergency O negative blood in neonates C. Fischer Fumeaux 2; S. Miller 1; A. Truttmann 2 for emergency blood transfusions and exchange transfusions (1. Canada; 2. Switzerland) P. Tormey; D. Sweetman; J. Quigley; J. Fitzgerald (Ireland) 14:10 - 14:15 Influence of human milk and parenteral lipid solutions on serum fatty acid profiles in extremely preterm infants A.K. Nilsson 1; C. Löfqvist 1; S. Najm 1; G. Hellgren 1; E. Engström 1; 13:30 – 15:00 POSTER SESSION 5 (NUTRITION 1) |VERONA ROOM P. Lundgren 1; A-L. Hård 1; A. Lapillonne 2; K. Sävman 1; M.X. Andersson 1; L.E.H. Smith 3; A. Hellström 1 Chairs: Silvia Iacobelli (Italy); Sissel Moltu (Norway) (1. Sweden; 2. France; 3. United States) 13:30 - 13:35 Comparative clinical effectiveness of two methods of 14:15 - 14:20 Evaluation of milk and blood irisin levels in preterm newborns hyperglycemia correction in very low birth weight preterm diagnosed with either small or appropriate weight for infants gestational age compared to full term newborns O. Dobush; D. Dobryanskyy; Z. Salabay; O. Borysiuk (Ukraine) N. Mól; P. Tomasik; M. Zasada; P. Kwinta (Poland) 13:35 - 13:40 Role of breast milk and fecal microbial content in 14:20 - 14:25 Positive relationship between transthyretin and insulin-like development of breast milk jaundice growth factor 1 during the anabolic period in very preterm N. Koksal; O Bagcı; H. Ozkan; I. Varal; P Dogan (Turkey) infants I. Hansen Pupp; C. Löfqvist; D. Ley; A. Hellström (Sweden) 13:40 - 13:45 Protein and caloric deficit during the neonatal period in infants with birth weight less than 1500 g and its association 14:25 - 14:30 Hormone profile and anthropometric assessment of very with blood pressure in the adolescence preterm newborns at follow-up A. Dinerstein; C. Solana; R. Nieto; M. Casale; R. Conti; M. Moiron; C. Balcells; B. del Rey Hurtado de Mendoza; M. Izquierdo-Renau; F. General (Argentina) I. Iglesias-Platas (Spain) 13:45 - 13:50 Long term growth and neurodevelopmental outcome in 14:30 - 14:35 Human milk composition in relation to growth and body preterm infants born small for gestational age (SGA) and composition in preterm infants at term age infants with intrauterine growth restriction (IUGR) K.P.T. Vu; D.F.J. Yumani; A.R.C. Laarman; H.N. Lafeber; C. Binder; A. Huber-Dangl; J. Binder; A. Kreissl; M. Thanhaeuser; M.M. van Weissenbruch (The Netherlands) A. Repa; A. Berger; N. Haiden (Austria) 44 44 1st November, 2017 1st November, 2017 45 45 13:30 - 15:00 Respiratory Syncytial Virus: 15:00 - 17:00 PARALLEL SESSION 8 (BRAIN 2) Should We Identify Paediatric Patients at MONITORING FOR INFANTS AT RISK Risk for Severe Disease? |LECCE ROOM |VENEZIA ROOM Industry Supported session - please see page 125 Chairs: Manon Benders (The Netherlands); Juliane Schneider (Switzerland) Chair: Paolo Manzoni (Italy) 15:00 - 15:20 Cerebral autoregulation in asphyxiated neonates treated Severe RSV disease: the worldwide burden with hypothermia Paolo Manzoni (Italy) A. Hendriksen; L. Dix; W. Baerts; F. van Bel; F. Groenendaal; P. Lemmers (The Netherlands) Who needs RSV infection prevention? A closer look at children with chronic diseases 15:20 - 15:35 Asynchrony and spectral EEG coherence in term neonates Bosco A. Paes (Canada) with intrauterine grow restriction B. Reyes Millán; J.R. Castro Conde; C. González Campo; Cases in identifying children at risk of severe RSV disease I. Quintero Fuentes; N.L. González González; D. González Barrios Panel (Spain) The acute and long-term consequences of severe RSV 15:35 - 15:50 Early amplitude integrated electroencephalogram as a disease predictor of brain injury in newborns with very low birth Maarten O. Blanken (The Netherlands) weight: a cohort study R.C. Silveira; L.V. Magalhaes; M.I. Winckler; J.A. Bragatti; “Ask the Faculty” and concluding remarks R.S. Procianoy (Brazil) 15:50 - 16:05 MRI-diagnosed white matter lesions in the brain of VLBW babies: risk factor analysis PARALLEL SESSION 7 (PULMONOLOGY 1) 15:00 - 17:00 A. Parodi; S. Raffa; M. Malova; A. Sannia; M. Severino; G. Morana; PULMONARY SYMPOSIUM |DARSENA ROOM D. Tortora; M.G. Calevo; A. Rossi; L. A. Ramenghi (Italy) Industry Supported session - please see page 125 Chairs: Charles C. Roehr (United Kingdom); Anna Lavizzari (Italy) 16:05 - 16:20 Perinatal associations with brain growth evaluated by sequential cranial ultrasonography in very preterm infants 15:00 - 16:00 nCPAP vs HFNC R. Cuzzilla 1; A.J. Spittle 1; K.J. Lee 1; S. Rogerson 1; F.M. Cowan 2; Haresh Kirpalani (United States) vs Peter Davis (Australia) L.W. Doyle 1; J.L.Y. Cheong 1 (1. Australia; 2. United Kingdom) 16:00 - 16:30 Newer strategies for surfactant delivery – who, when, where, why and how 16:20 - 16:35 Bedside monitoring of cerebral metabolism in neonates at Peter Dargaville (Australia) risk for hypoxic-ischemic encephalopathy M. El-Dib; S.J. Blackwell; F. Yi; R. Vyas; C.G. Ha; B. Walsh; T.E. Inder; 16:30 - 16:45 Sudden versus pressure wean from nasal CPAP in very P.E. Grant; S.L. Ferradal (United States) preterm infants: a multicenter randomized controlled trial C.F. Jensen; F. Ebbesen; A.S. Sørensen; T.B. Henriksen (Denmark) 16:35 - 16:50 Early neonatal EEG markers for dyslexia risk: a pilot study S. Martini; P. Cyr; L. Brightman; L. Amunts; G. Belteki; T. Austin; 16:45 - 17:00 Predictors and outcomes of continuous positive V. Leong (United Kingdom) airway pressure and nasal high-flow treatment failure in preterm infants: a secondary analysis of a randomized trial B. Manley 1; C. Roberts 1; D. Frøisland 2; L. Doyle 1; P. Davis 1; L. Owen 1 (1. Australia; 2. Norway) 46 46 1st November, 2017 1st November, 2017 47 47 15:00 - 17:00 PARALLEL SESSION 9 (CIRCULATION 2) 15:00 - 17:00 PARALLEL SESSION 10 (PHARMA 1) WHAT SHOULD WE MONITOR? GLOBAL CHALLENGES IN NEONATAL DRUG DEVELOPMENT HAEMODYNAMICS (SYSTEMIC BLOOD FLOW), |FIRENZE ROOM END-ORGAN PERFUSION (REGIONAL BLOOD FLOW) Chairs: Sinno Simons (The Netherlands); OR THE MICROCIRCULATION (CAPILLARY BLOOD Karel Allegaert (Belgium) FLOW)? |ROMA ROOM 15:00 - 15:20 What you need to know from EMA PDCO Chairs: Afif El-Khuffash (Ireland); Mayka Bravo (Spain) Mark Turner (United Kingdom) 15:00 - 15:20 It’s all about the heart 15:20 - 15:40 The HIP trial story Willem de Boode (The Netherlands) Eugene Dempsey (Ireland) 15:20 - 15:40 It’s all about the brain 15:40 - 16:00 Experiences from the NEO-CIRC trial Gorm Greisen (Denmark) Heike Rabe (United Kingdom) 15:40 - 16:00 It’s all about the microcirculation 16:00 - 16:15 Adrin 1 methodology study: adverse drug reactions in Dick Tibboel (The Netherlands) neonates: what are the best ways to evaluate suspected adverse drug reactions in neonates? 16:00 - 16:15 Patent ductus arteriosus, cerebral haemodynamics and E. Roberts; D. Hawcutt; J.J. Kirkham; M.A. Turner (United Kingdom) intraventricular haemorrhage in preterm neonates: a causal pathway study 16:15 - 16:30 Large differences in off-label and neonatal drug use still C. Kotidis; M. Weindling; A. Eleuteri; H. Rabe; M. Turner exist: time for consensus? (United Kingdom) R. Flint; F. Van Beek; P. Andriessen; P. Degraeuwe; D. Liem; I. Reiss; R. de Groot; D. Tibboel; D. Burger; S.H.P. Simons; DINO study group 16:15 - 16:30 Electrical velocimetry in preterm infants: (The Netherlands) effect of time and gestational age L. Van Wyk 1; W.P. De Boode 2; J. Smith 1; J. Lawrenson 1; 16:30 - 16:45 Urinary 17-α-hydroxy-progesterone as a potential marker of C.J. Lombaard 1 (1. South Africa; 2. The Netherlands) neonatal pain M. Brasseler; T. Hoehn (Germany) 16:30 - 16:45 Molecular and genetic markers for prediction of resistance 16:45 - 17:00 Β3-adrenoceptor regulation of nitric oxide in the cord to inotropic therapy in newborns with arterial hypotension D. Kryuchko; A. Donnikov; E. Baibarina; I. Nikitina; O. Ionov; vascular system D. Degtyarev (Russia) G. Cavallaro 1; A. Griggio 1; L. Provitera 1; G. Raffaeli 1; I. Amodeo 1; S. Gulden 1; G. Zuanetti 1; D. Lattuada 1; G. Ercoli 1; 16:45 - 17:00 Glial fibrillary acidic protein plasma levels during congenital S. Gatti 1; E. Villamor 2; F. Mosca 1 heart diseases surgery inversely correlate with vineland (1. Italy; 2. The Netherlands) adaptive behavior scales communication score L.Vedovelli; M. Padalino; M. Salvagno; S. Sartori; A. Suppiej; E. Cainelli; G. Stellin; G. Falasco; V.P. Carnielli; M. Simonato; P. Cogo (Italy) 48 48 1st November, 2017 1st November, 2017 49 49 15:00 - 17:00 PARALLEL SESSION 11 (NUTRITION 2) |SORRENTO ROOM 15:00 - 17:00 PARALLEL SESSION 12 (EFCNI 2) CONTROVERSIES IN NEONATAL NUTRITION FAMILY CENTRED DEVELOPMENTAL SUPPORTIVE Chairs: Sissel Moltu (Norway); Alexandre Lapillonne (France) CARE – EVIDENCE OR PHILOSOPHY? |LECCE ROOM Chairs: Silke Mader (Germany); Jacques Sizun (France) 15:00 - 15:20 Preterm parenteral nutrition: too much too soon or too little too late Colin Morgan (United Kingdom) 15:00 – 15:40 Family integrated care in the NICU - feasible and good for preterm infants? 15:20 - 15:40 Risks and benefits of insulin treatment in hyperglycaemic Shoo Lee (Canada) preterm neonates Elsa Kermorvant (France) 15:40 – 16:20 Developmental care – impact on the brain Stéphane Sizonenko (Switzerland) 15:40 - 15:55 Target fortification of breast milk with protein, carbohydrate and fat for preterm infants improves growth outcomes: a 16:20 – 17:00 Influence of auditive NICU environment on the preterm baby doubleblind randomized controlled trial Pierre Kuhn (France) N. Rochow 1; G. Fusch 1; A. Ali 1; A. Bhatia 1; S. Ahmad 1; A. Nguyen 1; L. Chessell 1; S. el Helou 1; C. Fusch 1,2 (1. Canada; 2. Germany) 17:00 - 17:30 COFFEE BREAK 15:55 - 16:10 Targetting glucose control with real time continuous glucose monitoring L. Thomson; D. Elleri; D. Dunger; K. Beardsall (United Kingdom) 17:30 - 18:30 PLENARY SESSION 3 |DARSENA ROOM BENGT ROBERTSON AWARD 16:10 - 16:25 Bovine colostrum for preterm infants in the first days of life: a randomized controlled pilot trial Industry Supported session - please see page 126 S.M. Juhl 1; X. Ye 2; P. Zhou 2; Y. Li 1; E.O. Iyore 1; L. Zhang 2; Chairs: Kajsa Bohlin (Sweden); Virgilio P. Carnielli (Italy) P. Jiang 1; J.B. v. Goudoever 3; G. Greisen 1; P.T. Sangild 1 (1. Denmark; 2. China; 3. The Netherlands) 17:30 – 17:40 Introduction 16:25 - 16:40 Reducing variability in macronutrient intakes improves 17:40 – 18:15 Steroids, surfactant and the preterm lung: bench to bedside growth in preterm infants: target fortification of breast milk - and back again a double-blind randomized controlled trial Roberta and Phil Ballard (United States) A. Bhatia 1; N. Rochow 1; G. Fusch 1; A. Ali 1; A. Nguyen 1; A. Bahonjic 1; C. Fusch 1,2 18:15 – 18:30 Impact of preterm birth on respiratory muscle function in (1. Canada; 2. Germany) childhood Aggeliki Vervenioti (Greece) 16:40 - 16:55 The effect of fish oil emulsions on lung function in preterm infants receiving parenteral nutrition V.P. Carnielli; C. Biagetti; P. Marchionni; A. Correani; M. Carfagna; S. Nobile (Italy) 50 50 1st November, 2017 1st November, 2017 51 51 DARSENA VENEZIA ROMA FIRENZE SORRENTO LECCE NAPOLI ROOM ROOM ROOM ROOM ROOM ROOM ROOM (Mosaici 1) (Mosaici 2) GROUND FLOOR GROUND FLOOR GROUND FLOOR GROUND FLOOR THIRD FLOOR THIRD FLOOR GROUND FLOOR 08:00 08:00 PLENARY Neonatologist SESSION 4 Performed Young Investigator Prize session Echocardiography 10:00 (NPE) 10:00 COFFEE BREAK COFFEE BREAK 10:30 10:30 Parallel Parallel Parallel Parallel Parallel NUTRITION Session 13 Session 14 Session 15 Session 16 Session 17 SECTION MEETING (PULMONOLOGY 2) (BRAIN 3) (EFCNI 3) (EPIDEMIOLOGY 1) (INFECTIOUS DISEASES) Medicines for lung Transition to adult life Bridging the gap Outcome measures protection / between neonatal in clinical studies of Severe BPD palliative care and preterm babies developmental care 12:30 12:30 LUNCHEON LUNCHEON SYMPOSIUM SYMPOSIUM Pulse Oximetry CCHD ROP in 2017 & Beyond Screening: focus on LUNCH BREAK - Latest Strategies the recent EU Improving Patient consensus towards Care implementation 13:30 13:30 POSTER SATELLITE POSTER POSTER POSTER POSTER SESSION 6 SYMPOSIUM SESSION 7 SESSION 8 SESSION 9 SESSION 10 Importance LUNG 2 of Human Milk in LUNG 3 CARDIOLOGY + INFECTIOUS DISEASE NEUROLOGY 1 Preterm Nutrition MICROCIRCULATION 2 14:30 14:30 Parallel Parallel Parallel Parallel Parallel Parallel EPIDEMIOLOGY Session 18 Session 19 Session 20 Session 21 Session 22 Session 23 SECTION MEETING (PULMONOLOGY 3) (NUTRITION 3) Neonatal ARDS: (EFCNI 4) Oxygenation in the (BRAIN 4) Ventilation support Nutrition of the ELBWI: recognising the exi- Digital patient care – newborn and infant Biomarkers in term Improving Nutritional stence of a syndrome the new dimension? period neonatal Care across the age encephalopathy 16:30 16:30 COFFEE BREAK 17:00 17:00 PLENARY SESSION 5 Will Big Data change the future? 18:00 18:00 EXECUTIVE SATELLITE SYMPOSIUM Enhancing the Success of Respiratory Management in nRDS 19:30 19:30 Mother’s milk – 08:00 - 10:00 PLENARY SESSION 4 |DARSENA ROOM YOUNG INVESTIGATOR PRIZE SESSION our passion Chairs: Umberto Simeoni (Switzerland); Luc Zimmermann (The Netherlands) 08:00 - 08:15 Individualized growth trajectories for preterm infants using a Medela exists to enhance mother and baby health through growth trajectory calculator tool the life-giving benefits of human milk. For more information, E. Landau-Crangle; N. Rochow; T.R. Fenton; K. Liu; H.Y. So; G. Fusch; visit www.medela.com A. Ali; M.L. Marrin; C. Fusch (Canada) 08:15 - 08:30 Touchscreens for cognitive assessment of toddlers D.M. Twomey 1; C. Wrigley 1; C. Ahearne 1; R. Murphy 1; M. de Haan 2; N. Marlow 2; D.M. Murray 1 (1. Ireland; 2. United Kingdom) 08:30 - 08:45 Tracking childhood height of small for gestational age infants in Ireland F. Maguire; E. Loftus; D. Gibbons; N. O’Connor; O. O’Brien; S. Carolan; J. Byrne; E.J. Molloy (Ireland) 08:45 - 09:00 Evaluation of effect of caffeine onset time on surfactant synthesis of premature infants of 30 gestational weeks and below with respiratory distress N. Okur; M. Buyuktiryaki; H. Bezirganoglu; O. Ertekin; E.D. Alyamac; F.E. Canpolat; S.S. Oguz (Turkey) 09:00 - 09:15 Use of specialist services until two years of age in the epice cohort of very preterm births in Europe A.V. Seppänen 1; F. Bodeau-Livinec 1; E.M. Boyle 2; A.K. Edstedt-Bonamy 3; M. Cuttini 4; L. Toome 3; R.F. Maier 6; E. Cloet 7; C. Koopman-Esseboom 8; J. Gadzinowski 9; J. Zeitlin 1 (1. France; 2. United Kigdom; 3. Sweden; 4. Italy; 5. Estonia; 6. Germany; 7. Belgium; 8. The Netherlands; 9. Poland) 09:15 - 09:30 Impact of neonatal white matter injury and brain volumes to school-age neurodevelopment in children with congenital heart disease N.H.P. Claessens; S.O. Algra; T.L. Ouwehand; N.J.G. Jansen; P. Moeskops; I. Išgum; R. Schappin; I.C. van Haastert; M.J.C. Eijsermans; F. Groenendaal; L.S. de Vries; M.J.N.L. Benders (The Netherlands) 2nd November, 2017 53 53 09:30 - 09:45 Nanomolecular signalling in the developing brain: PARALLEL SESSION 13 (PULMONOLOGY 2) 10:30 – 12:30 characteristics of exosomes in the cerebrospinal fluid of preterm infants SEVERE BPD |DARSENA ROOM R. Spaull; B. McPherson; A. Clayton; J. Uney; O. Cordero-Llana; Chairs: Daniele de Luca (France); A. Heep (United Kingdom) Kerstin Jost (Switzerland) 09:45 - 10:00 Blood plasma profile of temporal microrna expression of 10:30 – 10:50 Ethical decision making in lung failure inflammation in lipopolysaccharide sensitised porcine Eduard Verhagen (The Netherland) model of hypoxic ischaemic encephalopathy A. Avdic-Belltheus 1; I. Lingam 1; C. Meehan 1; K. Martinello 1; 10:50 – 11:10 BPD-associated pulmonary hypertension S. Ragab 1; I. Tachtsidis 1; C. Tann 1; M. Hristova 1; B. Fleiss 1; Robin Steinhorn (United States) T. Wolfs 2; B. Kramer 2; N. Klein 1; H. Hagberg 1; P. Gressens 1; N.J. Robertson 1 (United Kingdom) 11:10 - 11:25 Physiological basis of the NICHD BPD classification: a prospective observational study in very preterm infants 10:00 - 10:10 Cerebral monitoring during neonatal surgery for non-cardiac J. Svedenkrans 1, 2; B. Stoecklin 2; J.G. Jones 3; A.W. Gill 2; congenital anomalies: a first step to improve outcome D. Doherty 2; J.J. Pillow 2 Lisanne Stolwijk (The Netherlands) (1. Sweden; 2. Australia; 3. United Kigdom) 11:25 - 11:40 Identification of a regulatory alveogenesis gene cluster using a novel genetic approach NEONATOLOGIST PERFORMED |SORRENTO ROOM 08:30 – 12:30 F. Gao; C. Li; R. Ramanathan; P. Minoo (United States) ECHOCARDIOGRAPHY (NPE) Chairs: Willem de Boode (The Netherlands); 11:40 - 11:55 Healthcare burden of bronchopulmonary dysplasia among Afif El-Khuffash (Ireland) extremely preterm infants in the United States M. Mowitz; S. Sarda; A. Mangili; R. Ayyagari; W. Gao; J. Zhao; (United States) 08:30 – 08:35 Welcome Afif El-Khuffash (Ireland) 11:55 - 12:10 Relationship between secretory phospholipase A2 pathway and short term outcomes in preterm neonates with RDS 08:35 – 09:00 Physics of ultrasound and artefact recognition S. Shankar-Aguilera 1; C. Fitting 1; R. Raschetti 1; M. Sminato 2; Willem de Boode (The Netherlands) V. Dell’Orto 1; L. Vedovili 1; V.P. Carnielli 2; L. Touqui 1; D. De Luca 1 (1. France; 2. Italy) 09:00 – 09:30 Routine ultrasound views Afif El-Khuffash (Ireland) 12:10 - 12:25 Relaxation rate of the respiratory muscles and prediction of extubation outcome in prematurely born infants 09:30 – 10:00 Assessment of PDA T. Dassios; O. Kaltsogianni; A. Greenough (United Kingdom) Patrick McNamara (Canada) 10:00 – 10:30 COFFEE BREAK 10:30 – 11:00 Assessment of PPHN Shahab Noori (United States) 11:00 – 11:30 Assessment of flow and contractility Nick Evans (Australia) 11:30 – 12:00 Advanced ecocardiographic technologies Eirik Nestaas (Norway) 12:00 – 12:30 Panel discussion - All speakers 54 54 2nd November, 2017 2nd November, 2017 55 55 10:30 – 12:30 PARALLEL SESSION 14 (BRAIN 3) PARALLEL SESSION 15 (EFCNI 3) 10:30 – 12:30 TRANSITION TO ADULT LIFE |VENEZIA ROOM BRIDGING THE GAP BETWEEN NEONATAL Chairs: Petteri Hovi (Finland); Neil Marlow (United Kingdom) PALLIATIVE CARE AND DEVELOPMENTAL CARE |ROMA ROOM 10:30 – 10:50 Cognition and attainment Chairs: Jacques Sizun (France); Nicole Thiele (Germany) Neil Marlow (United Kingdom) 10:30 – 10:50 Neonatal palliative care, developmental care: 10:50 – 11:10 Psychiatric outcomes different wording for one single concept? Chiara Nosarti (United Kingdom) Jacques Sizun (France) 11:10 – 11:30 Cardiovascular health 10:50 – 11:10 How involved are parents in difficult life decisions Petteri Hovi (Finland) Jos Latour (United Kingdom) 11:30 – 11:45 Cognitive functioning in adolescents born moderately preterm at 32-26 weeks’ gestation: a Swedish regional 11:10 – 11:25 Retrospective analyses of parental counseling population based case control study and decision making for extreme preterm birth in a tertiary M. Adamsson; B. Hägglöf; M. Bäckman; A. Farooqi (Sweden) Dutch perinatal center E. de Booij; J. de Boer; A. Eggink; I. Reiss; S.H.P. Simons; I.A. Brussé 11:45 – 12:00 Cognitive trajectories from infancy to early adulthood (The Netherlands) following birth before 26 weeks of gestation L. Linsell; S. Johnson; D. Wolke; H. O’Reilly; J. Morris; J. Kurinczuk; 11:25 – 11:40 Health care professionals’ and parents’ attitudes toward N. Marlow (United Kingdom) parental autonomy and the best interest of the extreme preterm infant: a national study in Switzerland 12:00 – 12:15 Persistent mathematics learning difficulties from childhood to M. Hendriks; H. Bucher; S. Klein; R. Baumann-Holzle; J. Streuli; adolescence in very preterm children in mainstream school J. Fauchère (Switzerland) S. Clayton; L. Cragg; C. Gilmore; N. Marlow; V. Simms; R. Spong; S. Johnson (United Kingdom) 11:40 – 11:55 Children’s outcomes at two-year follow-up after four years of structured multi-professional medical-ethical decision- 12:15 – 12:30 Inhibitory control at 20 months predicts VP/VLBW and term making in a neonatal intensive care unit adults’ attention, IQ, and wealth at age 26 years J. de Boer; L. Gennissen; M. Williams; M. van Dijk; D. Tibboel; I. Reiss; J. Jaekel 1,2; N. Baumann 2; P. Bartmann 3; D. Wolke 2 S. Naghib; J. Sol (The Netherlands) (1. United States; 2. United Kingdom; 3. Germany) 11:55 – 12:10 The delivery of bad news: a one or 2-step approach? The case for Trisomy 21 M.S. Schimmel; M.Y. kassirer; H.M. Towers (United States) 12:10 – 12:25 Neonatal organ donation: a potential new donor source for cell and organ transplantation C. Jorns; E. Henckel; G. Nowak; A. Karadagi; T. Kjellin; E. Bluhme; Ö. Jynge; M. Hending; A. Croon; M. Söderström; B. Fischler; A. Nemeth; R. Gramignoli; S. Strom; E. Ellis; B. Hallberg (Sweden) 56 56 2nd November, 2017 2nd November, 2017 57 57 10:30 – 12:30 PARALLEL SESSION 16 (EPIDEMIOLOGY 1) 10:30 – 12:30 PARALLEL SESSION 17 OUTCOME MEASURES IN CLINICAL STUDIES OF INFECTIOUS DISEASES |LECCE ROOM PRETERM BABIES |FIRENZE ROOM Chairs: Christoph Bührer (Germany); Chairs: Tine Brink Henriksen (Denmark); Sinno Simons (The Netherlands) Anne-Cathrine Finnemann Viuff (Denmark) 10:30 – 10:50 Antimicrobial – impregnated catheters and prevention of 11:00 - 11:20 Composite outcomes in clinical NICU studies - infection in newborn infants pros and cons Sam Oddie (United Kingdom) Keith Barrington (Canada) 10:50 – 11:10 Food additives for prevention of sepsis and necrotizing 11:20 - 11:40 Measuring risk of postnatal endpoints enterocolitis Olga Basso (Canada) Christoph Bührer (Germany) 11:40 - 11:55 Rends in mortality and major morbidity of very preterm 11:10 – 11:25 Colonisation with gram-negative bacteria (GNB) in neonates in 10 national neonatal database: the international infants in a tertiary neonatal unit network for evaluation of outcomes (INEO) experience C. Kortsalioudaki; M. Sellwood; G. Kendall; B. Shuttleworth; K. Lui 1; S. Lee 2; S. Kusuda 3; M. Adams 4; M. Vento Torres 5; N. Shetty; C.J. Tann; P. Wilson (United Kingdom) B. Reichman 6; B. Darlow 7; L. Lehtonen 8; N. Modi 9; M. Norman 10; S. Hakansson 11; D. Bassler 4; F. Rusconi 12; P. Shah 2 11:25 – 11:40 Antimicrobial activity of copper in reducing enviromental on behalf of the International Network for Evaluating Outcomes of burden in a neonatal intensive care unit (NICU) Neonates C. Petropoulou; E. Kouskouni; P. Efstathiou; Helen Bouza; (1. Australia; 2. Canada; 3. Japan; 4. Switzerland; 5. Spain; 6. Israel; Z. Manolidou; K. Karageorgou; A. Efstathiou; M. Logothetis 7. New Zealand; 8. United Kingdom; 10. Sweden; 11. Italy) (Greece) 11:55 - 12:10 Impact of major neonatal morbidities on the outcome at 6.5 11:40 – 11:55 The antisecretory factor in relation to preterm birth and years of children born extremely preterm: a Swedish inflammatory response national prospective study (express) A. Gustafsson; E. Henckel; E. Johansson; M. Oshalim; S. Lange; A. Farooqi; K. Källén; K. Maršál; F. Serenius (Sweden) A. Olin; P. Brodin; K. Bohlin (Sweden) 12:10 - 12:25 Differential susceptibility effects of maternal sensitivity at age 11:55 – 12:10 Can endocan predict late neonatal sepsis? 6 on small for gestational age adults’ attention regulation M. Buyuktiryaki; N. Okur; C. Tayman; U. Serkant; U. Cakır; H. Halil; and wealth at age 26 M.Y. Oncel; SS. Oguz (Turkey) T. Nichols 1; J. Jaekel 1,2; P. Bartmann 3; D. Wolke 2 (1. United States; 2. United Kingdom; 3. Germany) 12:10 – 12:25 Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates 12:25 - 12:40 Educational trajectories of school outcome after preterm J.F. Hsu; S.M. Chu; M.H. Tsai (Taiwan) birth D. Odd; D. Evans; A. Emond (United Kingdom) 12:40 - 12:55 In utero exposure to perfluoroalkyl and polyfluoroalkyl 12:30 – 13:30 LUNCH BREAK substances and attention and executive function in the offspring C.C. Bach 1; Z. Liew 2; N.B. Matthiesen 1; T.B. Henriksen 1; B.H. Bech 1; E.A. Nohr 1; E.C. Bonefeld-Jørgensen 1; J. Olsen 1,2 (1. Denmark; 2. United States) 58 58 2nd November, 2017 2nd November, 2017 59 59 Pulse Oximetry CCHD Screening: 12:30 – 13:30 13:30 – 14:30 POSTER SESSION 6 (LUNG 2)|DARSENA ROOM focus on the recent EU consensus towards Chairs: Roland Hentschel (Germany); Ola D. Saugstad (Norway) implementation |DARSENA ROOM Industry Supported session - please see page 126 13:30 - 13:35 Assessment of cardio-respiratory rates by non-invasive (Lunch will be provided) measurement methods in hospitalized preterm neonates Chair: Paolo Manzoni (Italy); Manuel Sanchez-Luna (Spain) L. Antognoli; P. Marchionni; L. Scalis; S. Nobile; E.P. Tomasini; V.P. Carnielli (Italy) 12:30 - 13:00 Pulse Oximetry Screening for Critical Congenital Heart defects: a European Consensus 13:35 - 13:40 Oxygen saturation trends in late preterm infants Andrew Ewer (United Kingdom) L.Z.J. Williams; D. McNamara; J.M. Alsweiler (New Zealand) 13:00 - 13:30 Practical aspects of Pulse Oximetry Screening for Critical 13:40 - 13:45 Reliability of manually collected cardio-pulmonary Congenital Heart defects: any hurdles for implementation? parameters in patients’ charts Paolo Manzoni (Italy) P. Marchionni; L. Scalise; L. Antognoli; S. Nobile; E.P. Tomasini; V.P. Carnielli (Italy) 13:45 - 13:50 Correlation between body temperature and cerebral 12:30 – 13:30 ROP in 2017 & Beyond - Latest Strategies oxygenation in neonates during transition after birth Improving Patient Care |LECCE ROOM L.P. Mileder; A. Richter; N. Baik-Schneditz; B. Schwaberger; Industry Supported session - please see page 126 C. Binder-Heschl; B. Urlesberger; G. Pichler (Austria) (Lunch will be provided) Chair: Maximo Vento Torres (Spain) 13:50 - 13:55 Accuracy of obtaining neonatal heart rate from a novel hat mounted, green wavelength optical device Oxygen Targeting in the Delivery Room and International C. Henry; L. Shipley; C. Ward; S. Mirahamdi; B. Hayes-Gill; Trends in the Management of ROP in the Neonatal Period J. Carpenter; D. McCartney; D. Sharkey (United Kingdom) Maximo Vento Torres (Spain) 13:55 - 14:00 Drops in saturation and heart rate in healthy newborns: Retinopathy of Prematurity: Improving Patient Safety – more than we think Preventative Strategies and Clinical Advances S.J.A. Balink; R.C.J. de Jonge; T.G. Goos; R.H.T. van Beek Ann Hellström (Sweden) (The Netherlands) Oxidative Stress and Oxygen Monitoring: 14:00 - 14:05 Sudden unexpected collapse of newborn infants: incidence, From Theory to Practice – Are We Improving Outcomes? risk factors and role of perinatal transition Augusto Sola (United states) E. Herlenius; D. Forsberg; G. Drevin; N.J. Pejovic (Sweden) 14:05 - 14:10 Improvement of face mask ventilation technique 13:30 – 14:30 Importance of Human Milk in Preterm Nutrition using a live feedback system |VENEZIA ROOM S. Bhayat; H. Gowda (United Kingdom) Industry Supported session - please see page 126 14:10 - 14:15 Is APGAR score a predictor of severity in preterm infants? 13:30 - 14:00 Human Milk Oligosaccharides and Necrotizing Enterocolitis W.A. Gonçalves-Ferri; P.P. Paiva; A.B. Gouvea; E. Sacramento; Lars Bode (United States) C. Calixto; D.C. Aragon (Brazil) 14:00 - 14:30 Preterm nutrition and HM fortification Jean-Charles Picaud (France) 60 60 2nd November, 2017 2nd November, 2017 61 61 14:15 - 14:20 Blood glucose level and cerebral oxygenation in neonates 13:55 - 14:00 Octreotide for chylothorax? A systematic immediately after birth approach to answering the question B. Urlesberger; C.H. Matterberger; N. Baik-Schneditz; G. Zuanetti; G. Cavallaro; G. Raffaeli; M. Colnaghi; F. Ciralli; B. Schwaberger; G.M. Schmölzer; L. Mileder; G. Pichler (Austria) I. Amodeo; S. Gulden; E. Leva; L. Pugni; F. Mosca (Italy) 14:20 - 14:25 A neonatal resuscitation algorithm for mid-to-low resource 14:00 - 14:05 Prevention of hypocapnia with inhalative CO2 in neonates settings in medecins sans frontieres’ programs with hypoxic-ischemic encephalopathy-the henric study L. Umphrey 1; M. Blennow 2; M. Breindahl 2; A. Brown 3; E. Szakmar 1; K. Kovacs 1; U. Meder 1; C.S. Andorka 1; K. Kaila 2; O.D. Saugstad 4; M. Thio Lluch 3; D. Trevisanuto 5; C.C. Roehr 6 M. Szabo 1; A. Jermendy 1 (1. France; 2. Sweden; 3. Australia; 4. Norway; 5. Italy; (1. Hungary; 2. Finland) 6. United Kingdom) 14:05 - 14:10 In vitro analyses of gastric aspirates from preterm neonates 14:25 - 14:30 Reliability and accuracy of pulse oxymetry to determine after corticosteroid therapy SAO2 and PAO2 in preterm infants V. Milov; D. Manoylov; A. Jordanova; A. Tsanova; V. Stoyanova; D. Wackernagel; M. Blennow; A. Hellström (Sweden) E. Stoimenova; D. Petrova; E. Hristova; Z. Lalchev (Bulgaria) 14:10 - 14:15 The SAFE protocol: a sonographic algorithm for liFe-threatening emergencies in the NICU 13:30 – 14:30 POSTER SESSION 7 (LUNG 3) |ROMA ROOM N. Yousef; S. Shankar-Aguilera; D. De Luca (France) Chairs: Daniel Klotz (Germany); Luc Zimmermann (The Netherlands) 14:15 - 14:20 Changes in expression of connective tissue growth factor (CTGF) in newborn rat lungs after ventilation 13:30 - 13:35 Evaluation of oxidative stress in neonates A. Remesal; E. Gutierrez; L. San Feliciano; M. Mateos; M. Matyas; M. Hăsmăsanu; D. Leucuta; L. Blaga; G. Zaharie A. García-Sánchez; M. Isidoro-García; D. Ludeña (Spain) (Romania) 14:20 - 14:25 Oxygen saturation targeting using automated versus manual 13:35 - 13:40 Simplified Australian and New Zealand neonatal network control of inspired oxygen in preterm infants: (ANZNN) shift test accurately predicts rightward shift of the a systematic review and meta-analysis SPO2-PIO2 curve in an extremely preterm infant population S. Mitra; B. Singh; W. El-Naggar; D. McMillan (Canada) Y.J. Choi; B. Stoecklin; M.A. Hakeem; P. Woods; J.J. Pillow (Australia) 13:40 - 13:45 Normalisation of pulmonary gas exchange capacity in very preterm infants following initial hospital discharge defined by shift of the SPO2-PIO2 curve Y.J. Choi; B. Stoecklin; J.J. Pillow (Australia) 13:45 - 13:50 Measuring oxygen diffusion at 36 weeks’ PMA in preterm infants: analysis of the SATO2/FIO2 ratio and its correlation with early respiratory patterns of disease S. Nobile; P. Marchionni; F. Porcarelli; A. Boria; V.P. Carnielli (Italy) 13:50 - 13:55 Macrolide therapy and increased patent ductus arteriosus treatment in ureaplasma-positive premature infants S. Kim; E. Jung; H. Kim; W. Sun Song; J. Hye Hwang; C. Young Kim; B.S. Lee; E. Ai-Rhan Kim; K.S. Kim (Korea) 62 62 2nd November, 2017 2nd November, 2017 63 63 13:30 – 14:30 POSTER SESSION 8 |FIRENZE ROOM 14:05 - 14:10 Experience of infants born with a diagnosis of (CARDIOLOGY + MICRO CIRCULATION 2) down syndrome in a tertiary neonatal centre: burden of disease and length of hospital stay Chairs: Mayka Bravo (Spain); Colm Breatnach (Ireland) T. Martin 1; A. Smith 1; C.R. Breatnach 1; E. Kent 1; I. Shanahan 1; M. Boyle 1; P.T. Levy 2; O. Franklin 1; A. EL-Khuffash 1 13:30 - 13:35 Resistence index (RI) of arteria cerebri anterior and cerebral (1. Ireland; 2. United States) oxygenation in preterm infants N. Baik-Schneditz; B. Urlesberger; B. Schwaberger; L. Mileder; 14:10 - 14:15 Influence of type of congenital heart defects on epithelial N. Höller; G. Pichler (Austria) lining fluid composition in infants undergoing cardiac surgery with cardiopulmonary-bypass 13:35 - 13:40 Influence of global hypoxia and remote ischemic M. Simonato; A. Baritussio; M. Salvagno; L. Vedovelli; G. Falasco; postconditioning on natriuretic peptide expression in V.P. Carnielli; M. Padalino; P. Cogo (Italy) newborn piglet heart chambers H. Kierkegaard; K.J. Kyng; B.S. Kousholt; S. Kerrn-Jespersen; 14:15 - 14:20 A randomised crossover study comparing speed of heart K. Bennedsgaard; M. Kjeldsen; N. Gregersen; R.K. Olsen; rate display in newborns using electrocardiogram plus pulse T.B. Henriksen (Denmark) oximeter versus pulse oximeter alone M. Murphy 1; L. De Angelis 2; E. Fitzgerald 1; L. McCarthy 1; 13:40 - 13:45 Arginase up-regulation and eNOS uncoupling contribute to C. O’Donnell 1 impaired endothelium-dependent vasodilation in a rat (1. Ireland; 2. Italy) model of intrauterine growth restriction I. Grandvuillemin 1; C. Buffat 1; F. Boubred1; E. Lamy 1; 14:20 - 14:25 Computer analysis of infant heart sound recordings J. Fromonot 1; A.C. Peyter 2; U. Simeoni 2; C. Yzydorczyk 2 D. Wertheim; K. Naicker; J. Chang; M. Chang; M. Rigby; A. Kumar; (1. France; 2. Switzerland) R. Kayyali (United Kingdom) 13:45 - 13:50 Low serum cortisol levels in asphyxiated infants with 14:25 - 14:30 Simulation hemodynamics Neocardiosim™ - haemodynamic instability perinatal and critical congenital heart scenarios K. Kovacs; E. Szakmar; U. Meder; A. Cseko; M. Szabo; A. Jermendy W. Blaz; A. Eberhardt; A. Szadkowska; B. Chmielarz; B. Zych; (Hungary) B. Andraka (Poland) 13:50 - 13:55 Changes of NT-PROBNP concentration wthin the first week of life in preterm newborns with birth body mass ≤ 1200g T. Talar; E. Gulczyńska; B. Cyranowicz; J. Moll (Poland) 13:30 – 14:30 POSTER SESSION 9 (INFECTIOUS DISEASE) |SORRENTO ROOM 13:55 - 14:00 Avoiding hypotension in preterm neonates (AHIP) – Chairs: Sam Oddie (United Kingdom); Chirstoph Bührer (Germany) a single-center randomised controlled study G. Pichler; N. Höller; N. Baik-Schneditz; B. Schwaberger; L. Mileder; A. Avian; J. Pansy; B. Urlesberger (Austria) 13:30 - 13:35 Maternal contribution to neonatal microbiota R.S. Procianoy 1; L.F. Roesch 1; A.L. Corso 1; V. Mai 2 ; R.C. Silveira 1 14:00 - 14:05 Two year outcomes in extremely preterm infants with (1. Brazil; 2. United States) differing blood pressure management P. Chisholm; A. Sinha; J. Tan; S. Kempley; A. Matthew; J. Banerjee; 13:35 - 13:40 Human breast milk supplies newborn infants with high J. Morris; N. Aladangady (United Kingdom) amounts of S100-alarmins protecting from sepsis S. Pirr; M. Richter; J. Pagel; C. Härtel; B. Fehlhaber; J. Roth; T. Vogl; D. Viemann (Germany) 64 64 2nd November, 2017 2nd November, 2017 65 65 13:40 - 13:45 Variability in immunological response to oropharyngeal 13:30 – 14:30 POSTER SESSION 10 (NEUROLOGY 1) colostrum administration in preterm newborn based on sex |LECCE ROOM E. Martin-Alvarez; L. Serrano-Lopez; J. Díaz-Castro; M. Peña-Caballero; M.B. Sánchez-Martínez; F. Martín-Peregrina; Chairs: Luca Ramenghi (Italy); Sandra Horsch (Germany) J.J. Ochoa; J.A. Hurtado-Suazo (Spain) 13:30 - 13:35 Longitudinal study of brain tissue volumes in preterm 13:45 - 13:50 Neonatal intestinal colonization with ESBL-producing infants and their relation with neonatal risk factors and enterobacteriaceae – a 5 year follow up study neurodevelopmental outcome V. Nordberg; K. Jonsson; C.G. Giske; A. Iversen; O. Aspevall; L. Gui; F. Lazeyras; P.S. Hüppi; C. Borradori (Switzerland) B. Jonsson; A. Camporeale; M. Norman; L. Navér (Sweden) 13:35 - 13:40 A new evaluation index for left-right unequal 13:50 - 13:55 Characterization of resistance plasmids during a nosocomial ventriculomegaly in very low birth weight infants: association epe-outbreak using optical DNA mapping with walking disabilities at 1.6 years of corrected age S. Kumar Bikkarolla; V. Nordberg; M. Humaun Kabir; V. Müller; T. Ikuta; M. Mizobuchi; Y. Katayama; S. Yoshimoto; T. Ioroi; T. Ambjörnsson; C.G. Giske; L. Navér; L. Sandegren; F. Westerlund M. Yamane; T. Morisawa; A. Takatera; M. Ueda; A. Shibata; (Sweden) K. Maeyama; K. Fujioka; N. Nishimura; K. Iijima; I. Morioka (Japan) 13:55 - 14:00 Long term follow up of hearing disorders in patients 13:40 - 13:45 Differences between intrauterine and extrauterine growth of with congenital cytomegalovirus infection the cerebellum A. Giannattasio; R. Alfani; P. Di Costanzo; D. Bruzzese; L. Bucci; A.I. Toma; I. Cuzino; A. Cozinov; R.G. Olteanu (Romania) M.R. Augurio; L. Capasso; F. Raimondi (Italy) 13:45 - 13:50 Prognostic value of early conventional proton magnetic 14:00 - 14:05 Outcomes of congenital cytomegalovirus disease following resonance spectroscopy in cooled asphyxiated newborns maternal primary and non-primary infection H. Barta; A. Jermendy; M. Kolossvary; L. R. Kozak; A. Lakatos; A. Giannattasio; S. Cenni; D. De Martino; T. Ferrara; L. Capasso; U. Meder; G. Rudas; M. Szabo (Hungary) E. Capone; P. Di Costanzo; F. Raimondi (Italy) 13:50 - 13:55 Autism spectrum disorder in ex-preterms is preceded by 14:05 - 14:10 The frequency of mannan-binding lectin (MBL) deficiency altered neonatal brain volumes in multimodal association in premature babies and the effect on long term morbidities areas and altered patterns of brain asymmetry H. Ozkan; P.Dogan; N. Koksal; B. Oral; O. Bagcı; I. Varal (Turkey) N. Padilla; E. Eklöf; G. Mårtensson; S. Bölte; H. Lagercrantz; U. Åden (Sweden) 14:10 - 14:15 The early onset risk calculator to evaluate early-onset sepsis in infants born ≥35 weeks gestation ≥35 weeks’ gestation 13:55 - 14:00 Characterisation of the neonatal corpus callosum (CC) using S. Stokes; R. Cuzzilla; A.J. Daley; S.E. Jacobs (Australia) MRI and cranial ultrasound (US) M. Mills; V. Pelling; L. Harris; J. Smith; H. Rabe; J.R. Fernandez Alvarez 14:15 - 14:20 HeRO as a tool for predicting morbidity and mortality in (United Kingdom) preterm infants with late onset sepsis admitted to tertiary level neonatal unit 14:00 - 14:05 Brain growth and relationships with illnesses and E. Hoyle; C. Dewhurst (United Kingdom) neurodevelopment outcome R. D’Ascenzo 1; B. Pieroni 1; A. Pianesi 1; A. Peretti 1 ; L. Regnicolo 1; 14:20 - 14:25 S100-alarmin-induced innate immune G. Polonara 1; M.J.N.L. Benders 2; V.P. Carnielli 1 programming protects newborn infants from sepsis (1. Italy; 2. The Netherlands) S. Pirr; T. Ulas; B. Fehlhaber; M.S. Bickes; T.G. Loof; T. Vogl; L. Mellinger; A.S. Heinemann; J. Burgmann; J. Schöning; S. Schreek; 14:05 - 14:10 Predicting the development of cerebral palsy: a comparison S. Pfeifer; F. Reuner; L. Völlger; M. Stanulla; between DTI-MRI and early hand assessment in infants with M. von Köckritz-Blickwede; S. Glander; K. Barczyk-Kahlert; unilateral perinatal brain injury C.S. von Kaisenberg; J. Friesenhagen; L. Fischer-Riepe; S. Zenker; B. van Gasselt; N. Wagenaar; C. Verhage; M.J.N.L. Benders; J.L. Schultze; J. Roth; D. Viemann (Germany) F. Groenendaal; L. de Vries; N. van der Aa (The Netherlands) 66 66 2nd November, 2017 2nd November, 2017 67 67 14:10 - 14:15 Low-grade IVH and low-grade CBH: which influence on 14:30 - 16:30 PARALLEL SESSION 19 (NUTRITION 3) Griffiths score at 2 years of age? A. Parodi; M. Malova; S. Uccella; L. Boeri; E. De Grandis; A. Sannia; NUTRITION OF THE ELBWI: M. Severino; G. Morana; D. Tortora; A. Rossi; E. Veneselli; IMPROVING NUTRITIONAL CARE |VENEZIA ROOM L.A. Ramenghi (Italy) Chairs: Alexandre Lapillonne (France); Mark Jonhson (United Kingdom) 14:15 - 14:20 Long-term effects of neonatal complications on brain growth at 10 years of age in children born 14:30 - 14:50 Electrolyte needs and balance in the EBLW, how to avoid extremely preterm disturbances Silvia Iacobelli (France) N. Padilla; C. Jimenez-Espinoza; H. Kvanta; U. Adén (Sweden) 14:20 - 14:25 Music effects in preterm infants’ brain: a structural 14:50 - 15:10 How to integrate enteral intake when administering neuroimaging investigation parenteral nutrition in ELBW infants? Sissel Moltu (Norway) J.R. Alves Sá de Almeida; N. Kunz; L. Lordier; A. Darque; F. Lazeyras; P. Hüppi (Switzerland) 15:10 - 15:30 Feeding strategies in neonates: the SIFT feeding trial Jon Dorling (United Kingdom) 14:25 - 14:30 Noise in the NICU Unit: Introducing a noise reduction policy to Southmead Neonatal Intensive Care Unit: primary results from a 3 month service improvement project 15:30 - 15:45 The Norwegian preterm infant gut (PINGU) study: a J. Hawksley; E. Helliwell; F. Emery (United Kingdom) metagenomic approach to gut microbiota composition and resistome in infants supplemented with probiotics E. Esaiassen; E. Hjerde; P. Cavanagh; T. Pedersen; J. Andresen; S. Rettedal; R. Støen; B. Nakstad; N.P. Willassen; C. Klingenberg 14:30 - 16:30 PARALLEL SESSION 18 (PULMONOLOGY 2) (Norway) VENTILATION SUPPORT |DARSENA ROOM 15:45 - 16:00 Assessment of enzymotherapy efficacy in case of lactase Chairs: Manuel Sanchez-Luna (Spain); Christian Poets (Germany) insufficiency in preterm infants O. Vlasova; L. Koliubakina (Ukraine) 14:30 – 15:00 Update on NIVM Corrado Moretti (Italy) 16:00 - 16:15 Detrimental mucosal effect of ibuprofen in the immature human intestine 15:00 – 15:30 Closed loop FiO2 controle E. Tremblay; E. Ferretti; M.P. Thibault; D. Grynspan; K.M. Burghardt; Nelson Claure (United States) M. Bettolli; C. Babakissa; E. Levy; J.F. Beaulieu (Canada) 15:30 – 16:00 Automated oxygen control in the NICU 16:15 - 16:30 Patched skin bilirubin assay to monitor extremely preterm Peter Dargaville (Australia) neonates undergoing phototherapy 16:00 – 16:15 Volume controlled or volume guarantee ventilation in D. De Luca; V. Dell’Orto (France) preterm infants: a randomised controlled trial H. Chitty; W. Tin; D. Stocken; R. Agbeko; J Vormoor; S. Sinha (United Kingdom) 16:15 – 16:30 Volume-targeted versus pressure-limited ventilation in neonates - a cochrane systematic review and meta-analysis updated 2017 C. Klingenberg 1; K.I. Wheeler 2; N. McCallion 3; C.J. Morley 4; P.G. Davis 2 (1. Norway; 2. Australia; 3. Irelands; 4. United Kingdom) 68 68 2nd November, 2017 2nd November, 2017 69 69 14:30 - 16:30 PARALLEL SESSION 20 |ROMA ROOM 16:00 - 16:15 Development and evaluation of e learning education to support breastfeeding in NICU NEONATAL ARDS: RECOGNISING THE W. Higman; L. Wallace; A. Turner; S. Law; K. Blake EXISTENCE OF A SYNDROME ACROSS THE AGE (United Kingdom) Scientific session endorsed by ESPR and ESPNIC Chairs: Luc Zimmerman (The Netherlands); Virgilio P. Carnielli (Italy) 14:30 - 16:30 PARALLEL SESSION 22 |SORRENTO ROOM 14:30 – 15:00 Physiopathology of ARDS across the ages OXYGENATION IN THE NEWBORN AND INFANT Peter Rimensberger (Switzerland) PERIOD 15:00 – 15:30 Biology of ARDS across the ages Chairs: Ola D. Saugstad (Norway); Robin Steinhorn (United States) Daniele De Luca (France) 14:30 – 15:00 Embryonic and fetal oxygenation and oxygen control 15:30 – 16:00 The Montreux definition of neonatal ARDS Satyan Lakshminrusimha (United States) Martin K. Kneyber (The Netherlands) 15:00 – 15:30 Oxygenation in the transition from fetal to newborn life 16:00 – 16:20 The fate of neonates with ARDS: the second phase of Maximo Vento Torres (Spain) neonatal ARDS project Anton van Kaam (The Netherlands) 15:30 – 16:00 Oxygen targets beyond the delivery room Ola D. Saugstad (Norway) 16:00 – 16:30 Oxygenation and growth in BPD 14:30 - 16:30 PARALLEL SESSION 21 (EFCNI 4) |FIRENZE ROOM Robin Steinhorn (United States) DIGITAL PATIENT CARE – THE NEW DIMENSION? Chairs: Silke Mader (Germany); Agnes Van Den Hoogen (Netherland); 14:30 - 16:30 PARALLEL SESSION 23 (BRAIN) BIOMARKERS IN TERM NEONATAL 14:30 - 14:50 Digital information – support or challenge? ENCEPHALOPATHY |LECCE ROOM Silke Mader (Germany) Chairs: Deirdre Murray (Ireland); Bobbi Fleiss (France) 14:50 - 15:10 Web camera use in the neonatal intensive care unit: 14:30 - 14:50 Biomarkers in neonatal brak injury: can a systems biology impact on nursing workflow approach lead us to the Holy Grail? Gillian Kennedy (United Kingdom) Deidre Murray (Ireland) 15:10 - 15:30 Using technology to continue Family Centred 14:50 - 15:10 Metabolic phenotyping to understand neonatal Care post discharge encephalopathy Alison McNulty (Ireland) Bobbi Fleiss (France) 15:30 - 15:45 Development and implementation of an integrated family 15:10 - 15:25 Depression during pregnancy and DNA methylation delivered neonatal care model including a parent support changes in cord blood mobile app A.C. Viuff 1; G. Sharp 2.; D. Raj 2; K.J. Kyng 1; L.H. Pedersen 1; J. Banerjee; A. Aloysius; K. Platonos; A. Deierl (United Kingdom) T.B. Henriksen 1; C.L. Relton 2 (1. Denmark; 2. United Kingdom) 15:45 - 16:00 Tablet based parental feedback in neonatal transport P. Bhat; C. Garland; A. Frame; G. Bullimore; L. Watts; C. Leach; C. Lawn (United Kingdom) 70 70 2nd November, 2017 2nd November, 2017 71 71 15:25 - 15:40 A novel cerebral ultrasound scoring system is 18:00 - 19:30 Enhancing the Success of Respiratory associated with neurological outcome in neonates with hypoxic-ischemic encephalopathy Management in nRDS|VENEZIA ROOM K. Annink; F. Groenendaal; M. Lequin; D. Vijlbrief; L. de Vries; Industry Supported session - please see page 126 M.J.N.L. Benders; J. Dudink (The Netherlands) Chair: Anton Van Kaam (The Netherlands) 15:40 - 15:55 Placental histology findings as possible risk factors for MRI-detected brain lesions in VLBW infants 18:00 - 18:30 BPD: from trials to clinical practice Wolfgang Göpel (Germany) A. Parodi; M. Re; D. Brignole; MP Brisigotti; M.G. Calevo; M. Malova; A. Sannia; M. Severino; G. Morana; D. Tortora; A. Rossi; E. Fulcheri; L.A. Ramenghi (Italy) 18:30 - 19:00 Less Invasive Surfactant Administration (LISA), a new chapter in neonatal management 15:55 - 16:10 MicroRNA panel validation in hypoxic schemic Peter Dargaville (Australia) encephalopathy M.P. O’Sullivan 1; A.M. Looney 1; G. Moloney 1; B. Hallberg 2; 19:00 - 19:30 Success of intervention: the importance of Training with LISA G. Clarke 1; G.B. Boylan 1; D.M. Murray 1 Maximo Vento Torres (Spain) (1. Ireland; 2. Sweden) 16:10 - 16:25 Phospholipid synthesis related biomarkers in plasma from newborns with hypoxic-ischemic encephalopathy M. Vento Torres; J. Kuligowski; Á. Sánchez-Illana; J.D. Piñeiro-Ramos; A. Núñez-Ramiro; M. Cernada; A. Parra; E. Valverde; D. Blanco; M.T. Moral-Pumarega; F. Cabañas; H. Boix; A. Pavon; M. Chaffanel; I. Benavente-Fernández; I. Tofe; B. Loureir (Spain) 16:30 - 17:00 COFFEE BREAK 17:00 - 18:00 PLENARY SESSION 5 |DARSENA ROOM WILL BIG DATA CHANGE THE FUTURE? Chairs: Manon Benders (The Netherlands); Pierre Gressens (France) 17:00 – 17:30 Using big data for cognitive computing approaches to personalised medicine for neonatal care Carolyn McGregor (Canada) 17:30 – 18:00 Big data and genetic encephalopathic epilepsy Michael Johnson (United Kingdom) 72 72 2nd November, 2017 2nd November, 2017 73 73 DARSENA VENEZIA ROMA FIRENZE SORRENTO LECCE NAPOLI ROOM ROOM ROOM ROOM ROOM ROOM ROOM (Mosaici 1) (Mosaici 2) GROUND FLOOR GROUND FLOOR GROUND FLOOR GROUND FLOOR THIRD FLOOR THIRD FLOOR GROUND FLOOR 08:00 08:00 POSTER WALK EBN Business Meeting POSTER WALK 09:00 09:00 Parallel Parallel Parallel Parallel Parallel PULMONOLOGY Session 24 Session 25 Session 26 Session 27 Session 28 SECTION MEETING Stress and (BRAIN 5) (PHARMA 2) (CIRCULATION 3) (EFCNI 4) development Neuroprotection New insights in future Training guidelines Measuring quality of EPO trial neonatal care for Neonatologist care in neonatal care Performed Echo- 11:00 cardiography (NPE) 11:00 COFFEE BREAK - an intercontinental COFFEE BREAK 11:30 debate 11:30 IPRF PLENARY SESSION 6 12:30 12:30 LUNCH BREAK 13:30 13:30 POSTER SYMPOSIUM POSTER POSTER POSTER POSTER SESSION 11 Human Milk SESSION 12 SESSION 13 SESSION 14 SESSION 15 NEUROLOGY 2 Fortification: benefits EPIDEMIOLOGY NUTRITION 2 LUNG 4 ETHICS + PERINATAL of an exclusive human PRACTICE milk diet for premature infants 15:00 15:00 Parallel Parallel Parallel Parallel Parallel Parallel CIRCULATION Session 29 Session 30 Session 31 Session 32 Session 33 Session 34 SECTION MEETING (BRAIN 6) (PULMONOLOGY 4) (EPIDEMIOLOGY 2) Children Born Preterm IUGR across COINN Global Congenital brain Pharmacology of lung Perinatal perspcetives in SPECIALITIES infections protection epidemiology neonatal care 17:00 17:00 COFFEE BREAK 17:30 17:30 PLENARY ESPR Business Meeting SESSION 7 The Need of multidisciplinary 18:30 approaches in 18:30 research 19:30 19:30 Up to 35% Special Congress Discount 08:00 – 09:00 POSTER WALK | GROUND FLOOR Neonatal Hematology and Bilirubin Chairs: Elsa Kermorvant (France) World Review of Nutrition and Dietetics Editor: B. Koletzko Vol. 110 Nutritional Care of Editor Z. Hochberg Preterm Infants ID 020 PROLONGED JAUNDICE SCREENING: FBC OR NO FBC! N. Storring; R. Doherty; V. Ponnusamy (United Kingdom) Practical Scientific Basis and Practical Guidelines Editors B. Koletzko Algorithms in B. Poindexter R. Uauy dexter ID 042 LABORATORY FINDINGS; DIAGNOSIS AND TREATMENT OF THE Pediatric NEWBORN ADMITTED DUE TO HEMATEMESIS OR BLOODY STOOL IN 11 YEARS Endocrinology 3rd, revised edition I. Hokuto; Y. Ito; T. Mori; S. Komachi (Japan) ID 154 AN UNUSUAL CAUSE OF CYANOSIS: SEVERE METHEMOGLOBINEMIA Practical Algorithms in Pediatrics Series Editor: Z. Hochberg IN A PRETERM INFANT WITH SEPSIS Editor: Z. Hochberg (Haifa) Editors: Koletzko, B. (Munich); Poindexter, B. List price: CHF 53.00 / EUR 50.00 / USD 62.00 (Indianapolis, Ind.); Uauy, R. (Santiago de Chile) F. Bakar; M. Berber (Turkey) Special offer: CHF 42.00 / EUR 40.00 / USD 50.00 List price: CHF 148.00 / EUR 138.00 / USD 174.00 ISBN 978–3–318–05917–5 Special offer: CHF 96.00 / EUR 90.00 / USD 113.00 ID 171 THE INFLUENCE OF INTRAUTERINE TRANSFUSION ON THE OUTCOMES ISBN 978–3–318–02640–5 (hard cover) OF NEWBORNS WITH SEVERE HEMOLYTIC DISEASE Order at: www.karger.com/pape Order at: E. Balashova; O. Bystrykh; T. Fedorova; O. Ionov; A. Kirtbaya; and use the promotional code: DPAPE17 www.karger.com/wrund D. Sharafutdinova; V. Zubkov; D. Degtyarev; O. Horoshkeeva; N. Fedorova; and use the promotional code: DJENS17 N. Tetruashvili; K. Kostukov; N. Karetnikova (Russia) Pediatric and Adolescent Medicine ID 491 IV FLUID SUPPLEMENTATION IN SEVERE NEONATAL SickKids Handbook Editor: W. Kiess HYPERBILIRUBINEMIA: YES or NO Vol. 18 of Pediatric Thrombosis and Hemostasis Neonatal M.T. Saleh; S. El Doory; S. Saleh; M.E.l. Halik (Saudi Arabia) Pharmacology and Editors Nutrition Update ID 543 RIGHT SUBCLAVIAN ARTERY THROMBOSIS. A CASE REPORT Victor S. Blanchette Leonardo R. Brandão Vicky R. Breakey G. Uclés; T. Fuentes; R. Villarino; M. González-Valcárcel; A. Martínez (Spain) Editors Shoshana Revel-Vilk 2nd, revised and extended edition F.B. Mimouni BMA Med J.N. van den Anker ical Book Awards 20 17 ‘highly co in Paedia mmende d’ ID 555 RISK FACTORS FOR PORTAL VENOUS THROMBOSIS IN NEWBORNS: trics A RETROSPECTIVE STUDY A. Zanin; M. Colella; C. Farnoux; S. Soudee; M. Leport; R. Stern; O. Bequet; M. Alison; V. Biran; O. Baud (France) Editors: V.S. Blanchette (Toronto, Ont.); L.R. Brandão Editors: Mimouni, F.B. (Tel Aviv); van den Anker, J.N. ID 611 RELATIONSHIP BETWEEN LEUKOCYTES AND PLATELETS AND (Toronto, Ont.); V.R. Breakey (Hamilton, Ont.); (Washington, D.C./Basel/Rotterdam) PREMATURE RETINOPATHY S. Revel-Vilk (Jerusalem) List price: CHF 126.00 / EUR 118.00 / USD 148.00 V. Filip; C. Lazar (Romania) List price: CHF 127.00 / EUR 119.00 / USD 149.00 Special offer: CHF 82.00 / EUR 77.00 / USD 96.00 Special offer: CHF 83.00 /EUR 77.00 / USD 97.00 ISBN 978–3–318–02735–8 (hard cover) ISBN 978–3–318–03026–6 ID 692 CONGENITAL HEPATOCELLULAR CARCINOMA ASSOCIATED WITH Order at: NEONATAL HEMOCHROMATOSIS Order at: www.karger.com/pamed P. Francalanci; C. Grimaldi; M.C. Saffioti; R. Angelico; R. Boldrini; F. Callea www.karger.com/sickkids and use the promotional code: DJENS17 and use the promotional code: DJENS17 (Italy) Special offers include the digital version. Prices subject to change, VAT not included. EUR price for eurozone countries, USD price for USA and Latin America only ID 740 OUTCOME OF BABIES WITH SERUM BILIRUBIN LEVEL OF GREATER THAN 400mmol/L R. Prasad; S.V. Rasiah (United Kingdom) Karger – Medical and Scientific Publishers CH–4009 Basel, Switzerland KI17451
[email protected], f: +41 61 306 12 34 Medical and Scientific Publishers www.karger.com 74 74 3rd November, 2017 75 75 Neurology ID 094 NEONATAL ADMISSIONS FOR HYPOXIC ISCHEMIC Chairs: Nicola Roberston (United Kingdom) ENCEPHALOPATHY: WEEKEND AND OUT OF HOURS EFFECT F. Ceroni; M. Parmar; S. Narayanan; N. Merchant (United Kingdom) ID 003 PRETERM BIRTH AND THE TIMING OF PUBERTY E. James; C. Wood; H. Nair; T. Williams (United Kigdom) ID 100 WHICH PARTS OF GROWTH SHOULD BE MONITORED FOR NEURODEVELOPMENT OF PRETERM INFANTS ID 036 PREVENTION OF CEREBRAL PALSY: FEASIBILITY OF UMBILICAL CORD I.G. Song; H.R. Yoon; Y.M. Yoon; J.S. Shin; S.H. Shin; E.K. Kim; H.S. Kim (Korea) BLOOD STEM CELLS AND UMBILICAL CORD MESENCHYMAL STROMAL CELLS ID 103 TARGETED METHYLATION TESTING OF A 154 PATIENT’S COHORT WITH H. Shintaku; M. Nabetani; T. Hamazaki; S. Kusuda; M. Tamura; S. Watabe; CLINICAL FEATURES OF IMPRINTING DISORDERS: EVIDENCE OF M. Hayakawa; Y. Sato; M. Tsuji; A. Taguchi; H. Ichiba; O. Akira; R. Mori; MULTILOCUS METHYLATION DEFECTS A. Taki; T. Mukai; T. Nagamura-Inoue (Japan) A. Touati; S. Nouri; F. Chioukh; M. Haddaji Mastouri; N. Ben Salah; S. Trabelsi; S. Hammami; S. Mougou; M. Gribaa; N. Guedich; H. Seboui; A. Nouri; ID 039 NO GENDER-RELATED DIFFERENCES IN FETAL CORPUS CALLOSUM K. Monastiri; A. Saad; D. H’mida-Ben Brahim (Tunisia) THICKNESS: IN-UTERO MRI STUDY R. Bercovitz; R. Achiron; C. Hoffmann; A. Achiron (Israel) ID 105 STEINERT MYOTONIC DYSTROPHY (DM1): WHAT ABOUT CARDIAC INVOLVEMENT? ID 040 NEUROMOTOR PROFILE OF HIGH-RISK INFANTS AT TERM OR NEAR H. Hadj Abdallah; Y. Halleb; N. Ben Salah; F.Z. Chioukh; K. Ben Ameur; TERM F. Kallel; L. Ben Slamia; S. Hidar; M. Bellallah; S. Nouri; S. Ben Amor; A. Hsin; I. Ereno; W.Y. Teh (Singapore) M. Grira; H. Ajmi; S. Zardi; S. Abroug; N. Mahdhaoui; H. Sboui; S. Ben Ammou; K. Mestiri; A. Saad; D. H’mida (Tunisia) ID 043 THE PREDICTIVE VALUE OF SEVERE BRONCHOPULMONARY DYSPLASIA FOR NEUROLOGICAL IMPAIRMENT IN 2-YEARS-OLD VERY PRETERM ID 150 HEAD MIDLINE POSITION FOR THE PREVENTION OF GERMINAL INFANTS IS HIGHER WHEN DIAGNOSED AT 40 THAN AT 36 WEEKS’ MATRIX-INTRAVENTRICULAR HEMORRHAGE IN PRETERM INFANTS: POSTMENSTRUAL WEEKS A SYSTEMATIC REVIEW AND META-ANALYSIS A.M. Malavolti 1; D. Bassler 1; R. Arlettaz-Mieth 1; G. Faldella 2; B. Latal 1 O. Romantsik 1; M.G. Calevo 2; M. Bruschettini 1 G. Natalucci 1 (1. Sweden; 2. Italy) (1. Switzerland; 2. Italy) ID 157 MOTOR FUNCTION AT EARLY SHCOOL-AGE IN EXTREMELY PRETERM ID 055 PSYCHOSOCIAL OUTCOME OF INFANTS WITH CONGENITAL BORN CHILDREN WITHOUT MAJOR IMPAIRMETNS IN RELATION TO MALFORMATIONS AFTER POSTNATAL SURGICAL REPAIR PERINATAL FACTORS: NATIONAL POPULATION-BASED STUDY N. Doberschuetz; A. Allendorf; R. Dewitz; B. Wittekindt; U. Rolle; R. Schloesser (EXPRESS) (Germany) J. Bolk; A. Farooqi; M. Hafström; U. Åden; F. Serenius (Sweden) ID 060 THERAPEUTIC HYPOTHERMIA AND HEARING IMPAIRMENT: INCIDENCE ID 169 EARLY RISK FACTORS FOR ADVERSE NEUROMOTOR DEVELOPMENT IN AND ASSOCIATED FACTORS TERM INFANTS AFTER MODERATE HYPOXIC-ISCHAEMIC M. PFitzgerald; G. Norman; C. Mc Garvey; A. Reynolds; M. King; B. Hayes ENCEPHALOPATHY (Ireland) A. Matic (Serbia) ID 070 PRETERM INFANTS 33-35 WEEKS’ GESTATION WITH SEVERE HYPOXIC- ID 175 THERAPEUTIC HYPOTHERMIA IN BABIES WITH HYPOXIC-ISCHAEMIC ISCHEMIC ENCEPHALOPATHY TREATED WITH HYPOTHERMIA DO NOT ENCEPHALOPATHY: EVIDENCE AND CLINICAL PRACTICE PRESENT MORE ORGAN DYSFUNCTION THAN TERM NEWBORNS K. Ghazal; A. Panickar; S. Garg (United Kingdom) M. Alsina; A. Martin-Ancel; M. Leon; G . Arca; E. Perez; A. García-Alix (Spain) ID 196 SECRETONEURIN SERUM CONCENTRATIONS CORRELATE WITH ID 080 IMPACT OF ENVIRONMENTAL FACTORS ON MOTOR AND COGNITIVE ABNORMAL NEURODEVELOPMENTAL OUTCOME AT THE AGE OF 24 PERFORMANCE OF LATE PRETERM INFANTS. MONTHS IN TERM NEONATES WITH ASPHYXIA M.M. Santos; C. Corsi; A.C. Campos; N.A.C.F. Rocha (Brazil) K. Wechselberger; A. Schmid; M. Höck; A. Posod; M. Urbanek (Austria) ID 206 SCREENING C677T POLYMORPHISM IN METHYLENETETRAHYDROFOLATE REDUCTASE GENE IN TAIWAN POPULATION C.Y. Chuang; C.C. Hung; Y.N. Su; P.N. Tsao (Taiwan) 76 76 3rd November, 2017 3rd November, 2017 77 77 ID 230 COGNITIVE OUTCOME IN ADULTS BORN WITH VERY LOW BIRTH ID 484 EARLY CRANIAL ULTRASOUND AND MRI AT TERM IN VERY WEIGHT OR SMALL FOR GESTATIONAL AGE PRETERM INFANTS: DIAGNOSIS OF BRAIN INJURY VERSUS S. Weider; A.M.W. Lærum; K. AI Evensen; S. Lydersen; A.M. Brubakk; NEURODEVELOPMENTAL OUTCOME AT 12 AND 24 MONTHS M.S. Indredavik (Norway) CORRECTED GESTATIONAL AGE K. Chatzidimitriou; A. Chebsey; D. Odd; M. El Brookle; M. Likeman; A. Heep ID 281 REACHING SKILLS OF INFANTS BORN VERY PRETERM PREDICT (United Kingdom) NEURODEVELOPMENT AT 3 YEARS Y. Fredriksson Kaul; K. Rosander; H. Grönqvist; K. Strand Brodd; ID 485 CRANIAL ULTRASOUND AT DAY 7 AND CLINICAL MRI AT L. Hellström-Westas; C. von Hofsten (Sweden) TERM IN VERY PRETERM INFANTS BORN AT LESS THAN 28 WEEKS: VENTRICULOMEGALY IS RELATED TO SUBTLE BRAIN PATHOLOGY AND ID 315 UNDERSTANDING ADHD AND ASD IN VERY PRETERM CHILDREN FROM UNFAVORABLE DEVELOPMENTAL OUTCOME AT 24 MONTH A SENSORY PROCESSING PERSPECTIVE: A CONTROLLED K. Chatzidimitriou; A Chebsey; D. Odd; M. El Brookle; M. Likeman; A. Heep NEUROPSYCHOLOGICAL STUDY (United Kingdom) T. Bröring; K. Oostrom; M. Königs; E. van Dijk-Lokkart; H. Lafeber; A. Brugman; J. Oosterlaan (The Netherlands) ID 502 VALIDITY OF THE KOREAN DEVELOPMENTAL SCREENING TEST FOR VERY LOW BIRTH WEIGHT INFANTS ID 319 SOCIAL-EMOTIONAL DEVELOPMENT IN VERY PRETERM INFANTS C.Y. Kim; J.H. Hwang; E. Jung; B.S. Lee; K.S. Kim; A.R. Kim (Korea) DURING EARLY INFANCY P.H. Gray; D.M. Edwards; M. Pritchard (Australia) ID 547 CYTOKINES TRAJECTORIES IN NEWBORNS WITH HYPOXIC-ISCHEMIC ENCEPHALOPATHY: THE ROLE OF HYPOTHERMIA ID 323 NEUROPROTECTIVE INTERVENTION AFTER HYPOXIA-ISCHEMIA MAY S. Perrone 1; S. Cornacchione 1; M.D. Weiss 2; R. Candace 2; M. Longini 1; CHANGE INTRACEREBRAL METABOLIC MEASURES IN A NEWBORN F. Proietti 1; M. Calderisi 1; G. Buonocore 1 PIGLET MODEL (1. Italy; 2. United States) T.C. Andelius; N. Bøgh; M.V. Pedersen; C. Omann; V.E. Hjortdal; M. Pedersen; T.B. Henriksen; K.J. Kyng (Denmark) ID 563 COLD-INDUCIBLE RBM3 AUGMENTS IGF2 EXPRESSION IN NEURAL STEM CELLS BY INTERACTING WITH IMP2 IN AN RNA-DEPENDENT ID 353 BRAIN VOLUMES BY CEREBRAL MRI AND CORRELATIONS WITH MANNER PSYCHIATRIC SYMPTOMS IN LOW BIRTHWEIGHT ADULTS J. Yan; X. Zhu; Z. Andrea; J. Kapfhammer; S. Wellmann (Switzerland) A.M.W. Lærum; L.M. Rimol; S.K. Reitan; A. Brubakk; K.A.I. Evensen; K.J. Bjuland; S. Lydersen; J. Skranes; M.S. Indredavik (Norway) ID 591 CHILDREN BORN VERY PRETERM WITH AUTISM EXPERIENCE INCREASED RISK OF PARENTING RELATIONSHIP PROBLEMS ID 371 POSTURE AND MOBILITY INFLUENCE ON ATTENTION ABILITIES IN H. Haydon; M. Pritchard; L. Johnston; J. Paynter (Canada) HEALTHY 7 YEARS OLD CHILDREN H. Ceyte; J. Rosenbaum; S. Caudron; J-M. Hascoet (France) ID 596 STABILITY of AUTISM DIAGNOSIS IN CHILDREN BORN VERY-PRETERM FROM AGE 2 TO 4 YEARS ID 424 SURGICAL DECISION MANAGEMENT IN CHIARI TYPE 2 M. Pritchard; H. Haydon; T. de Dassel; E. Beller; F. Bogossian; L. Johnston; MALFORMATION: SINGLE CENTER EXPERIENCE J. Paynter; S. Russo; J.G. Scott (Canada) S. Alkan Ozdemir; N. Ozdemir; A. Karadag; E. Arun Ozer (Turkey) ID 620 OUTBORN PRETERM INFANTS WITH POST-HAEMORRHAGIC ID 427 EFFECTS OF NEURAL STEM CELL MEDIA ON HYPOXIC INJURY IN RAT VENTRICULAR DILATATION: ARE THEY TRANSFERRED TOO LATE? HIPPOCAMPAL SLICE CULTURES A. Parodi; M. Malova; A. Sannia; A. Cama; M. Ravegnani; C. Bellini; N.M. Lee; S.A. Chae; H.J. Lee (Turkey) L.A. Ramenghi (Italy) ID 438 CEREBROSPINAL FLUID LACTATE IN NEW-BORN AND PRETERM ID 631 GENETIC CASUSES IN NEWBORNS WITH EPILEPTIC ENCEPHALOPATHIES INFANTS. PILOT DATA A. Soltirovska Salamon; D. Paro-Panjan (Slovenia) G. Uclés; D. Arjona; R. Borrego; R. Díaz; M.D. Sánchez-Redondo; A. Escobar (Spain) ID 643 OUTCOME AT FIVE YEARS OLD IN A SWISS NATIONAL COHORT OF VERY PRETERM INFANTS BORN IN 2006 M.P. Pittet; M. Adams; M. Bickle-Graz; S. Grunt; I. Mürner-Lavanchy; R.E. Pfister; G. Natalucci; C. Borradori Tolsa (Switzerland) 78 78 3rd November, 2017 3rd November, 2017 79 79 ID 680 OUTCOME PREDICTION IN HIE GRADE II NICU Quality Improvement, K. Goeral; B. Urlesberger; V. Giordano; G. Kasprian; M. Wagner; L. Schmidt; A. Berger; K. Klebermass-Schrehof; M. Olischar (Austria) Family Centre Care Chairs: Hugo Lagercrantz (Sweden) ID 696 COMPARISON OF 1-DIMENSIONAL AND 2-DIMENSIONAL SONOGRAPHIC (US) AND MRI MEASUREMENTS OF THE CEREBELLUM ID 026 PRETERM INFANTS WITH MEDICAL COMPLEXITY: IMPATC ON HEALTH IN TERM NEWBORNS CARE RESSOURCE USE; FAMILY EMPLOYMENT AND B. Reulecke; R. Fernandez; M. Mills; V. Pelling; H. Rabe; L. Harris NEURODEVELOPMENTAL OUTCOMES (United Kingdom) D. Nassel 1,2; C. Chartrand 2 ; M-J. Doré-Bergeron2; M. Ballantyne 2; F. Lefebvre 2; T.M. Luu 2 ID 713 MILD HYPOXIC ISCHAEMIC ENCEPHALOPATHY AND LONG TERM (1. Belgium; 2. Canada) NEURODEVELOPMENTAL OUTCOME- A SYSTEMATIC REVIEW J. Conway 1,2; B.H. Walsh 3; M. Dozier 2; G.B. Boylan 1; D.M. Murray 1 ID 046 BREAST MILK DONATION IN THE MUSLIM POPULATION (1. Ireland; 2. United Kingdom; 3. United States) S. Jebali; E. Ayachi; R. Terki Hassaine; A. Giuseppi; D. Vaiman; S. Brunet; V. Rigourd (France) ID 722 NEURODEVELOPMENTAL AND SENSORY OUTCOME AT TWO YEARS IN VLBW BABIES: CORRELATIONS WITH BRAIN LESIONS DETECTED AT ID 065 TO DETERMINE HOW MANYMOTHERS OF PRETERM BABIES WHO WERE TERM MRI DELIVERED BETWEEN 24 AND 34 WEEK GESTATION AND WERE M. Malova; L. Ceschi; C. Traggiai; S. Uccella; A. Parodi; A. Sannia; L. Boeri; ADMITTED TO NEONATAL UNIT AT ST.MARY’S HOSPITAL; DID NOT E. De Grandis; M. Severino; G. Morana; D. Tortora; M.G. Calevo; A. Rossi; RECEIVE ANTENATAL STERIOD E. Veneselli; C. Bellini; L.A. Ramenghi (Italy) Arunoday; A. Manou; I. Sadasivam (United Kingdom) ID 818 PERSISTENT MONOCYTE AND NEUTROPHIL ACTIVATION IN SCHOOL ID 085 MOVING BABIES: A CALENDAR YEAR OF TRANSPORT TO AND FROM AGE CHILDREN POST NEONATAL ENCEPHALOPATHY A REGIONAL NEONATAL CENTRE Z. Zareen; V. Mc Eneaney; N.A. Taher; L. Kelly; D. Sweetman; D. Doherty; C.M. Moore; M. Cassidy; M. Byrne; A. Bowden; J. Franta; I. Farombi; E.J. Molloy (Ireland) J.J. Fitzsimons (Ireland) ID 831 ARE THE 2 YEAR GRIFFITHS SCORES OF BABIES WITH CBH AND IVH ID 144 REDUCING THE WASTAGE OF PAEDIATRIC RED CELLS SIGNIFICANTLY DIFFERENT COMPARED TO THOSE OF BABIES C.C. Roehr; J. Staves; S. Hemmatpour; N. Mohanraj; S. Pavord SUFFERING FROM ISOLATED IVH? (United Kingdom) S. Uccella; A. Parodi; M. Malova; L. Boeri; E. De Grandis; C. Traggiai; A. Sannia; M. Severino; G. Morana; D. Tortora; A. Rossi; E. Veneselli; ID 155 ACCURATE DETECTION OF CEREBROSPINAL FLUID FROM THE TIP OF L.A. Ramenghi (Italy) INJEQ IQ-NEEDLE(TM) IN PEDIATRIC LUMBAR PUNCTURE – PRELIMINARY RESULTS OF CLINICAL STUDY ID 836 INCIDENCE AND CHARACTERISTICS OF INFANTS WITH RETINOPATHY S. Halonen; J. Kari; O. Tammela; K. Kronström; V. Eskola (Finland) OF PREMATURITY IN CROATIA M. Vucinovic; L.J. Znaor; A. Vucinovic (Croatia) ID 235 CONSERVATIVE TREATMENT OF IATROGENIC PERFORATIONS CAUSED BY GASTRIC TUBES IN EXTREMELY LOW BIRTH WEIGHT ID 873 NEUROPROTECTIVE DRUGS IN INFANTS WITH A CONGENITAL HEART INFANTS – EXPERIENCE OF A SINGLE CENTER DISEASE REQUIRING CARDIAC SURGERY WITH CARDIOPULMONARY M. Thanhaeuser; A. Repa; A. Berger; N. Haiden (Austria) BYPASS: A SYSTEMATIC REVIEW R. Stegeman; K.D. Lamur; A. van den Hoogen; J. (H.) M.P.J. Breur; ID 270 SCARRED FOR LIFE? F. Groenendaal; N.J.G. Jansen; M.J.N.L. Benders (The Netherlands) M. Kristiansen; C-A. Olsson Mägi (sweden) ID 884 NEUROPHYSIOLOGICAL; NEURORADIOLOGICAL AND ID 272 HOW CAN NEONATAL NURSES ENHANCE PARENT-INFANT BOND BY NEUROPATHOLOGICAL FINDINGS IN LETHAL NEONATAL RIGIDITY EMPOWERING PARENTS AND MULTIFOCAL SEIZURES SYNDROME ASSOCIATED WITH BRAT1 M.J. Ravn; J.B. Wigdel (Norway) MUTATIONS M-C. Cornet; R. Schubert; E. Huang; J. Shimotake; O. Danhaive; J. McGuire; ID 348 THE EFFECT OF BATHING AT TWO DIFFERENT TIMES ON BODY M-R. Cilio (United States) TEMPERATURE AND SKIN MOISTURE LEVEL IN NEWBORNS D. Gözen; S. Yalnızoğlu Çaka; S. Ateş Beşirik; Y. Perk (Turkey) 80 80 3rd November, 2017 3rd November, 2017 81 81 ID 370 THE FIRST MINUTES WHEN MY EXTREMLY PRETERM INFANT WAS BORN ID 742 SHORT AND LONG TERM OUTCOMES RELATED TO C. Israelsson; F. Thorolfson (Sweden) UMBILICAL VENOUS CATHETER PLACEMENT IN PRETERM INFANTS L. Arques; R. del Rio; C. Balcells; E. Inarejos; V. Aldecoa-Bilbao; ID 386 NEUROPROTECTIVE DEVELOPMENTAL CARE: STATE OF KNOWLEDGE I. Iglesias-Platas (Spain) AND IMPLICATIONS FOR PRACTICE A. Lavallée; G. De Clifford-Faugère; A. N. Fernandez Oviedo; C. Garcia; ID 756 ACHIEVING NORMOTHERMIA IN INFANTS ADMITTED TO THE M. Héon; M. Aita (Canada) NEONATOLOGY DEPARTMENT-A QUALITY IMPROVEMENT PROJECT AT THE KAROLINSKA UNIVERSITY HOSPITAL ID 446 EVALUATION OF PROLONGED PAIN IN PRETERM INFANTS WITH K. Jonsson; A. Gudmundsdottir; A. Chakhunashvili; A-S. Ingman; PNEUMOTHORAX USING HRV ANALYSIS AND EDIN SCORES C. Branvik-Ingelsson; E. Wilson; I. Edqvist; M. Viberg; B. Hallberg; M. Breindahl M. Buyuktiryaki; N. Uras; N. Okur; M.Y. Oncel; G. Kadioglu Simsek; S. Isik; (Sweden) S.S. Oguz (Turkey) ID 776 PERSONALITY TRAITS AND STYLES OF COPING WITH STRESS AMONG ID 487 COST-EFFECTIVENESS OF TRANSCUTANEOUS BILIRUBIN (TcB) MIDWIVES MONITORING IN A GROWING HEALTH ECONOMY B. Zych; W. Blaz; M. Muster; M. Mazur-Magoła; G. Raba (Poland) L. Mohammed; B.N. Ofoegbu (Saudi Arabia) ID 784 EVALUATING MATERNAL CLOSSENESS AND SEPARATION IN NICU. ID 495 IMPROVING THE QUALITY OF DISCHARGE IN BABIES WITH DOWN GUIDELINES FOR THE CREATION OF PERINATAL CENTERS SYNDROME A. Karkani; K. Kwnstadinidi; M. Theodoraki; S. Gancheva; M. Papadopoulou C.M. Moore; S.M. Eldaw; M. McCormack; J.J. Fitzsimons (Ireland) (Greece) ID 582 NOT A MONITORING PROBE LESION ID 823 ENHANCING NEONATAL AND PARENTAL OUTCOMES THROUGH THE A. Olariu; S.Nallagonda; J. Egyepong (United Kingdom) OPTIMIZATION OF EVIDENCE-BASED NURSING PRACTICES M. Aita; S. Semenic; N. Feeley; L. Haiek; M. Héon; A. Larone Juneau; ID 605 QUALITY IMPROVEMENT PROJECT: TOWARDS NEONATAL K. Levasseur; G. Roch; L. Talbot (Canada) MANAGEMENT OF PREGNANCIES COMPLICATED BY POLYHYDRAMNIOS ID 856 WHAT DOES THE PREMATURE BABY’S PARENTS FEEL AND HOW DOES R. Mardare; A. Olariu; M. Noureldein; J. Egyepong (United Kingdom) THEY SEE THE STAFF TAKING CARE OF THEIR CHILD? A. Bialas (Poland) ID 632 SITUATIONAL FAMILY INTERACTION N. Betzelos; J. Nilsson; J. Högström; M. Corrias; S. Lilliesköld; M. Norman; ID 861 CROSS-CULTURAL ADAPTATION AND VALIDATION OF THE NEONATAL K. Bohlin (Sweden) INFANT PAIN SCALE (NIPS) FOR BRAZILIAN PORTUGUESE G. de Cássia Pinheiro da Motta; M.L. Chollopetz da Cunha (Brazil) ID 695 MILK ANALYSIS USING MILK ANALYZERS IN A STANDARDIZED SETTING (MAMAS) STUDY ID 864 EARLY OUTCOME OF NEONATES AFTER CONTINUOUS G. Fusch 1; C. Kwan 1; N. Rochow 1; M. Belfort 2; J. Festival 1; A. Hair 2; AMNIOINFUSION VIA A SUBCUTANEOUSLY IMPLANTED PORT SYSTEM J-M. Hascoet 3; T. Kuehn 4; MIRIS 5; M. Nelle 6; D. O’Connor 1; G. Pelligra 1; WITH PPROM AND ANHYDRAMNIOS <28 + 0 WEEKS OF GESTATION B. Poindexter 2; B. Urlesberger 7; A. Wesolowska 8; C. Fusch 1,4 (FIRST EXPERIENCES IN RUSSIA) (1. Canada; 2. United States; 3. France; 4. Germany; 5. Sweden; Y. Naberezhnev 1; M. Beluga 2; O. Golovchenko 2; E. Golosovsky 2; 6. Switzerland; 7. Austria; 8. Poland) M. Tchirikov 1 (1. Germany; 2. Russia) ID 705 A SYSTEMATIC REVIEW OF THE EFFECTIVENESS OF INTERVENTIONS DURING NICU HOSPITALIZATION ON THE SHORT-TERM ID 865 EVALUATION OF DYNAMIC THIOL-DISULFIDE HOMEOSTASIS IN NEURODEVELOPMENT OF PRETERM INFANTS HEALTHY VERY LOW BIRTH WEIGHTED PRETERMS M. Aita; R. Stremler; N. Feeley; A. Lavallée; G. De Clifford-Faugère (Canada) S. Unal; D. Ulubas Isik; A. Yagmur Bas; S. Erol; İ. Arifoglu; M. Alisik; O. Erel; N. Demirel (Turkey) ID 731 SAFETY CULTURE ASSESSMENT IN A NEONATAL UNIT FOLLOWING A PLAN TO IMPROVE PATIENT SAFETY ID 867 THE EFFECT OF THE MODE OF DELIVERY ON THE MATERNAL AND M. Arriaga-Redondo; A. Rodriguez-Sanchez de la Blanca; E. Sanz-Lopez; NEONATAL DYNAMIC THIOL-DISULFIDE HOMEOSTASIS A. Diaz-Redondo; R. Gregorio-Hernandez; P. Chimenti-Camacho; D. Ulubas Isik; Y. Akdaş Reis; A. Yagmur Bas; S. Unal; B. Özcan; M. Sanchez-Luna (Spain) L. Mollamahmutoglu; S. Neşelioglu; O. Erel4; N. Demirel (Turkey) 82 82 3rd November, 2017 3rd November, 2017 83 83 ID 870 READMISSION RATES IN THE FIRST MONTH FOLLOWING DISCHARGE ID 355 INFANTS AND MATERNAL OUTCOME OF PREGNANCIES AMONG BABIES DISCHARGED FROM THE NEONATAL SERVICE: COMPLICATED BY H1N1 INFECTION NEEDING ECMO THERAPY: A SINGLE CENTRE EXPERIENCE A UK ECMO CENTRE EXPERIENCE R. Calthorpe; A.M. Mustafa Kamal; D. Jayasinghe (United Kingdom) N. Singh; J. Behrsin; F. Siddiqui; R. Porter; M. Charlton; A. Akuma; S. Mittal (United Kingdom) ID 871 SOUNDS MEASUREMENTS IN A WARD TO IMPROVE THE NICU ENVIRONMENT ID 447 THE ASSOCIATION OF NEONATAL MORBIDITIES AND MORTALITY OF A-A. Vinaixa Vergés; J. Romeu Garbí; M. Nicolau Manzano; PRETERM INFANTS WITH DIFFERENT COURSES OF ANTENATAL STEROIDS P. Morales De Mata; R. Puigarnau Vallhonrat; E. Quintana Rio; M. Buyuktiryaki; F.N. Sari; H. Bezirganoglu; N. Okur; E. Alyamac Dizdar; A. Mirada Vives (Spain) N. Uras; F.E. Canpolat; S.S. Oguz (Turkey) ID 872 REFERRAL REASONS AND OUTCOMES OF NEWBORN INFANT ID 475 REFERRAL CASE OF NEONATAL ADMISSION AND OUTCOME AT PHYSICAL EXAMINATION HIP REFERRALS NEONATAL UNIT IN TERTIARY HOSPITAL IN LOW-MIDDLE INCOME J. Hussain (United Kingdom) COUNTRY P.M.T. Marsubrin; E. Ameliana; R. Sari; R. Rohsiswatmo (Indonesia) ID 883 EFFICACY OF INTRAVENOUS; ENDOTRACHEAL OR NASAL ADRENALINE ADMINISTRATION DURING RESUSCITATION OF ID 479 MONITORING AND ASSESMENT OF NEONATAL CARE IN KYRGYZSTAN NEAR-TERM ASPHYXIATED LAMBS S.Abduvalieva; C.Rakmanova; G.Jumagulova; E. Jumalieva (Kyrgyzstan) N.T. Songstad 1; C. Klingenberg 1; K.J. Crossley 2; E.V. McGillick 2; G.R. Polglase 2; P.G. Davis 2; S.B. Hooper 2 ID 561 EVOLUTION OF PERINATAL MANAGEMENT AT THE LIMIT OF VIABILITY (1. Norway; 2. Australia) IN THE LAST DECADE S. Zeballos Sarrato; C. Ramos Navarro; G. Zeballos Sarrato; N. Navarro; M. Sánchez-Luna (Spain) Perinatal Practices Chairs: Pierre Kuhn (France); Shoo Lee (Canada) ID 649 EARLY ONSET INTRAUTERINE GROWTH RESTRICTION: AN INDEPENDENT RISK FACTOR FOR POOR PERINATAL OUTCOME IN VERY PRETERM ID 054 VACUUM EXTRACTION AND RISK OF NEONATAL COMPLICATIONS: INFANTS? A POPULATION-BASED COHORT STUDY T.D. Nguyen; D. Bassler; N. Ochsenbein-Kölble; G. Natalucci (Switzerland) D. Rossetti; AS Laganà; G. Valenti; B. Chiofalo; S. Butticè; G. Sanpietro; A.M.C. Rapisarda; F. Sapia; M. Noventa; A. Vitagliano; S.G. Vitale (Italy) ID 651 THE EFFECT OF GENDER ON NEONATAL MORBIDITIES AND MORTALITY ON TWIN PAIRS ID 109 ELECTIVE CAESAREAN SECTION AND RESPIRATORY MORBIDITIES IN B. Ozer Bekmez; H. G. Kanmaz Kutman; C. Tayman; M. Buyuktiryaki (Turkey) TERM INFANTS P. Mallya; S. Garg (United Kingdom) ID 679 IS FETAL ARTERIAL AND VENOUS DOPPLER VELOCIMETRY MANDATORY IN THE CASE OF THE IUGR RISK PREGNANCIES? ID 124 CESAREAN DELIVERY AMONG FOREIGN-BORN CHINESE AND US M. Tunescu; G. Olariu; A. Ratiu; D. Bujorescu (Romania) BORN-CHINESE WOMEN IN THE U.S T.A. Yen 1; M. Lahiff 2; N. Hosang 2; E. Brenda 2 ID 710 IN VITRO FERTILIZATION - NEONATAL OUTCOME (1. Taiwan; 2. United States) M.L. Ognean; R. Chicea; R. Dumitra; O. Boantă; M. Codru (Romania) ID 170 RISK FACTORS AND OUTCOME IN PREVIABLE PPROM AND CURRENT ID 732 NEONATAL JAUNDICE AND PHOTOTHERAPY: ARE WE DOING IT TREATMENT PRACTICE RIGHT? - A RETROSPECTIVE STUDY A. van Gennip; E.E.M. Mulder; R.M. Brohet; J. van Eyck; R.A. van Lingen M. Nogueira; C. Teles Silva; A. Reis e Melo; M. Rosário; J. Santos Silva; (The Netherlands) G. Silva; H. Guimarães (Portugal) ID 303 ASSESSMENT OF FUNCTIONAL STATUS IN PRETERM INFANTS: ONLINE ID 768 REVIEW OF OUTCOMES OF BABIES WITH BIRTH WEIGHT LESS THAN 500 SURVEY TO INFORM SCORING OF A CLINICIAN-REPORTED GRAMS IN A NEONATAL INTENSIVE CARE UNIT OUTCOMES (CLINRO) TOOL N. Gulati; N. Mahalingam; S. Vishna Rasiah; A. Singh (United Kingdom) M. Turner 1; I. Hansen-Pupp 2; J. Higginson 3; R. Ward 3; M. Vanya 3; E. Flood 3; E. Schwartz 3; H. Doll 3; A. Tocoian 4; A. Mangili 3; N. Barton 3; S. Sarda 3 (1. United Kingdom; 2. Sweden; 3. United States; 4. Switzerland) 84 84 3rd November, 2017 3rd November, 2017 85 85 9:00 - 11:00 PARALLEL SESSION 24 |DARSENA ROOM 9:00 - 11:00 PARALLEL SESSION 25 (BRAIN 5) STRESS AND DEVELOPMENT NEUROPROTECTION, EPO TRIAL |VENEZIA ROOM Chairs: Petra Hüppi (Switzerland); Aijaz Farooqi (Sweden) Chairs: Nicola Robertson (United Kingdom); Ivo Bendix (Germany) 09:00 - 09:20 Prenatal stress and its effects on the fetus and the child 09:00 - 09:20 Current global issues for optimising brain protection of the Francesca Cirulli (Italy) term infant Nicola Robertson (United Kingdom) 09:20 - 09:40 Stress in health and disease; stress, learning and plasticity Marian Joels (The Netherland) 09:20 - 09:40 Preterm Epo Neuroprotection: the PENUT Trial Sandra Juul (United States) 09:40 - 09:55 Differentiating the preterm phenotype: distinct profiles of development after late and moderately preterm birth 09:40 - 09:55 A mixed lipid emulsion – rich in docosahexaenoic acid S. Johnson; G. Waheed; B. N. Manktelow; D. Field; N. Marlow; (DHA)- and its effect on brain maturation in extremely low E.S. Draper; E.M. Boyle (United Kingdom) birth weight infants C. Binder 1; A. Repa 1; V. Giordano 1; M. Thanhaeuser 1; A. Kreissl 1; 09:55 - 10:10 Prenatal methadone exposure and neurodevelopmental N. Haiden 1; A. Berger 1; N. Longford 2; K. Klebermass-Schrehof 1 and neuroimaging outcomes: a systematic review (1. Austria; 2. United Kingdom) V. Monnelly; R. Hamilton; F. Chappell; H. Mactier; J. Boardman (United Kingdom) 09: 55 - 10:10 Thrombocytopenia is associated with severe retinopathy of prematurity clinically; in mice platelet transfusion suppresses 10:10 - 10:25 Atypical brain development associated with prenatal retinopathy methadone exposure P. Lundgren 1; R. Liegl 2; S. Klevebro 3; G. Hellgren 1; C. Löfqvist 1; V. Monnelly; D. Anblagan; A. Quigley; E. Cooper; H. Mactier; C. Mannheimer 1; Y. Sun 2; Z-J. Liu 2; M.C. Sola-Visner 2; S. Semple; M. Bastin; J. Boardman (United Kingdom) B. Hallberg 1; L.E.H. Smith 2; A. Hellström 1 (1. Sweden; 2. United States) 10:25 - 10:40 Epigenetic differences in cord blood of newborns exposed to antidepressant medication during pregnancy – a study in 10:10 - 10:25 Peripheral T-cell depletion by fingolimod is associated with the Aarhus birth cohort exacerbated hypoxic-ischemic brain injury in neonatal A-C. Viuff 1; G.C. Sharp 1; L.H. Pedersen 1,2; N.H. Staunstrup 2; mice K.J. Kyng2; D. Rai 3; C.L. Relton 1; T.B. Henriksen 1,2 I. Bendix; M. Crasmöller; C. Köster; M. Serdar; U. Felderhoff-Müser; (1. United Kingdom; 2. Denmark) J. Herz (Germany) 10:40 - 10:55 Mental health in adolescents born at 23-25 weeks of 10:25 - 10:40 Intranasally applied mesenchymal stem cells migrate to gestation injured brain regions of newborn non-human primates A. Farooqi; M. Samuelsson; A. Holsti; M. Adamsson; F. Serenius; N. Wagenaar 1; F. van Bel 1; M.J.N.L. Benders 1; C. Blanco 2; B. Hägglöf (Sweden) D. McCurmin 2; S. Mustafa 2; F. Groenendaal 1; L. de Vries 1; C. Heijnen 2; C. Nijboer 1 (1. The Netherlands; 2. United States) 10:40 - 10:55 Maternal swimming during pregnancy protects the neonatal rat brain from hypoxic-ischemic injury E.F. Sanches; Y. van de Looij; A. Silva; J. Romero; S.V. Sizonenko (Switzerland) 86 86 3rd November, 2017 3rd November, 2017 87 87 9:00 - 11:00 PARALLEL SESSION 26 (PHARMA 2)|ROMA ROOM 9:00 - 11:00 PARALLEL SESSION 27 (CIRCULATION 3) NEW INSIGHTS IN FUTURE NEONATAL CARE TRAINING GUIDELINES FOR NEONATOLOGIST PERFORMED Chairs: Sinno Simons (The Netherlands); Eugene Dempsey (Ireland) ECHOCARDIOGRAPHY (NPE) - AN INTERCONTINENTAL DEBATE |SORRENTO ROOM 09:00 - 09:20 Tick-tock… pharmacotherapy and our body clock Chairs: Willem de Boode (The Netherlands); Bert van der Horst (The Netherlands) Colm Breatnach (Ireland) 09:20 - 09:40 Chronobiology in neonatology 09:00 - 09:20 The North-American perspective Irwin Reiss (The Netherlands) Patrick McNamara (Canada) 09:40 - 09:55 Late cord clamping trial 09:20 - 09:40 The Australian perspective William Tarnow-Mordi (Australia) Nick Evans (Australia) 09:55 - 10:10 Pharmacokinetic and pharmacodynamic studies aiming for 09:40 - 10:00 The United Kingdom perspective rational drug dosing in preterm neonates: the DINO study Yogen Singh (United Kingdom) R.B. Flint; S. Völler; R. de Groot; D. Liem; P. Andriessen; P. Degrauewe; I. Reiss; D. Burger; D. Tibboel; C.A.J. Knibbe; S.H.P. Simons; DINO Research group (The Netherlands) 10:00 - 10:20 The European perspective Afif El-Khuffash (Ireland) 10:10 - 10:25 Fentanyl for procedural pain in preterm newborn infants – a pharmacokinetic and pharmacodynamic study 10:20 - 10:35 Incidental findings on routine targeted neonatal E. Norman 1; J.M. Kindblom 1; A-C. Berg 1; C. Halzius 1; G. Printz 1; echocardiography performed in preterm infants less A. Rane 1; H. Lagercrantz 1; B. Hallberg 1; V. Fellman 2 than 29 weeks gestation (1. Sweden; 2. Finland) A. Smith; C.R. Breatnach; A.T. James; O. Franklin; A. El-Khuffash (Ireland) 10:25 - 10:40 Big data analyses for continuous evaluation of pharmacotherapy: a proof of principle with doxapram for 10:35 - 10:50 Emerging quantitative echocardiographic markers of preterm infants pulmonary vasculae disease and right ventricular R.B. Flint; W. van Weteringen; S. Völler; J. Poppe; B. Koch; dysfunction in extreme preterm infants with late pulmonary R. de Groot; D. Tibboel; C. Knibbe; I. Reiss; S.H.P. Simons; hypertension DINO Research group (The Netherlands) P. Levy 1; C. Brennan 1; M. Patel; S. Choudhry 1; A.A. Sanchez 1; A. EL-Khuffash 2; C. Breatnach 2; O. Franklin 2; A. Hamvas 1; 10:40 - 10:55 Ibuprofen pharmacogenetic study in human milk Samples S. Gautam 1 V. Rigourd; C. Verstyuft; J.F. Méritet; P. Seraissol; B. De Villepin; (1. United States; 2. Ireland) A. Amirouche; R. Serreau (France) 10:50 - 11:00 Novel methods to characterize right ventricular - pulmonary arterial coupling in extreme preterm infants with late onset pulmonary hypertension P. Levy; M. Patel; S. Choudhry; M. Holland; T. Sekarski; A. Hamvas; G. Singh (United States) 88 88 3rd November, 2017 3rd November, 2017 89 89 9:00 - 11:00 PARALLEL SESSION 28 (EFCNI 4) |LECCE ROOM 11:30 – 12:30 IPRF PLENARY SESSION 6 |DARSENA ROOM MEASURING QUALITY OF CARE IN NEONATAL CARE Chairs: Heike Rabe (United Kingdom); Chairs: Boubou Hallberg (Sweden); Silke Mader (Germany); Topun Austin (United Kingdom) 09:00 - 09:20 Value based health care and improvement of health in the 11:30 – 12:00 Human cerebral organoids as a new tool to study human very youngest infants neocortex development Boubou Hallberg (Sweden) Wieland Huttner (Germany) 09:20 - 09:40 Nature and nurture – improving quality of care in a genetic 12:00 – 12:30 From Population and Personalized Genomics to Personalized cohort study Medicine Wolfgang Göpel (Germany) Manolis Dermitzakis (Switzerland) 09:40 - 09:55 The implementation of the close collaboration with parents training program in 5 neonatal units - a qualitative study M. Toivonen; L. Lehtonen; S. Ahlqvist-Björkroth; A. Axelin (Finland) 12:30 – 12:45 ESPR AWARDS SESSION |DARSENA ROOM Chairs: Charles C. Roehr (United Kingdom); 09:55 - 10:10 A pilot study assessing the effectiveness of a family- Luc Zimmermann (The Netherlands) centered care intervention in preterm infants in China R. Zhang 1; R. Huang 1; X. Gao 1; X. Peng 1; L. Zhu 1; Young Investigator Awards R. Ramanathan 2; J. Latour 1,3 ESPR Research Grants 2017 (1. China; 2. United States; 3. United Kingdom) 10:10 - 10:25 Core outcomes in neonatology: preliminary results 12:45 - 13:30 LUNCH BREAK J.W.H. Webbe; N. Modi; C. Gale On behalf of the COIN Steering Group (United Kingdom) 10:25 - 10:40 Close collaboration with parents™ intervention prevents Human Milk Fortification: Benefits of an 13:30 - 15:00 prolonged maternal postpartum depressive symptoms S. Ahlqvist-Björkroth; A. Axelin; R. Korja; M. Huhtala; L. Lehtonen Exclusive Human Milk Diet for Premature (Finland) Infants |VENEZIA ROOM Industry supported session - please see page 125 10:40 - 10:55 Reducing medication errors on NICU - Chairs: Victoria Niklas (United States); Enrico Bertino (Italy) a quality improvement project D.A. Al Masri; B. Ofoegbu; L. Yahya; K. Catroon; A. Saliba; 13:30 - 13:40 Introduction to human milk in the NICU - use and challenges H. Ibrahim (United Arab Emirates) Enrico Bertino (Italy) 13:40 - 14:10 Science and clinical impact of human breast milk feeding for premature infants 11:00 - 11:30 COFFEE BREAK Alan Lucas (United Kingdom) 14:10 - 14:40 Clinical benefits of an exclusive human milk diet in premature infants Sergio Golombek (United States) 14:40 - 15:00 Conclusion and discussion Victoria Niklas (United States) 90 90 3rd November, 2017 3rd November, 2017 91 91 13:30 - 15:00 POSTER SESSION 11 (NEUROLOGY 2) |FIRENZE ROOM 14:10 - 14:15 Reduced prevalence of severe intraventricular hemorrhage in very preterm infants delivered after Chairs: Pierre Gressens (France); Ola D. Saugstad (Norway) maternal pre-eclampsia E. Morsing; K. Maršál; D. Ley (Sweden) 13:30 - 13:35 Impact of parturition on maternal neuronal integrity K.S. Evers 1; S. Fouzas 2; C. Barro 1; J. Kuhle 1; U. Fisch 1; 14:15 - 14:20 Neurodevelopment in 7-year old children born with O. Lapaire 1; S. Wellmann 1 marginally low birth weight (1. Switzerland; 2. Greece) J. Starnberg; M. Norman; B. Westrup; M. Domellöf; S.K. Berglund (Sweden) 13:35 - 13:40 Mild germinal matrix-intraventricular hemorrhage in preterm infants: anatomical insights provided by SWI-venography D. Tortora 1; M. Malova 1; M. Severino 1; A Parodi 1; G. Morana 1; 14:20 - 14:25 Performance of the German version of the PARCA-R P. Govaert 2; J.J. Volpe 3; A. Rossi 1; L.A. Ramenghi 1 questionnaire as a cognitive screening tool in very preterm (1. Italy; 2. Belgium; 3. United States) infants at 2 years of corrected age G. Natalucci; N. Bechtel; C. Borradori-Tolsa; M. Bickle-Graz; 13:40 - 13:45 Association between transient neonatal hypoglycemia and M. Adams; S. Grunt for the Swiss Neonatal Network & Follow-Up adverse neurological development at 2-6 years of age Group (Switzerland) R. Wickström 1; B. Skiöld 1; G. Petersson 2; O. Stephansson 1; M. Altman 1,2 (1. Sweden; 2. Italy) 14:25 - 14:30 Cold-inducible RBM3 promotes neurogenesis after brain hypoxic-ischemia/reperfusion injury 13:45 - 13:50 Neurofilament serum levels as biomarker of neuronal injury X. Zhu; C. Brégère; J. Yan; U. Fisch; J. Kapfhammer; R. Guzman; in very preterm born infants S. Wellmann (Switzerland) A. Depoorter; C. Barro; R. Neumann; J. Kuhle; S. Wellmann (Switzerland) 14:30 - 14:35 Monitoring the energy metabolism in plasma from newborns with hypoxic-ischemic encephalopathy (HIE) 13:50 - 13:55 Effect of dehydroepiandrosterone and its sulfate ester on during therapeutic hypothermia neonatal hypoxic-ischemic brain injury – preliminary data Á. Sánchez-Illana; A. Núñez-Ramiro; M. Cernada; A. Parra; A. Posod; M. Lachinger; B. Vejnoska; E. Huber; M. Urbanek; E. Valverde; D. Blanco; M.T. Moral-Pumarega; F. Cabañas; H. Boix; U. Kiechl-Kohlendorfer; E. Griesmaier (Austria) A. Pavon; M. Chaffanel; I. Benavente-Fernández; I. Tofe; B. Loureiro; JR. Fernández-Lorenzo; B. Fernández-Colomer; 13:55 - 14:00 Long-term neurodevelopmental outcomes among young J. Kuligowski; M. Vento Torres and the HYPOTOP Study Group adults born preterm (Spain) M. Tei; S. Negro; M.C. Muraca; M.G. Gatti; D. Urilli; G. Buonocore; S. Perrone (Italy) 14:35 - 14:40 Decreased impact of poor weight gain as a predictor for ROP after implementation of higher oxygen saturation 14:00 - 14:05 Genetic contributions to the development of intraventricular targets hemorrhage in preterm newborns P. Lundgren 1; A–L. Hård 1; Å. Wilde1; C. Löfqvist 1; L.E.H. Smith 3; D. Szpecht; J. Gadzinowski; A. Seremak-Mrozikiewicz; A. Hellström 1 G. Kurzawińska; K. Drews; M. Szymankiewicz (Poland) (1. Sweden; 2. United States) 14:05 - 14:10 Neurodevelopment follow-up for high-risk babies in liverpool: a qualitative study. foundation study “follow-up for neurodevelopmentally at risk infants of neonatal care” A. Komoriyama; F. Paize; C. Dewhurst; M. Gladstone (United Kingdom) 92 92 3rd November, 2017 3rd November, 2017 93 93 13:30 - 15:00 POSTER SESSION 12 (EPIDEMIOLOGY 2) 14:10 - 14:15 Femoral pulse examination’s ability to predict coarctation of the aorta |SORRENTO ROOM F. Khammari Nystroem; S. Johansson; O. Stephansson; Chairs: Thomas Williams (United Kingdom) M. Altman (Sweden) Anne-Cathrine Finnemann Viuff (Denmark) 14:15 - 14:20 Variations in initial oxygen concentration at resuscitation 13:30 - 13:35 Incidence of bronchopulmonary dysplasia and of preterm neonates <29 weeks gestation: an international intraventricular haemorrhage among extremely preterm survey infants in Europe: a systematic literature review K. Lui 1; M. Vento Torres 2; A. Noguchi 3; S. Hakannson 4; C. Siffel; K. Kistler; J. Lewis; S. Sarda (United States) B. Reichman 5; P. Shah 6; G. Sjörs 4; F. Rusconi 7; M. Adams 8; S. Lee 6; L. Lehtonen 9; S. Kusuda 10; T. Isayama 6; N. Modi 11; 13:35 - 13:40 Chronic conditions and health care needs of adolescents D. Bassler 6; M. Beltempo 6; K. Helenius 9; N. Morisaki 10 ; born moderately preterm at 32-26 weeks’ gestation: B.A. Darlow 12 (1. Australia; 2. Spain; 3. United States; 4. Sweden; a Swedish regional population based case control study 5. Israel; 6. Canada; 7. Italy; 8. Switzerland; 9. Finland; 10. Japan; A. Farooqi; A. Sjöström; M. Adamsson; M. Bäckman; B. Hägglöf 11. United Kingdom; 12. New Zealand) (Sweden) 14:20 - 14:25 Morbidity, mortality and 2-year outcome of babies born with 13:40 - 13:45 A registry-based descriptive analysis of end stage renal birth weight ≤ 500g over 11 years in a tertiary neonatal unit disease and renal replacement therapy in Swedish neonates M. Noureldein; A. Olariu; J. Egyepong (United Kingdom) S. Nolbrant; O. Andersson; B. Hallberg; L. Sartz (Sweden) 14:25 - 14:30 Trends in mortality rates at the limit of viability in the last 13:45 - 13:50 Preterm children’s social inhibition before school entry decade predicts their friendships in 2nd grade A. Rodriguez Sánchez de la Blanca; S. Zeballos Sarrato; J. Jaekel 1,2; K. Heuser 3; L. Miranda 1; D. Wolke 2 G. Zeballos Sarrato; I. Pescador Chamorro; A. Rodriguez; (1. United States; 2. United Kingdom; 3. Germany) S. Villar Castro; M. Sánchez-Luna (Spain) 13:50 - 13:55 Children with cerebral palsy (non-post-neonatal) born at 14:30 - 14:35 Applying data mining techniques to predict term, non-admitted to neonatal intensive care, from the bronchopulmonary dysplasia in very-low-birth-weight Portuguese national register (VLBW) infants- a population-based study D. Virella; T. Folha; M.G. Andrada; A. Cadete; R. Gouveia; T. Gaia; Y.J. Lin; C.H. Lin; Y.C. Lin; Y.S. Chang; C.C. Huang; K.I. Tsou (Taiwan) J.J. Alvarelhão; E. Calado (Portugal) 14:35 - 14:40 Caregiver burden associated with extremely preterm birth 13:55 - 14:00 Risk factors associated with mortality at the limit of viability S. Sarda; W. Lenderking; R. Pokrzywinski; S. Stringer; A. Mangili S. Zeballos Sarrato; N. González Pacheco; I. Pescador Chamorro; (United States) A. Rodriguez Sánchez de la Blanca; M. Sánchez-Luna (Spain) 14:40 - 14:45 The gestation study – deep machine learning algorithm for 14:00 - 14:05 Epidemiology of esbl-producing multidrug-resistant accurate postnatal gestational age assessment gram-negative bacilli in three NICUs in Italy C. Henry; C. Ward; M. Torres Torres; M. Valstar; D. Sharkey D. Vecchio; L. Saporito; C. Achille; D.M. Geraci; S. Giampietro; (United Kingdom) M. Trancassini; C. Tzialla; C.M. Maida; M. Mario (Italy) 14:45 - 14:50 A systematic review of incidence of neonatal necrotising 14:05 - 14:10 Temporal trends in preterm infant mortality over the last 15 enterocolitis in high income countries years (2001-2015), with particular reference to 23 week C. Battersby; T. Santhalingam; K. Costeloe; N. Modi gestation infants. Results from a UK single centre case series (United Kingdom) with comparison to the Vermont Oxford network A. Doerr; D. Odd (United Kingdom) 14:50 - 14:55 Impact of elective caesarian section on neonatal retrieval in Western Australia during a 12 year period A. Tho; S. Resnick; J.W. Davis (Australia) 94 94 3rd November, 2017 3rd November, 2017 95 95 13:30 - 15:00 POSTER SESSION 13 (NUTRITION 2) |FIRENZE ROOM 14:15 - 14:20 Use of pasteurised human donor milk in England C. Battersby; R. Marciano Alves Mousinho; N. Longford; Chairs: Umberto Simeoni (Switzerland); Petteri Hovi (Finland) N. Modi for the UK Neonatal Collaborative Necrotising Enterocolitis (UKNC-NEC) Study Group (United Kingdom) 13:30 - 13:35 Individualized fortification of human milk improves nutritional supplies and growth in preterm infants 14:20 - 14:25 Neonatal body composition of infants born to mothers with V. de Halleux; C. Pieltain; T. Senterre; F. Studzinski; J. Rigo (Belgium) gestational diabetes mellitus FA.M. Pavel; M. O’Riordan; L. Culliney; T. Nabialek; 13:35 - 13:40 Birth weight percentiles based on maternal height are J. De Meulemeester; F. Caulfield; A. Stanescu; Z. Coffrey; D. Coffey; universally applicable and valid for different ethnic groups A. Doolan (Ireland) D. Olbertz 1; N. Rochow 2; M. Al Samnan 2; J. Däbritz 1; R. Hentschel 1; U. Wittwer-Backofen 1; M. Voigt 1 14:25 - 14:30 Current practice and beliefs: survey of breast milk handling (1. Germany; 2. Canada) routines in German, Swiss and Austrian neonatal units reveals large centre specific differences 13:40 - 13:45 Comparison of the postnatal catch up growth according to D. Klotz; S. Jansen; H. Schneider; C. Gebauer; H. Fuchs (Germany) the definition of small for gestational age infants J. Huh; J.Y. Kwon; E.H. Lee; H.R. Kim; K.H. Lee (Korea) 14:30 - 14:35 Variability in the protein and fat content of the donor human milk supply revealed by mid-infrared spectrometer 13:45 - 13:50 Measuring postnatal growth: a comparison of neonatal analysis: a fist step towards preventing disruption of growth using international intergrowth-21st standards and “per natal programming” established UK charts V. Rigourd; Z. Assaf; A. Lapillonne; J.F. Magny (France) O.M. Bendor-Samuel; S. Zivanovic; C.C. Roehr (United Kingdom) 14:35 - 14:40 Decreasing extrauterine growth restriction in very low birth 13:50 - 13:55 Human milk and human milk derived products: how weight (VLBW) infants after implementation of a nutritional bioactive component analysis may inform clinical outcomes protocol in the NICU J.A. Asaro; R. Snyder; C. Aikey; I. Griffin; A. Herdt; M. Rogido V. Niklas; D. Rechtman; M. Lee; A. Lebouedec; A. Sun (United States) (United States) 13:55 - 14:00 Effect of a nationwide program for promoting breastfeeding in-hospital in China 13:30 - 15:00 POSTER SESSION 14 (LUNG 4)|SORRENTO ROOM Y. Zhang; H.S. Wang; X. Jin; B. Cao; D.H. Wang; M. Jiang; L.X. Wang; Chairs: Kajsa Bohlin (Sweden); Kerstin Jost (Switzerland) S.M. Wang; W.W. Feng; L.M. Yao (China) 13:30 - 13:35 Perinatal inflammation and intrauterine growth retardation 14:00 - 14:05 Association between maternal knowledge on breastfeeding are both associated with lung function impairment at 12 and the assessment of the newborn’s latch in a maternity years of age in very preterm infants center in the university hospital of the south region of Brazil C. Hagman; L.J. Björklund; E. Tufvesson; I. Hansen Pupp (Sweden) S.S. Nader; P.J.H. Nader; N.T. Canabarro (Brazil) 13:35 - 13:40 Early predictive factors for insure failure in the management 14:05 - 14:10 Prevalence of breastfeeding at 6th months in sick neonates of preterm infants with neonatal respiratory distress S. Kositamongkol; K. Moungsuwan (Thailand) syndrome: a systematic review B. De Bisschop; F. Derriks; F. Cools (Belgium) 14:10 - 14:15 Is there any association between lamellar body counts and cord blood vitamin d levels of term and late preterm infants N.Okur; H.G. Kanmaz; M. Buyuktiryaki; H. Bezirganoglu; G. Kadioglu Simsek; F.E. Canpolat; N. Uras; S.S. Oguz (Turkey) 96 96 3rd November, 2017 3rd November, 2017 97 97 13:40 - 13:45 Outcomes of postnatal hydrocortısone therapy ın preterm 14:30 - 14:35 Protocolized weaning in mechanical ventilation infants wıth bronchopulmonary dysplasıa: experıence ın a B. Bol 1; H. van Zanten 1; J. Wielenga 1; A. vd Hoogen 1; tertıary center P. Mansvelt 1; B. Blackwood 2; O.K. Helder 1 M. Buyuktiryaki; E. Alyamac Dizdar; N. Okur; H. Bezirganoglu; (1. The Netherlands; 2. United Kingdom) F.N. Sari; N. Uras; F.E. Canpolat; S.S. Oguz (Turkey) 14:35 - 14:40 NEO (Neonatal Esophageal Observation) Tube - 13:45 - 13:50 Maternal preeclampsia and the risk of respiratory distress a feeding tube with monitoring function syndrome in VLBW infants P. Simmen; B. Jesacher; P-A. Tran; L. Suter; A. Haeberlin; T.A. Yen; Y.H. Wen; H.I. Yang; W.S. Hsieh; H.C. Chou; C.Y. Chen; S.M. Schulzke; T. Niederhauser; K. Jost (Switzerland) K.I. Tsou; P.N. Tsao (Taiwan) 14:40 - 14:45 Helping babies breathe, second edition: strengthening the 13:50 - 13:55 Comparison of RSV hospitalisation in preterm infants with program to increase global newborn survival chronic lung disease who do not qualify for palivizumab B. Kamath-Rayne 1; M. Visick 1; W. Keenan 1; G. Little 1; prophylaxis with those who qualify in Nottingham, UK N. Singhal 2; S. Niermeyer 1 S. Tsilika; D. Batra (United Kingdom) (1. United States; 2. Canada) 13:55 - 14:00 The effect of antenatal steroid on different gestational age of 14:45 - 14:50 Ventfirst: a multicenter RCT of assested ventilation during VLBW infant - a population study delayed cord clamping for extremely preterm infants Y-T. Chen; S-Y. Liu; H-I Yang; C-Y. Chen; H-C. Chou; W-S. Hsieh; K. Fairchild; S. Niermeyer; J. Winter; C. Chisholm; J. Kattwinkel; K-I. Tsou; P-N. Tsao (Taiwan) on behalf of the VentFirst Steering Committee (J. Fang, C. Colby; J. Barry; M. Al-Hosni; M. Strand; T. Gorman; L. van Marter; 14:00 - 14:05 Effects of passive smoking on lung function tests in preschool R. Schelonka; J. Warren; S. Thomas; G. Schmolzer; A. Camblos; children born late-preterm S. Fowler; M. Haynes; G. Petroni; M. Thielen) (United States) A. Günlemez; I. Er; C. Baydemir; A.E. Arısoy; A.S. Gökalp (Turkey) 14:50 - 14:55 Inhaled nitric oxide improves survival in preterm infants 14:05 - 14:10 Transfusion-related acute lung injury in (pre)term infants in diagnosed with pulmonary hypoplasia the neonatal intensive care K.R. Ellsworth; M. Ellsworth; L. Sangaralingham; R. Clark; G. Asay; M. van Tuyl; L. Snoek; R.M. Wösten-van Asperen; C. Colby; W.A. Carey (United States) A.H.L.C. van Kaam; W. Onland (The Netherlands) 14:55 - 15:00 Inhaled nitric oxide in congenital diaphragmatic hernia – results from the European inhaled nitric oxide 14:15 - 14:20 Lung ultrasound for the diagnosis of pulmonary registr consolidations in patients with bronchopulmonary dysplasia R. Kettle; N.V. Subhedar (United Kingdom) I. Koltunov; M. Degtyareva; A. Mazaev; A. Gorbunov; A. Erokhina (Russia) 14:20 - 14:25 Bedside lung ultrasonography for the diagnosis of neonatal respiratory distress in the first 24 hours of life I. Corsini; N. Parri; E. Gozzini; C. Coviello; V. Leonardi; C. Poggi; M. Giacalone; T. Bianconi; L. Tofani; C. Dani (Italy) 14:25 - 14:30 Is the double lung point an accurate diagnostic marker for TTN? A prospective, international study F. Migliaro; N. Yousef; J. Rodriguez Fanjul; D. De Luca; I. Corsini; C. Dani; V. Di Guardo; M. Giampietri; L. Capasso; A. Sodano; F. Raimondi (Italy) 98 98 3rd November, 2017 3rd November, 2017 99 99 13:30 - 15:00 POSTER SESSION 15 (ETHICS + PERINATAL PRACTICE) 15:40 - 15:55 Neonatal neuroimaging in symptomatic congenital CMV (cCMV) and its correlation with |LECCE ROOM outcome: emphasis on white matter disease Chairs: Sandra Horsch (Germany); Gorm Greisen (Denmark) A. Alarcon 1,2; A. Garcia-Alix 2; M. Martinez-Biarge 3; I. van Straaten 3; F. Cabañas 2; J. Quero 2; L. de Vries 3 13:30 - 13:35 Changing parental perceptions in trisomies – a potential (1. United Kingdom; 2. Spain; 3. The Netherlands) ethical dilemma for neonatologists? E.A. Simons; P. Nath; P. Parthasarathy (United Kingdom) 15:55 - 16:10 Postnatal MR-imaging and ADC measures in congential cytomegalovirus infection provide an added diagnostic 13:35 - 13:40 Evaluation of parental informed consent procedure in value on cerebral ultrasound in characterizing white matter neonatal intensive care unit disease E.(P.G.) van ’t Verlaat; E. de Kort; I. Reiss; M. van Weissenbruch; C. Martins 1; J. Schneider 2; M. Bickle Graz 1; M. Kobas 1; S. Asner 1; S.H.P. Simons (The Netherlands) A.C. Truttmann 1 (1. Switzerland; 2. Canada) 13:40 - 13:45 Alarm visibility and infusion continuity: environmental change and technology assistance 16:10 - 16:25 Hyperechogenicity of the lenticulostriate arteries: incidense M. Bastanie; H. Blom; L. Mahieu; M. Meeus; S. Laroche; and clinical impact in a tertiary NICU D. Van Laere; M. Voeten; V. Demeulemeester; R. Vermeulen; P. Triantafyllidou; M. Papadopoulou; S. Gantseva-Patsoura; A. Mulder (Belgium) F. Kokkori; E. Varxalama; M. Theodoraki; A. Gounaris (Greece) 13:45 - 13:50 Fast and meticulous: improving quality of neonatal 16:25 - 16:40 Systemic alterations in Hypoxia-inducible factor 1 expression resuscitation documentation and the NLRP3 inflammasome in post neonatal M. Karam; N. Merchant; A. Sierra; S. Narayanan (The Netherlands) encephalopathy in school age children and response to melatonin in vitro 13:50 - 13:55 Early discharge of premature infants <36 weeks gestational L. Russo; V. Mc Eneaney; Z. Zareen; L.A Kelly; E.J. Molloy (Ireland) age with nasogastric tube feeding, new standard of care? F.S. van Kampen; A.C. de Mol; J.P. Korstanje; F. Maingay-de Groof; 16:40 - 16:55 Systemic inflammasome activation in neonatal L. van Meurs-Asseler; H.G. Stas; R. Willemsen; G.M.S.J. Stoelhorst encephalopathy (The Netherlands) M. O’Dea; L. Kelly; J.J. O’Leary; E.J. Molloy (Ireland) 13:55 - 14:00 Incidence of hypothermia associated with birth and intrahospital transport of newborn infants requiring admission to a NICU - a quantitative observational study 15:00 - 17:00 PARALLEL SESSION 30 (PULMONOLOGY 4) V. Hansson; M. Hedin; A. Örtenstrand; M. Viberg (Sweden) PHARMACOLOGY OF LUNG PROTECTION |VENEZIA ROOM Chairs: Daniele De Luca (France) 15:00 - 17:00 PARALLEL SESSION 29 (BRAIN 6) |DARSENA ROOM CONGENITAL BRAIN INFECTIONS 15:00 - 15:20 Antenatal corticosteroids – current controversies Lex Doyle (Australia) Chairs: Pierre Gressens (France); Steven Miller (Canada) 15:20 - 15:40 Update on postnatal systemic and inhaled corticosteroids 15:00 - 15:20 CMV cellular and molecular mechanisms Olivier Baud (Switzerland) Pierre Szepetowski (France) 15:40 - 16:00 Update on respiratory stimulants and diuretics in BPD 15:20 - 15:40 ZIKA congenital encephalopathies prevention Ferdinando Di Cunto (Italy) Christian Poets (Germany) 100 100 3rd November, 2017 3rd November, 2017 101 101 16:00 - 16:15 Using the combination of surfactant and budesonide the 16:10 - 16:25 Perinatal infections and cerebral palsy: are prevention of chronic lung disease in preterm infants with prolonged ruptures of membranes a risk factor in RDS children born at term? O. Sapun; E. Kleshchenko; O. Shishkina; T. Senyuk; N. Petrukhina; M. Mynarek; S. Bjellmo; S. Lydersen; J. Afset; G. Andersen; T. Vik D. Kryuchko (Russia) (Norway) 16:15 - 16:30 Antenatal glucocorticoids attenuate changes by ventilation 16:25 - 16:40 Congenital heart defects and the risk of spontaneous in expression of connective tissue growth factor (CTGF) in preterm birth: a nationwide study of 924,422 liveborn infants newborn rat lung N.B. Matthiesen; J.R. Østergaard; C.C. Bach; V. Hjortdal; M. Mateos; E. Gutierrez; L. San Feliciano; A. Remesal; T.B. Henriksen (Denmark) M. Isidoro-García; A. García-Sánchez; D. Ludeña (Spain) 16:40 - 16:55 The dose-effect relationship between gestational age and 16:30 - 16:45 Effect of commercially available surfactants on mortality and severe school difficulties - a Danish population-based respiratory outcomes in preterm neonates with RDS: register study systematic reviews and meta-analysis R. Wiingreen; G. Greisen; J. Svensson; BM. Hansen (Denmark) L. De Martino; D. De Luca (France) 16:45 - 17:00 Secretory phospholipase A2 and inflammation profile in preterm babies with RDS receiving one or multiple surfactant 15:00 - 17:00 PARALLEL SESSION 32 |FIRENZE ROOM doses CHILDREN BORN PRETERM S. Shankar-Aguilera 1; C. Fitting 1; L. Vedovelli 2; V. Dell’Orto 1; V.P. Carnielli 2; L. Touqui 1; D. De Luca 1; M. Simonato 2 Chairs: Neil Marlow (United Kingdom); Hugo Lagercrantz (Sweden) (1. France; 2. Italy) 15:00 - 15:20 RECAP, a EU Horizon2020 collaborative effort to harmonize existing and new follow-up data on preterm survivor children, adolsecents and adults 15:00 - 17:00 PARALLEL SESSION 31 (EPIDEMIOLOGY 2) Dieter Wolke (United Kingdom) PERINATAL EPIDEMIOLOGY |ROMA ROOM 15:20 – 15:40 Psychiatric outcomes following very preterm birth Chairs: Tine Brink Henriksen (Denmark); Peter Anderson (Australia) Thomas Williams (United Kingdom) 15:40 – 16:00 The brain and neuropsychiatric disorders in children born 15:00 - 15:40 Registry based perinatal epidemiology: the importance of preterm sibling and generation data Nelly Padilla (Sweden) Rolv Skjaerven (Norway) 16:00 - 16:15 Two-year outcome of extremely preterm infants < 26 weeks 15:40 - 15:55 Association between maternal body mass index in early of gestation born in Switzerland: is intensity of perinatal care pregnancy and incidence of cerebral palsy associated with increased neurodevelopmental S. Johansson; E. Villamor; K. Tedroff; M. Peterson; M. Neovius; impairment? G. Petersson; S. Cnattingius (Sweden) G. Natalucci; T.M. Berger; C. Borradori-Tolsa; M. Bickle-Graz; S. Grunt; R. Gerull; D. Bassler; M. Adams (Switzerland) 15:55 - 16:10 Prevalence of long-term neurodevelopmental impairment following extremely preterm birth in Europe: a systematic 16:15 - 16:30 Cognitive and behavioral aspects of executive functioning literature review at age 6.5 years in children born extremely preterm: S. Sarda 1; G. Sarri 2; S. Abogunrin 2; C. Siffel 1 a Swedish national prospective study (EXPRESS) (1. United States; 2. United Kingdom) A. Farooqi; F. Serenius; M. Adamsson; M. Hafström; U. Åden; K. Stjernqvist (Sweden) 102 102 3rd November, 2017 3rd November, 2017 103 103 15:00 – 17:00 PARALLEL SESSION 34 |LECCE ROOM 16:30 - 16:45 Delineating the behavioural phenotype among children born extremely preterm COINN Global perspectives in neonatal care J. Trickett; D. Wolke; C. Hollis; N. Marlow; S. Johnson Chairs: Agnes van den Hoogen (The Netherlands); (United Kingdom) Karen Walker (Australia) 16:45 - 17:00 Prevalence of autism in extreme preterm children born in 15:00 – 15:30 COINN’s leadership and partnerships to decrease mortality Stockholm 2004-2007 and morbidity and improve neonatal care – global E. Eklöf; A. Hedfors Moretti; H. Lagercrantz; S. Bolte; U. Aden perspective Karen New (Australia) (Sweden) 15:30 – 16:00 Using parent experiences for learning - exploring the use of parent narratives to inform education in neonatal care 15:00 - 17:00 PARALLEL SESSION 33 |SORRENTO ROOM Julia Petty (United Kingdom) IUGR across SPECIALITIES 16:00 – 16:30 Global neonatal nursing - opportunities and challanges Chairs: Chiara Mandò (Italy); Luca Ramenghi (Italy) Carole Kenner (United States) 15:00 – 15:20 Metabolic and oxidative phenotype of IUGR 16:30 – 17:00 Developmental Surveillance in children born very preterm Chiara Mandò (Italy) Margo Pritchard (Australia) 15.20 – 15:40 Cardiovascular assessment and outcome of the early IUGR Tiziana Frusca (Italy) 17:00 - 17:30 COFFEE BREAK 15:40 – 16:00 The very preterm IUGR between lung and nutrition Virgilio P. Carnielli (Italy) 17:30 - 19:00 PLENARY SESSION 7 |DARSENA ROOM 16:00 – 16:20 1The premature brain and the IUGR brain developmental trajectories THE NEED OF MULTIDISCIPLINARY APPROACHES Petra Hüppi (Switzerland) IN RESEARCH Chairs: Silke Mader (Germany); Neil Marlow (United Kingdom) 16:20 – 16:40 IVH and IUGR: thoughts for improving neonatal care? Luca Ramenghi (Italy) 17:30 – 18:00 The benefit of an equal partnership with parents in research Mark Turner (United Kingdom) 16:40 – 17:00 Discussion 18:00 – 18:30 How to involve and empower parents in research projects Nicole Thiele (Germany) 18:30 – 19:00 The benefit of an active partnership with nurses in research Agnes van den Hoogen (The Netherlands) 104 104 3rd November, 2017 3rd November, 2017 105 105 DARSENA VENEZIA ROMA FIRENZE SORRENTO LECCE NAPOLI ROOM ROOM ROOM ROOM ROOM ROOM ROOM (Mosaici 1) (Mosaici 2) GROUND FLOOR GROUND FLOOR GROUND FLOOR GROUND FLOOR THIRD FLOOR THIRD FLOOR GROUND FLOOR 08:00 08:00 POSTER WALK 09:00 09:00 Parallel Parallel Parallel Parallel Parallel Parallel Session 35 Session 36 Session 37 Session 38 Session 39 Session 40 Sensory outcomes (BRAIN 5) (PULMONOLOGY 5) (NUTRITION 4) Nurse specialist and (EFCNI 5) and pain Autophagy in Fetal growth – Programming by early Nurse practioner roles Bridging the gap developing brain size matters nutrition in preterm and practices between hospital and out-patient care for hospitalised newborns 11:00 11:00 COFFEE BREAK 11:30 11:30 CLOSING SESSION Personalized medicine 13:00 13:00 08:00 – 09:00 POSTER WALK | GROUND FLOOR Cardiac Physiology Pathology Chairs: Daria Kryuchko (Russia); Lizelle Van Wyk (South Africa) ID 106 DIAGNOSIS OF DIGEORGE SYNDROME: THE CONTRIBUTION OF MOLECULAR GENETICS Y. Halleb; H. Hadj-Abdallah; S. Nouri; A. Touati; M. Bellallah; J. Mathlouthi; N. Mahdhaoui; H. Sboui; A. Saad; D. H’mida (Tunisia) ID 168 EFFICACY OF MEDICAL TREATMENT IN CLOSING PATENT DUCTUS ARTERIOSUS IN ELBW INFANTS S. Bellis; Y. Singh (United Kingdom) ID 178 ACETAMINOPHEN FOR CLOSING PDA. SHOULD IT BE A FIRST LINE THERAPEUTIC OPTION? I. Tofé; M.D. Ruiz; M.P. Jaraba; M.V. Rodriguez; R.L. Rueda; M.D. Ordoñez; M.J. Parraga (Spain) ID 190 PATENT DUCTUS ARTERIOSUS WITH HEMODYNAMIC REPERCUSSION IN VERY LOW WEIGHT PRETERM INFANTS TREATED WITH ORAL IBUPROFEN PRESENT A HIGH RATE OF BRONCHOPULMONARY DYSPLASIA M.M. Lourenço; E. Sacramento; F. Carmona; C. Calixto; F. Martin-Celini; G.H. Seribelli; W.A. Gonçalves-Ferri (Brazil) ID 231 PRENATAL DIAGNOSIS OF THE SYSTEMIC BLOOD FLOW RESTRICTION DEFECTS IMPROVES HEMODYNAMIC STABILITY OF THE NEONATES WITH CONGENITAL CARDIAC DEFECT AT THE ADMITTANCE IN NEONATAL INTENSIVE CARE UNIT M. Cucerea; M. Simon; M. Ungureanu; R. Marian; E. Moldovan; M. Rusneac; C. Gliga; L. Suciu (Romania) ID 247 ASSOCIATION BETWEEN ASYMPTOMATIC PATENT DUCTUS ARTERIOSUS BEYOND THE EARLY POSTNATAL PERIOD AND 3-YEAR NEUROLOGICAL OUTCOME K. Inomata; S. Taniguchi; T. Inoue; A. Kawase; Y. Kondo (Japan) ID 380 THE SUDDEN CHANGE IN CARDIAC FUNCTION AFTER PATENT DUCTUS ARTERIOSUS LIGATION MEASURED BY ELECTRICAL CARDIOMETRY IN AN EXTREME LOW BIRTH WEIGHT INFANT Y.H. Chien; K.Y. Chao; Y.L. Chen; L.Y. Tsai; C.E. Chiang; S.C. Mu (Taiwan) ID 509 PULSE OXIMETRY SCREENING IN THE ASYMPTOMATIC NEWBORNS S. Chaudhry; Y. Singh (United Kingdom) ID 513 CHANGES IN THE MANAGEMENT OF PATENT DUCTUS ARTERIOSUS OVER 10 YEARS IN A TERTIARY NEONATAL CENTRE D. Panjwani; S. Mittal (United Kingdom) 106 106 4th November, 2017 107 107 ID 515 COARCTATION OF THE AORTA - THE CONGENITAL HEART DEFECT ID 273 HEMODYNAMIC RELEVANCE OF PATENT DUCTUS WITH A MILLION FACES ARTERIOSUS IN PRETERM INFANTS ASSESSED BY CEREBRAL M. Simon; R. Sánta; L.M. Suciu; Z.S. Gáll; R. Marian; M. Rusneac; C. Gliga; OXYGENATION OF FREQUENCY DOMAIN NEAR-INFRARED M.C. Cucerea (Romania) SPECTROSCOPY; ECHOCARDIOGRAPHIC AND DOPPLER-ULTRASOUND PARAMETERS AND NT-PROBNP: A ID 550 RARE CONGENITAL MITRAL VALVE MALFORMATION PROSPECTIVE OBSERVATIONAL STUDY R. Stroescu; A. Popoiu; M. Gafencu; O. Marginean; G. Doros (Romania) C.E. Schwarz; A. Preusche; M. Wolf; C.F. Poets; A.R. Franz (Germany) ID 628 ASSESSMENT OF NEONATAL HEART RATE IMMEDIATELY AFTER BIRTH ID 417 ULTRASONOGRAPHIC MONITORING FOR POSTNATAL ADAPTATION IN USING DIGITAL STETHOSCOPE; HAND HELD ULTRASOUND AND PRETERM INFANTS ELECTROCARDIOGRAPHY V. Nardi 1; M.L. Tataranno 2; S. Di Fabio 1 B. Treston; J. Semberova; R. Kernan; E. Crothers; A. Branagan; N. O’Cathain; (1. Italy; 2. The Netherlands) J. Miletin (Ireland) ID 464 RETROSPECTIVE ANALYSIS OF CATHETER RELATED VEIN THROMBOSIS ID 639 COINCIDENTAL LEFT ATRIAL THROMBUS AMONG NEWBORNS IN THE NICU SETTINGS. I. Mungan Akin; P. Canizci; S. Sevuk Ozumut; S. Arslanoglu (Turkey) K. Chojnacka; Z. Krasinski; K. Wróblewska-Seniuk; J. Mazela (Poland) ID 683 PERICARDIAL EFFUSION: SEVERE COMPLICATION OF CENTRAL ID 676 TREATMENT FOR PATENT DUCTUS ARTERIOSUS AND NEUROCOGNITIVE VENOUS CATHETERIZATION IN THE NEWBORN (REPORT OF 12 OUTCOME AT 6.5 YEARS OF AGE IN CHILDREN BORN EXTREMELY SURVIVORS) PRETERM S. Nouri Merchaoui; J. Methlouthi; H. Ayache; M. Bellalah; I. Kacem; A. Gudmundsdottir; L. Broström; B. Skiöld; K. Källén; M. Norman; U. Ådén; H. Barbouche; A. Ghith; N. Mahdhaoui; H. Seboui (Tunisia) A-K. Edstedt Bonamy (Sweden) ID 694 GENETIC ABNORMALITIES AND CONGENITAL HEART DISEASE ID 715 SYSTEMIC HYPOPERFUSION AND REGIONAL OXYGENATION IN PDA: S. Nouri Merchaoui; J. Methlouthi; H. Ayech; M. Bellaleh; I. Kacem; A CASE REPORT H. Barbouche; A. Ghith; S. Mougou; D. Hmida; N. Mahdhaoui; H. Seboui V. Comito; A. Falcone; L. Bruno; E. Paviglianiti; I. Mondello; A. Rossi (Italy) (Tunisia) ID 724 LONG-TERM OUTCOME AFTER PATENT DUCTUS ARTERIOSUS ID 704 USE OF PROSTIN IN A TERTIARY NEONATAL UNIT TREATMENT IN EXTREMELY PRETERM INFANTS R. Prasad; H. Wood; O. Nolan; S.V. Rasiah (United Kingdom) M.S. Veldhuis; L.M.L. Dix; J.M.P. Breur; W.B. de Vries; I.C. van Haastert; P.M.A. Lemmers; D.C. Vijlbrief (The Netherlands) ID 769 THE USABILITY OF ICON FOR NEONATOLOGY W.P. de Boode; B.M. Wulterkens; B.A.M. Nieuweweme (The Netherlands) ID 794 PROGNOSTIC VALUE OF THE VALUE OF SUPERIOR VENA CAVA FLOW DURING THE FIRST DAY IN PRETERM INFANTS ≤32 WEEKS GESTATION ID 810 WHAT IS THAT PULSATING ON THE ANTERIOR ABDOMINAL WALL? G.C. Zaharie; T. Drugan; D. Muresan; M. Matyas; O. Nolan; R. Prasad; P. Miller; M. Singh; SV. Rasiah (United Kingdom) H. Rabe; Behalf of the NEO-Circ; M. Hasmasanu (Romania) ID 796 COMPARISON OF CARDIAC OUTPUT MEASURED BY BIOREACTANCE WITH ECHOCARDIOGRAPHY MEASUREMENTS IN INFANTS WITH BIRTH Circulation Macro Microcirculation WEIGHT BELOW 1250G. J. Miletin 1,2; J. Semberova 1,2; Z. Stranak 1,2 Chairs: Willem de Boode (The Netherlands) (1. Ireland; 2. Czech Republic) ID 236 THE INFLUENCE OF MATERNAL MEDICATION ON CLOSURE OF THE ID 807 SPONTANEOUS NEONATAL ARTERIAL THROMBOSIS: A REPORT OF 6 DUCTUS ARTERIOSUS IN THE PREMATURE NEWBORN NEONATES W.P. de Boode; J. van Drongelen; M.J.A. Raaymakers (The Netherlands) J. Mathlouthi; S. Nouri; H. Ayech; M. Bellaleh; I. Kacem; H. Barbouch; N. Mahdhaoui (Tunisia) ID 263 CHRONOLOGICAL EX-UTERINE ADAPTATION OF HEMODYNAMIC PERFORMANCE IN VERY LOW BIRTH WEIGHT (VLBW) PRETERM INFANTS ID 859 THE USE OF ETCO2 (CAPNOGRAPHY) IN NEONATAL INTUBATION R. Lien; S. Hsu; D. Mok; W.M. Chen; L.C. See (Taiwan) A. Davies; A. Walker; L. Elsaadany; P. Shires; D. Batra (United Kingdom) 108 108 4th November, 2017 4th November, 2017 109 109 ID 877 COMPARISON BETWEEN NIRS AND THE TRADITIONAL AND NOVEL ID 202 PROACTIVE USE OF BREAST MILK FORTIFIER AND APPROACH OF SVC FLOW ASSESSMENT IN VLBW INFANTS BREASTMILK AT DISCHARGE: IS THERE A LINK? A NATIONAL B. Ficial; A. Boschetti; E. Bonafiglia; A. Pietrobelli; P. Biban (Italy) SURVEY OF PRACTICE S. Stiles; L. de Rooy (United Kingdom) ID 220 SODIUM SUPPLY BUT NOT HYPERNATREMIA IS ASSOCIATED Neonatal Fetal Nutrition and Metabolism WITH SEVERE INTRAVENTRICULAR HEMORRHAGE IN EXTREMELY PRETERM INFANTS Chairs: Colin Morgan (United Kingdom); Sissel Moltu (Norway); C. Späth; E. Stoltz Sjöström; J. Ågren; F. Ahlsson; M. Domellöf (Sweden) Mark Johnson (United Kingdom) ID 245 RELATION OF CORD SERUM LEVELS OF INSULIN-LIKE GROWTH ID 033 GUIDE LINES FOR MULTIVITAMINS ADMINISTRATION IN FORTIFIED FACTOR-I; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3; HUMAN MILK PREPARE FOR PRETERM INFANT GLUCAGON AND LEPTIN ON BIRTH INDICES BETWEEN KOREAN V. Rigourd; I. Dridi Brahim; H. Razafimahefa; F. Quetin; E. Leroy; C. Pichon; PRETERM AND TERM INFANTS A. Giuseppi; L. Berthie (France) J.H. Park; S.J. Kang; L.H. Lee; S.Y. Shin; C.S. Kim; S.L. Lee; J.G. Bae; S. Kim (Korea) ID 077 EFFECTS OF EXCLUSIVE DONOR HUMAN MILK FEEDING IN A SHORT PERIOD AFTER BIRTH ON MORBIDITY AND GROWTH OF PRETERM ID 264 USE OF DONOR BREAST MILK IN A TERTIARY NEONATAL UNIT – INFANTS DURING HOSPITALIZATION COMPLIANCE WITH A GUIDELINE S.H. Chung; E.J. Kim (Korea) C. Apsey; K; Williams; K. Johnson; H. Shore (United Kingdom) ID 130 ASSAY OF IRISIN CONCENTRATION IN INFANT FORMULAS AND ID 265 COPPER AND ZINC CONTENT OF BREASTMILK FROM WOMEN BREAST MILK SUFFERING FROM WILSON’S DISEASE N. Mól; P. Tomasik; M. Zasada; P. Kwinta (Poland) T. Reicherzer; G. Schütze; M. Vogeser; A. Schulze; A.W. Flemmer (Germany) ID 140 ENTERAL FEEDING STRATEGIES FOR VERY LOW BIRTH WEIGHT INFANTS: ID 276 EARLY ENERGY AND PROTEIN INTAKE AFFECTS GROWTH AND A NATIONWIDE SURVEY IN JAPAN MORBIDITY IN EXTREMELY PRETERM INFANTS M. Ashina; K. Fujioka; S. Totsu; H. Shoji; T. Miyazawa; K. Wada; K. Iijima; S. Klevebro; V. Westin; E. Stoltz Sjöström; M. Norman; M Domellöf; I. Morioka (Japan) A-K Edstedt Bonamy; B Hallberg (Sweden) ID 160 DONOR HUMAN MILK MACRONUTRIENT CONTENT: THE EFFECT OF ID 293 USE OF PROBIOTICS IN PRETERM NEWBORNS. DOES FEEDING HOLDER PASTEURIZATION TOLERANCE IMPROVE? P. Piemontese; D. Mallardi; N. Liotto; C. Menis; C. Tabasso; M. Perrone; M.I. Huescar; M.G. Espinosa; T. Sanchez; E. Salguero (Spain) M.L. Giannì; P. Roggero; F. Mosca (Italy) ID 339 EXTRAUTERINE GROWTH RESTRICTION ASSOCIATED FACTORS IN ID 161 NEW PARENTERAL NUTRITION AND ACIDOSIS IN PRETERM INFANTS SMALL AND APPROPRIATE FOR GESTATIONAL AGE INFANTS: F. Bonsante; JB. Gouyon; S. Iacobelli (France) A COHORT STUDY C. Morcelli-Tovar; A.A.Vieira (Brazil) ID 172 IMPACT ON BREASTFEEDING RATES OF PRETERM INFANTS WITH LESS THAN 29 WEEKS WITH RESTRICTION OF RAW HUMAN MILK IN THE FIRST ID 362 NEONATAL INTESTINAL FAILURE IN THE UK – WHO CARES? EIGHT WEEKS OF LIFE DUE TO THE RISK OF PERINATAL R. Jones; P. Cairns (United Kingdom) CYTOMEGALOVIRUS INFECTION F.P. Martins-Celini; W.A. Gonçalves-Ferri; B.B. Lima; D.C. Aragon; M.M. Mussi ID 398 HYPOARGININAEMIA AND SEPSIS IN VERY PRETERM INFANTS (Brazil) RECEIVING PARENTERAL NUTRITION C. Morgan; L. Burgess (United Kingdom) ID 179 VITAMIN D STATUS AMONG PRETERM INFANTS AS A HIGH RISK MORBIDITY MARKER ID 399 TARGET PARENTERAL PROTEIN ATTAINMENT IN PARENTERALLY FED I. Tofe; M.D. Cañete M.J. de la Torre; J.L. Perez-Navero; PRETERM INFANTS FOLLOWING THE IMPLEMENTATION OF THE J. Caballero-Villarraso (Spain) CONCENTRATED MACRONUTRIENTS IN PARENTERAL STANDARDISED SOLUTIONS (CoMPaSS) PROGRAMME F. Callaghan; C. Morgan (United Kingdom) 110 110 4th November, 2017 4th November, 2017 111 111 ID 435 LEVELS OF GLUCOSE IN CORD BLOOD SAMPLES (LOGICS) ID 721 TYPE OF FEEDING IN BABIES FROM THE NEONATAL N. Ó Catháin 1; A. Stanzelova 1; B. Treston 1; R. O’Kelly 2; A. Killalea 2; INTENSIVE THERAPY UNIT OF A BABY FRIENDLY HOSPITAL AT J. Kelly 2; J. Semberova 1; J. Miletin 1,2 THE TIME OF HOSPITAL DISCHARGE (1. Ireland; 2. Czech Republic) A.M. Miranda; A.L.L. Ledesma; G.M. Fernandes; I.C.L. Firmino; G. Berretim-Felix (Brazil) ID 455 SANJAD SAKATI SYNDROME: ABOUT NEW TUNISIAN CASES A. Touati 1; S. Nouri 1 ;Y. Hallab 1; J. mathlouthi 1; N. Ben Salah 1; ID 725 DONOR HUMAN MILK IMPACT ON NUTRITIONAL STATUS M. Mastouri Haddeji 1; Y. El Abed 1; A. Ben Ahmed 1; A. Saad 1; OF VERY PRETERM INFANTS C. Ben Singor 2; D. H’mida Ben Brahim 1 S. Salas; D. Cañizo; M. Izquierdo; I. Iglesias (Spain) (1. Tunisia; 2. France) ID 730 INFLUENCE OF THE USE OF DONOR HUMAN MILK IN THE CLINICAL ID 466 THE EFFECT OF DRESSING AFTER TUB BATHING ON MOISTURE LOSS IN COURSE OF TWO COHORTS OF VERY PRETERM INFANTS PRETERM INFANTS D. Cañizo; S. Salas; M. Izquierdo; I.Iglesias (Spain) Z. Kan Onturk; D. Gozen (Turkey) ID 770 GROWTH AND BODY COMPOSITION ASSESSMENT AT FOLLOW-UP OF ID 508 THE IMPACT OF EARLY VERSUS LATE NUTRITIONAL SUPPORT ON VERY PRETERM INFANTS GROWTH AND NEURODEVELOPMENTAL OUTCOME IN VERY LOW B. del Rey Hurtado de Mendoza; C. Balcells; M. Izquierdo-Renau; BIRTH WEIGHT INFANTS I. Iglesias-Platas (Spain) C.Y. Kim; J.H. Hwang; E. Jung; B.S. Lee; A.R. Kim; K.S. Kim (Korea) ID 782 GROWTH OF VERY PRETERM INFANTS (<32 WEEKS) WITHIN 3 YEARS ID 574 INSULIN INFUSION FOR HYPERGLYCEMIA IN EXTREMELY PRETERM - AFTER BIRTH A PILOT STUDY K. Suzuki; Y Murayama; H Masaki (Japan) W. Hellström; S. Najm; K. Sävman; I. Pupp Hansen; D. Ley; G. Hellgren; A. Hellström; C. Löfqvist (Sweden) ID 786 THE ASSOCİATİON BETWEEN 25 OH-D VİTAMİN LEVELS AND AORTİC; CAROTİD İNTİMA MEDİA THİCKNESS İN HEALTY NEWBORN ID 600 PONDERAL INDEX IN SGA NEONATES: IS IT RELIABLE INDEX? İNFANTS S. Erçin; T. Gursoy (Turkey) D. Arman; Z. Cetiner; A. Erdil; E.Yurdakul (Turkey) ID 609 POSTNATAL GROWTH VELOCITY CALCULATION: ACCURACY OF ID 828 GROWTH PARAMETERS AT BIRTH IN INFANTS WITH CONGENITAL ZIKA DIFFERENT METHODS VIRUS SYNDROME AND MICROCEPHALY A. Ali 1; N. Rochow 1; A; Alkhoraidly 2; R. Iskander 1; G. Fusch 1; C. Fusch 1,3 I. García-García; L. Gely; J. Negrón; L. García-Fragoso (Puerto Rico) (1. Canada; 2. Saudi Arabia; Germany) ID 848 MICROBIOA AND SCFA OF TERM INFANTS ID 640 NEONATAL HYPOGLYCEMIA DETECTED BY A GLUCOSE METER: A. Bartnicka; M. Szewc; K. Mielnik; M. Gałęcka; J. Mazela (Poland) IS IT RELIABLE? K. Ben Ameur; K. Msalbi; T. Khemis; H. Ben Hamida; F.Z. Chioukh; K. Monastiri ID 857 URINARY METABOLIC PROFILE OF NEONATES IN WESTERN GREECE: (Tunisia) PRELIMINARY DATA I. Giannakopoulos; A. Tsintoni; I. Christopoulou; L. Vitsa; N. Malic; ID 688 CLINICAL EFFECTS OF OROPHARYNGEAL COLOSTRUM M.M. Pogka; S. E. Bariamis; I. Georgakopoulou; S.A. Chasapi; ADMINISTRATION IN VERY LOW BIRTH WEIGHT INFANTS IN THE FIRST G.A. Spyroulias; A. Varvarigou (Greece) MONTH OF LIFE E. Martin-Alvarez; M. Peña-Caballero; L. Serrano-Lopez; ID 858 DIETARY MANIPULATION OF MOTHERS OF PRETERM INFANTS: EFFECT M.B. Sánchez-Martínez; M. Alonso-Moya; J.J. Ochoa; J. Maldonado; ON BREASTMILK COMPOSITION AND MEETING MACRONUTRIENT J.A. Hurtado-Suazo (Spain) REQUIREMENTS K. Megaw (South Africa) ID 719 MACRONUTRIENT PROFILE OF DONATED BREAST MILK: DOES LONG TIME BREASTFEEDING MODIFY IT? ID 866 THE CONSEQUENCE OF PHOTOTHERAPY EXPOSURE ON OXIDATIVE N. Sarmiento-Carrera; N. Gonzalez-Freiria; A. Concheiro-Guisan; STRESS STATUS OF EXPRESSED HUMAN MILK M. Suarez-Albo; S. Alonso-Clemente; Jr Fernandez-Lorenzo (Spain) S. Unal; N. Demirel; D. Yaprak Sul; D. Ulubas Isik; S. Erol; S. Neselioglu; O. Erel; A. Yagmur Bas (Turkey) 112 112 4th November, 2017 4th November, 2017 113 113 ID 869 MONITORING THE GUT MICROBIOTA ESTABLISHMENT IN VERY ID 352 C-REACTIVE PROTEIN: AN ADJUNCT OR DILEMMA LOW-WEIGHT PRETERM INFANTS FOR DIAGNOSIS OF NEONATAL MENINGITIS E. Escribano; C. Saralegui; R. del Campo; S. del Pozo; L. Moles; F. Yasin; S.F. Virupachi; R.A. Khan (Ireland) J.M. Rodríguez; M. Saenz de Pipaon (Spain) ID 408 DNA VIRUSES: THEIR ROLE IN ACUTE RESPIRATORY ID 876 BABIES WITH FEEDING DIFFICULTIES HAVE HIGHER CONCENTRATIONS INFECTIONS IN NEONATAL UNIT IN TUNISIA OF BETA-HYDROXYBUTYRATE I. Brini 1,2; N. Hannachi 1; A. Guerrero 2; B. Hetzer 2; W. Borena 2; D.L. Harris; P.J. Weston; J.E.Harding (New Zealand) S. Nouri Merchaoui 1; H. Sboui 1; D. Von Laer 2; J. Boukadida 1; H. Stoiber 2 (1. Tunisia; 2. Austria) Neonatal Infections Diseases / Immunology ID 429 REVIEW OF ADVERSE VACCINE REACTIONS IN AN IRISH NEONATAL UNIT Chairs: Charles C. Roehr (United Kingdom) C. Fox; E. Gordon (Ireland) ID 019 UPTAKE OF PERTUSSIS AND INFLUENZA VACCINES IN PREGNANCY ID 445 DOES DURATION OF BLOOD CULTURE REPORTING IMPACT ON THE A. Saso; B. Donaldson; B. Kampmann (United Kingdom) CARE OF NEONATES AT RISK OF EARLY ONSET NEONATAL SEPSIS? L. Woodgate; C. Chetcuti Ganado (United Kingdom) ID 034 SEVERE COMBINED IMMUNE DEFICIENCY AND CONTINUED BREASTFEEDING: REPORT OF 5 OWN MOTHER’S MILK DONATION ID 459 A CANDIDA TROPICALIS OUTBREAK DURING EL NINO IN A NEONATAL (OMM) AT THE REGIONAL ILE DE FRANCE MILK BANK INTENSIVE CARE UNIT IN SOUTHERN PHILIPPINES V. Rigourd; D. Moshous; J.F. Méritet; M. Nicloux; C. Hovhannisyan; M. Dorsi; C. Masilungan; R. Aunal; J. Peralta (Philippines) T. Hachem; P. Frange; A. Lapillonne; J.F. Magny (France) ID 483 CONGENITAL CYTOMEGALOVIRUS INFECTION- NEONATOLOGICAL ID 251 ANTIBIOTIC EXPOSURE IN NEONATES AND IMPACT ON GUT ASPECT MICROBIOTA AND ANTIBIOTIC RESISTANCE DEVELOPMENT: S. Stefanovic; V. Stefanovic; V. Stefanovic (Serbia) A SYSTEMATIC REVIEW J. Fjalstad 1; E. Esaiassen 1; L. Juvet 1; J. van den Anker 2; C. Klingenberg 3 ID 548 DIAGNOSTIC VALUE OF SERUM AMYLOID A IN NEONATAL BACTERIAL (1. Norway; 2. Switzerland; 3. United States) INFECTIONS AND ASSOCIATIONS WITH CIRCULATING HDL AND CYTOKINE LEVELS ID 252 EFFECT OF CATHETER DWELL TIME ON RISK OF CENTRAL LINE V. Bourika; E. Hantzi; A. Margeli; I. Papassotiriou; T. Siahanidou (Greece) ASSOCIATED BLOOD STREAM INFECTION IN NEONATES IN A DEVELOPING HEALTHCARE SYSTEM ID 558 CONGENITAL TUBERCULOSIS AS A RESUL OF DISSEMINATED S.B. Chaaya; R. Durmush; C.P.H. Ibrahim (United Arab Emirates) MATERNAL DISEASE. IS CORRECT THE ACTUAL MANAGEMENT? A.B. Escobar Izquierdo; G. Uclés López; M.J. Cobas Pazos; Y. Lopez Lozano; ID 258 20 YEARS OF EARLY NEONATAL SEPSIS DUE TO ESCHERICHIA COLI: M.D. Sanchez-Redondo Sanchez-Gabriel; A. Martinez Gimeno (Spain) SHOULD WE CHANGE EMPIRICAL ANTIBIOTIC THERAPY? M.C. Céspedes; N. Mendoza; M. Balasch; S. Gonzalez; A. Andreu; M.A. Frick; ID 562 NEONATAL SEPSIS: FREQUENCY; RISK FACTORS AND OUTCOME IN A MA. Linde; J.J. Gonzalez; P. Soler (Spain) LEVEL II NICU UNIT L. Blaga; M. Matyas; C. Vidra; M. Hasmasanu; G. Abrudan; G. Zaharie ID 288 HAND HYGIENE COMPILENCE IN NICU; A OBSERVATIONAL STUDY (Romania) A. Gürol; K.Ş. Tekgündüz; S. Polat; S.E. Tekgündüz; S. Ejder Apay (Turkey) ID 567 LUMBAR PUNCTURE SUCCESS & FAILURE IN A TERTIARY NEONATAL ID 296 NEONATAL SEPTIC ARTHRITIS IN NICU UNIT - A PROSPECTIVE COHORT STUDY F. Krasniqi; I. Krasniqi; X. Gojnovci; H. Jashari (Kosovo) A. Marshall 1; M. Sadarangani 1; C.C. Roehr 1,2; M. Anthony 1 (1. United Kingdom; 2. Germany) ID 301 CURRENT PRACTICE AND NEONATAL STAFF’S KNOWLEDGE ON ANTIBIOTIC USE AND ANTIBIOTIC STEWARDSHIP PROGRAMMES ID 614 HOSPITALISATION FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) ACROSS TWO NEONATAL NETWORKS INFECTION IN PREMATURE INFANTS BORN IN MULTIPLE BIRTHS M. Scott; M. Carpenter; P. Satodia; P. Nath (United Kingdom) R. Thwaites; S. Buchan; C. Morris; B. Rodgers-Gray; J. Fullarton; J. Coutts (United Kingdom) ID 333 PREDICTORS OF MORTALITY IN NEONATAL SEPSIS G. Irawan Sarosa; R. Rahim (Indonesia) 114 114 4th November, 2017 4th November, 2017 115 115 ID 619 ANTIBIOTICS FOR EARLY ONSET NEONATAL SEPSIS: AUDITING ID 750 NEONATAL INFECTIONS AT PREMATURE AND AT TERM PRACTICE AND ANALYSING COST NEWBORN O. Kazeem; M. Saunders; R. Roy; C. Tremlett (United Kingdom) M. Dima; I. Petre; A Baros; E.R. Iacob; D. Iacob (Romania) ID 630 DYSFUNCTIONAL INFLAMMATION; THE SIGNIFICANCE OF TLR2 ID 752 PROSTAGLANDIN E2 URINARY METABOLITE IN PRETERM SIGNALING IN HYPOXIC NEONATES PREDISPOSED TO NEURAL INFANTS – A BIOMARKER FOR INFLAMMATION? ENCEPHALOPATHY V. Siljehav; L. Gerbaulet; G. Aquilano; A. Honore; S. Psyllidou; M. Vanpée; B. Wright; K. Lynne; M. Eleanor; M. Omer; N. A Taher; M. O’Dea; A. Melorz; E. Herlenius (Sweden) A. Moreno (Ireland) ID 755 APPLICATION OF EVIDENCE-BASED MEDICINE METHODS TO ID 658 NEONATAL THYMIC CHARACTERISTICS IN A RAT MODEL OF DIAGNOSE EARLY NEONATAL SEPSIS INTRAUTERINE GROWTH RESTRICTION O.Vlasova; L. Koliubakina; L. Bezrukov (Ukraine) J.B. Armengaud; K. Nardou; F. Pre-Curto; F. Candotti; F. Angelini; M. Hofer; U. Simeoni; C. Yzydorczyk (Switzerland) ID 787 NEONATAL BRONCHIOLITIS: CLINICAL PRESENTATION; MANAGEMENT AND PREVENTION ID 682 IMPACT OF MICROBIAL-ASSOCIATED INTRA-AMNIOTIC H. Ben Salem; M.T. Lamouchi; M. Sellami; I. Kasraoui; N. Kasdallah; S. Blibech; INFLAMMATION AND “STERILE” INTRA-AMNIOTIC INFLAMMATION M. Doagi (Tunisia) ON SHORT-TERM NEONATAL OUTCOME IN WOMEN WITH PRETERM LABOR AND INTACT MEMBRANES ID 801 SHOULD WE LUMBAR PUNCTURE TERM BABIES BASED ON CRP A. Herranz Barbero; R. Amoedo Blanco; M. Izquierdo Renau; C. Murillo; CRITERIA SET BY NICE? C. Rueda; J. Ponce; T. Cobo (Spain) H. Wood; S. Steadman; J. Gray; V. Rasiah (United Kingdom) ID 685 PCT; IL-6 AND IL-8; BUT NOT HA ARE USEFUL FOR DIAGNOSTIC UTILITY ID 840 MENB (BEXSERO®) IMMUNISATION IN NICU: EXPERIENCE IN A UK IN NEONATES AT RISK THAT FULFILL THE NORWEGIAN CONSENSUS TERTIARY NEONATAL UNIT POST INTRODUCTION OF VACCINE DEFINITION OF NEONATAL SEPSIS A. Mukherjee; S. Senthil; A. Razai; D. Mukherjee (United Kingdom) B. Nakstad; H.C.D. Østerholt; A.L. Solevåg (Norway) ID 699 NEONATAL INVASIVE CANDIDIASIS: STUDY OF 108 CASES COLLECTED IN NEONATOLOGY DEPARTMENT OF SOUSSE (TUNISIA) S. Nouri Merchaoui; N. Mahdhaoui ; H. Ayache; F. Saghrouni; M. Bellalah; I. Kacem; H. Barbouche; A. Ghith; J. Methlouthi; H. Seboui (Tunisia) ID 706 NEWBORN SCREENING TESTS IN INFANTS WITH CONGENITAL ZIKA VIRUS SYNDROME AND MICROCEPHALY L. García-Fragoso; L. Gely; S. Rivera-Sánchez; I. García-García (Puerto Rico) ID 716 PREVENTIVE EFFECT OF LACTATIONAL MASTITIS BY ADMINISTRATION OF LACTOBACILLUS FERMENTUM CECT5716. A RANDOMIZED CONTROLLED TRIAL. L. Serrano López; E. Martín Álvarez; M. Peña Caballero; J. Fonollá Joya; J.A. Hurtado Suazo (Spain) ID 728 UMBILICAL CORD CARE AND OMPHALITIS IN NEWBORNS OF NORTHERN PORTUGAL: A MULTICENTRIC RETROSPECTIVE STUDY C. Teles Silva; M. Nogueira; I. Falcão; A.L. Santos; M. Rodrigues; G. Silva; H. Guimarães (Portugal) ID 743 CENTRAL LINE ASSOCIATED INFECTION IN NEWBORNS ADMITTED TO A PORTUGUESE NEONATAL INTENSIVE CARE UNIT T. Lopes; M. Branco; A. Freitas; I. Falcão; C. Carvalho; E. Proença; A. Almeida (Portugal) 116 116 4th November, 2017 4th November, 2017 117 117 9:00 - 11:00 PARALLEL SESSION 35 09:00 – 11:00 PARALLEL SESSION 36 (BRAIN 5) SENSORY OUTCOMES AND PAIN |DARSENA ROOM AUTOPHAGY IN DEVELOPING BRAIN |VENEZIA ROOM Chairs: Jurgen C. de Graaff (The Netherlands); Chairs: Anita Truttmann (Switzerland); Ola D. Saugstad (Norway) Ingran Lingam (United Kingdom) 09:00 – 09:20 Long term effects of neonatal pain 09:00 – 09:20 Role of mitochondria and autophagy in perinatal brain Suellen Walker (United Kingdom) damage Henrik Hagberg (United Kingdom) 09:20 – 09:40 Anaesthetic toxicity in children Jurgen C. de Graaff (The Netherlands) 09:20 – 09:40 Autophagic cell death in perinatal brain injury: does it matter? 09:40 - 09:55 Neonatal pain, opioid and anaesthetic exposure; what Anita Truttmann (Switzerland) remains in the human brain after the wheels of time? G.E. van den Bosch; D. Tibboel; J.C. de Graaff; H. El Marroun; 09:40 - 09:55 Blood based proteins that differentiate inflammation- A. van der Lugt; T. White; M. van Dijk (The Netherlands) sensitized hypoxia versus hypoxia alone within the 6h therapeutic window in a piglet model 09:55 - 10:10 Mode of delivery influences nociceptive sensitivity in I. Lingam 1; A. Avdic-Belltheus 1; K. Martinello 1; C. Meehan 1; newborn infants – the NociCop trial S. Ragab 1; I. Tachtsidis 1; C. Tann 1; M. Hristova 1; B. Fleiss 1; N. Klarer 1; S. Kasser 1; H. Rickenbacher 1; C. Hartley 2; T. Wolfs 2; B. Kramer 2; N. Klein 1; H. Hagberg 1; P. Gressens 1; A. Depoorter 1; A.N. Datta 1; W. Magerl 3; E.A. Huhn 1; G. Green 2; N.J. Robertson 1 R. Slater 2; Wellmann 1 (1. United Kingdom; 2. The Netherlands) (1. Switzerland; 2. United Kingdom; 3. Germany) 09:55 - 10:10 Autophagy inhibition protects in a preterm rat model of 10:10 - 10:25 Can differences in early functional connectivity in healthy excitotoxic brain injury newborns exposed to olfactory stimulation help us C. Descloux; V. Ginetì; J. Puyal; A.C. Truttmann (Switzerland) understand crying behaviour at 6 weeks of life? L. Freitas; A. Adam-Darque; F. Grouiller; J. Sauser; F. Lazeyras; 10:10 - 10:25 Interaction between acute therapeutic hypothermia and a A. Merglen; P. Pollien; C.L. Garcia-Rodenas; delayed mesenchymal stem cell therapy in neonatal G. Bergonzelli Degonda; D. Van De Ville; P. Hüppi; hypoxia-ischemia R. Ha-Vinh Leuchter (Switzerland) J. Herz; C. Köster; B. S. Reinboth; M. Dzietko; I. Bendix; U. Felderhoff-Müser (Germany) 10:25 - 10:40 The effect of morphine on early brain activity in extremely preterm infants: an observational multi-center study 10:25 - 10:40 A comparison of the effects of short term whole body M.L. Tataranno1; L.S. deVries 1; L. Hellström-Westas 1; vibration, as experienced during neonatal ambulance O. Dammann 2; M. Toet 1; F. Groenendaal 1; N.H.P. Claessens 1; transportation, on the developing brain V. Fellman 3; K. Sävman 3; M.J.N.L. Benders 1 L. Shipley; I. Bloor; D. Sharkey (United Kingdom) (1. The Netherlands; 2. Germany; 3. Sweden) 10:40 - 10:55 CEACAM1 expression in the cerebellum 10:40 - 10:55 Self-reported widespread pain in adults born early and late S. Prager; B.B. Singer; I. Bendix; J. Herz; U. Felderhoff-Müser preterm (Germany) K.A.I. Evensen 1; M. Tikanmäki 2; K. Heinonen 2; H-M. Matinolli 2; M. Sipola-Leppänen 2; A. Lano 2; D. Wolke 3; M. Vääräsmäki 2; J.G. Eriksson 2; S. Andersson 2,3; M-R. Järvelin 1; P. Hovi 2; K. Räikkönen 1; E. Kajantie 2 (1. Norway; 2. Finland; 3. United Kingdom) 118 118 4th November, 2017 4th November, 2017 119 119 09:00 – 11:00 PARALLEL SESSION 37 (PULMONOLOGY 6) 09:00 – 11:00 PARALLEL SESSION 38 (NUTRITION 5) FETAL GROWTH – SIZE MATTERS |ROMA ROOM PROGRAMMING BY EARLY NUTRITION IN PRETERM Chairs: Olivier Danhaive (Belgium) INFANTS: WHAT IS KNOWN, WHAT IS HYPOTHESIZED? |FIRENZE ROOM 09:00 – 09:30 A database on fetal growth Chairs: Umberto Simeoni (Switzerland); Stephen Kennedy (United KIngdom) 09:00 – 09:20 Early nutrition and long term cardiovascular health 09:30 - 09:45 Can we assess the severity of neonatal respiratory distress by Umberto Simeoni (Switzerland) ultrasound? A comparison of three methods F. Raimondi; F. Migliaro; L. Verdoliva; D. Gragnaniello; G. Poggi; 09:20 – 09:40 Decisions in early nutrition and later metabolic C. Sansone; R. Kosova; L. Capasso (Italy) consequences Petteri Hovi (Finland) 09:45 - 10:00 PCO2 levels and clinical and neurodevelopmental outcomes of extremely low birthweight infants 09:40 - 09:55 Early-life protein intake in infants born extremely preterm is T.H. Ulrich 1; J. Dreyhaupt 1; O. Genzel-Boroviczeny 1; associated with higher blood pressure at school-age - Itay B. Bohnhorst 1; M. Schmid 2; H. Fuchs 1; O. Rohde 1; S. Avenarius 1; I. Zamir; E. Stoltz Sjöström; A.K. Edstedt Bonamy; H-G. Topf 1; A. Zimmermann 1; D. Faas 1; K. Timme 1; B. Kleinlein 1; L.A. Mohlkert; M. Norman; M. Domellöf (Sweden) H. Buxmann 1; W. Schenk 1; H. Segerer 1; N. Teig 1; F. Pulzer 1; R. Hentschel 1; M. Heckmann 1; R. Schlösser 1; J. Peters 1; R. Rossi 1; 09:55 - 10:10 Prevalence of prediabetes and type 2 diabetes in young W. Rascher 1; R. Böttger 1; J. Seidenberg 1; G. Hansen 1; adults born with very low birth weight M. Zernickel 1; R. Muche 1; H.D. Hummler 1; for the PHELBI Study M. Talman; P. Nixon; E. Jensen; L. Washburn (United States) Group (1. Germany; 2. Switzerland) 10:10 - 10:25 Transient postnatal overfeeding in mice leads to metabolic and hepatic disorders at adulthood 10:00 - 10:15 Alveolar surfactant composition in preterm infants with C. Yzydorczyk 1; N. Li 2; D. Mosig1; M. Bidho 1; B. Keshavjee 1; respiratory distress syndrome before exogenous surfactant J.B. Armengaud 1; C. Vergely 2; U. Simeoni 1 administration: effect of gestational age and inflammation (1. Switzerland; 2.France) G. Verlato; M. Simonato; E. Bassi; M. Fantinato; A. Correani; I. Giretti; E. Baraldi; P. Cogo; V.P. Carnielli (Italy) 10:25 - 10:40 Effect of infant formula with protein content of 1.6g/100kcal fed between 3-12 months on body composition and 10:15 - 10:30 TGFβ signaling is critical for regulating a proximal adiposity at age 5 years differentiation program and lung branching morphogenesis E.E. Ziegler 1; D.A. Fields 1; S.D. Chernausek 1; D. Grathwohl 3; through activating notch signaling J.M. Jeter 1; S.E. Nelson 1; M. Chen 1; N.P. Hays 1; F. Haschke 3 P.N. Tsao 1; H.K. Chen 1; T.Y. Ling 1; W.V. Cardoso 2 (1. United States; 2. Switzerland; 3. Austria) (1. Taiwan; 2. United States) 10:40 - 10:55 Newborn bone health is affected by maternal bariatric 10:30 - 10:45 A randomised controlled trial of needle aspiration or surgery chest drain insertion for pneumothorax in newborns E. Malchau Carlsen; K. Martha Renault; B. KanijoMøller; (The NORD Trial), ISRCTN65161530 K. Nørgaard; L. Nilas; J-E. Bech Jensen; J. Lauenborg; D. Cortes; M. Murphy 1; C. Heiring 2; N. Doglioni 3; D. Trevisanuto 3; O. Pryds (Denmark) M. Blennow 4; K. Bohlin 4; G. Lista 3; I. Stucchi 3; C. O’Donnell 1 (1. Ireland; 2. Denmark; 3. Italy; 4. Sweden) 120 120 4th November, 2017 4th November, 2017 121 121 09:00 - 11:00 PARALLEL SESSION 39 09:55 - 10:10 Supporting the peer supporter G. Thomson; M-C. Balaam (United Kingdom) NURSE SPECIALIST AND NURSE PRACTIONER ROLES AND PRACTICES |SORRENTO ROOM 10:10 - 10:25 Postpartum depression, bonding and coping strategies in Chairs: Karen New (Australia); Carol Kenner (United States) mothers of newborns admitted to the neonatal unit R. Porta; G. Lasheras; E. Capdevila; B. Farré-Sender ; J.M. Farré 09:00 - 09:30 New professional role in neonatology, challenges and (Spain) regulations Odile Frauenfelder (The Netherlands) 10:25 - 10:40 Two year neurodevelopmental follow up data: meeting metrics vs delivering quality assessments 09:30 - 10:00 Neonatal nursing, where we are and where we are going – M. Parmar; F. Ceroni; S. Narayanan; N. Merchant the evolving role of NPs (United Kingdom) Karen Walker (Australia) 10:40 – 11:00 Discussion 10:00 - 10:30 Case presentation: a neonate who suddenly collapses- deciphering the differential diagnoses Karen Walker (Australia) 11:00 – 11:30 COFFEE BREAK 10:30 - 11:00 Not just neonatal survival – the effects of cerebral palsy and long term morbidity & long term outcomes in terms of autism etc Margo Pritchard (Australia) 11:30 - 13:00 CLOSING SESSION |DARSENA ROOM PERSONALIZED MEDICINE Chairs: Charles C. Roehr (United Kingdom); Corrado Moretti (Italy) 09:00 - 11:00 PARALLEL SESSION 40 (EFCNI 5) 11:30 – 12:10 Epigenetics: an evolutionary perspective on chronic disease BRIDGING THE GAP BETWEEN HOSPITAL AND Jonathan Wells (United Kigdom) OUT-PATIENT CARE FOR HOSPITALISED NEWBORNS 12:10 – 12:50 The impact of early life experiences in neurodevelopmental |LECCE ROOM disorders Chairs: Silke Mader (Germany) Pierre Gressens (France) 09:00 - 09:20 Being a neonatal nurse practitioner working with parents is: 12:50 – 13:00 Closing Words transferring, supporting and accompanying towards parenthood George Damhuis (The Netherlands) 09:20 – 09:40 Graduating from the NICU and transition to the outpatient setting - what the primary care physician likes to know Kai König (Switzerland) 09:40 - 09:55 Mother-infant closeness supports the breastfeeding of preterm infants at discharge S. Raiskila 1; A. Axelin 1; L. Toome 2; S. Caballero 3; B. Tandberg 4; R. Montirosso 5; E. Normann 6; B. Hallberg 6; B. Westrup 6; U. Ewald 6; L. Lehtonen 1 (1. Finland; 2. Estonia; 3. Spain; 4. Norway; 5. Italy; 6. Sweden) 122 122 4th November, 2017 4th November, 2017 123 123 SPONSORED SESSIONS 30/10/2017 09:00 - 17:30 PRE-CONGRESS COURSE | CAPRI ROOM (PALAZZO DEL CASINÒ) ESN COURSE 1 - Neonatal Infections Supported by an unrestricted educational grant from 31/10/2017 09:00 - 17:00 PRE-CONGRESS COURSE |CAPRI ROOM (PALAZZO DEL CASINÒ) ESN COURSE 2 - Neonatal Haemodynamics Supported by an unrestricted educational grant from 01/11/2017 12:30 - 13:30 WORKSHOP |SORRENTO ROOM (MOSAICI 1) Respiratory Support in Neonates: How to ventilate term and preterm infants – Insights into new possibilities and neonatal ventilation strategies Supported by 12:30 - 13:30 LUNCHEON SYMPOSIUM |SORRENTO ROOM (MOSAICI 1) Early optimal nutrition in the NICU Supported by 12:30 - 13:30 LUNCHEON SYMPOSIUM |LECCE ROOM (MOSAICI 2) Strategies and modern technologies of continuous noninvasive blood gas monitoring Supported by 13:30 - 15:00 ROUND TABLE |FIRENZE ROOM Interactive clinical session: are babies with serious hypoxemic conditions still being missed? Supported by 13:30 - 15:00 SATELLITE SYMPOSIUM |LECCE ROOM (MOSAICI 2) Respiratory syncytial virus: should we identify paediatric patients at risk for severe disease? Peer Voice (This activity is supported by an educational grant from Abbvie) 15:00 - 17:00 PARALLEL SESSION 7 (PULMONOLOGY 1) |DARSENA ROOM Pulmonary Symposium Supported by an unrestricted educational grant from 124 124 125 125 SPONSORED SESSIONS Despeena. 6 Years. “When I was born at 24 weeks of gestation, I couldn’t 01/11/2017 breathe by myself. Thanks to your neonatal care, I can now discover the world just like my friends do and live the 17:30 - 18:30 PLENARY SESSION 3 |DARSENA ROOM Bengt Robertson Award happy life of a six years old girl.” Supported by an unrestricted educational grant from 02/11/2017 12:30 - 13:30 LUNCHEON SYMPOSIUM |DARSENA ROOM Pulse Oximetry CCHD Screening: focus on the recent EU consensus towards implementation Supported by 12:30 - 13:30 LUNCHEON SYMPOSIUM |LECCE ROOM (MOSAICI 2) ROP in 2017 & beyond - Present and future of the prevention and treatment of retinopathy of prematurity Supported by 13:30 - 14:30 SATELLITE SYMPOSIUM |VENEZIA ROOM Importance of human milk in preterm nutrition Supported by 18:00 - 19:30 EXECUTIVE SATELLITE SYMPOSIUM |VENEZIA ROOM Enhancing the success of respiratory management in nRDS Supported by 03/11/2017 13:30 - 15:00 EXECUTIVE SATELLITE SYMPOSIUM |VENEZIA ROOM Human milk fortification: benefits of an The European Foundation for the Care of Newborn exclusive human milk diet for premature Infants (EFCNI) is the first pan-European organisation infants and network to represent the interests of preterm and Supported by Become a newborn infants and their families. supporter for the best start in life. www.efcni.org/ european foundation for 126 126 donate the care of newborn infants Chiesi Satellite Symposium Thursday, November 2nd 2017 h. 18:00 - 19:30 | Hall Venezia, ground floor ENHANCING THE SUCCESS OF RESPIRATORY MANAGEMENT IN nRDS Chair Prof. A. Van Kaam, The Netherlands BPD: from trials to clinical practice Prof. W. Göpel, Germany Less Invasive Surfactant Administration (LISA), a new chapter in Neonatal Management Prof. P. Dargaville, Australia Success of intervention: the importance of Training with LISA Prof. M. Vento, Spain LISA Training with LISAcath® Prof. P. Dargaville, Australia Wednesday, November 1st Thursday, November 2nd Friday, November 3rd h. 11:00 - 11:30 I Chiesi booth, Stand nb.1, Exhibitory Area, third floor During morning coffee breaks* *Please verify in the official congress agenda the definitive slots of morning coffee breaks SPONSORS & EXHIBITORS 130 130 131 131 EXHIBITORS FLOOR PLAN THIRD FLOOR - PALAZZO DEL CASINÒ platform 1 7 12 FUTURE CONGRESSES 17 23 33 2 8 13 18 24 34 3&5 9 14 19 25 4 10 15 20 26 platform 6 11 16 21 32 &22 132 132 133 133 ACUTRONIC Medical Systems AG CHIESI FARMACEUTICI S.p.A. Address: Fabrik im Schiffli, CH-8816 Hirzel, Switzerland Address: Via Palermo 26/A – 43122 Parma - Italy Website: www.acutronic-medical.ch Website: www.chiesi.com Email:
[email protected] Email:
[email protected] Telephone number: +41 44 729 70 80 Telephone number: +39 0521 2791 Booth N°. : 10 Booth N°. : 1 ACUTRONIC is a swiss company developing, manufacturing and di- Based in Parma, Italy, Chiesi Farmaceutici is an international rese- stributing high tech ventilation solutions for worldwide NICU’s/PICU’s, arch-focused Healthcare Group, with over 80 years of experience, ICU’s and Intensive Care Transportation. We are the leading partner present in 26 countries. Chiesi researches, develops and markets in- for hospitals when it comes to the most critical areas of respiratory novative drugs in respiratory therapeutics, specialist medicine and care: Neonatalogy/Pediatrics, Jet Ventilation and Difficult Airway rare disease areas. Its R&D organisation is headquartered in Parma Management. and integrated with 6 other R&D groups. Our innovative products simplify the busy clinical routine for caregi- Curosurf is the leading surfactant for the treatment of RDS in pre- vers and increase the safety of patients. We challenge ourselves to matures, launched 25 years ago. Curosurf is now available in 94 continuously improve and set standards – like the ‘fabian’, the most countries. The Less Invasive Surfactant Administration (LISA) was ap- silent neo-ventilator in the marketplace today. And we strive every- proved in 2016, while in 2011 Chiesi launched Peyona, a pharma- day to provide the technologically best solutions that are needed for ceutical standard caffeine citrate for the treatment of AoP. the most medically challenging patients. ACUTRONIC. Ventilation Beyond Limits. BAXTER Drägerwerk AG & Co. KGaA - Medical Division Address: Thurgauerstrasse 130, CH-8152 Glattpark – Address: Moislinger Allee 53/55, 23558 Lübeck, Germany Opfikon, Switzerland Website: www.draeger.com Website: www.baxterhealthcare.ie Email:
[email protected] Booth N°. : 9 Telephone number: +49 451 882- 0 Booth N°. : 7 Baxter assisted clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins. Technology for Life: Dräger is an international leader in the fields of Since then, Baxter has continued to advance parenteral nutrition (PN) medical and safety technology. Dräger products protect, support therapy. For example, Baxter pioneered the world’s first “triple-cham- and save lives. The current product range of the medical division ber system” internationally for IV nutrition, which provides many of the includes anaesthesia workstations, medical ventilation, patient essential ingredients of balanced nutrition – protein, carbohydrates, monitoring as well as neonatal care for premature babies and lipids and electrolytes in a single container – simplifying the prepara- newborns. With ceiling supply units, IT solutions for the OR, and gas tion of PN. Today, Baxter provides one of the broadest PN portfolios management systems the company is at the customer’s side throu- globally, which includes premix IV solutions, vitamins and lipids, as well ghout the entire hospital. Dräger has more than 13,000 employees as pharmacy workflow management, labeling, compounding tech- worldwide and is currently present in more than 190 countries. nology and enteral nutrition syringes and accessories. 134 134 135 135 EMERGENCY NGO Fritz Stephan GmbH Address: Via Santa Croce 19 – 20122 Milan, Italy Address: Kirchstr. 19, 56412 Gackenbach, Germany Website: www.emergency.it Website: www.stephan-gmbh.com Email: fo.recruitingmergency.it Email:
[email protected] Telephone number: +39 02 86316316 Telephone number: +49 6439-9125-0 Booth N°. : 20 Booth N°. : 23 EMERGENCY is an independent Italian organization that provides Fritz Stephan GmbH, Germany has been providing innovative me- free, high quality medical and surgical treatment to the victims of dicai technology and constantly setting new standards in artificial war, landmines and poverty. It promotes a culture of peace, solidarity respiration, anesthesia and oxygen supply systems since 1978. and respect for human rights. Particular emphasis is placed on manufacturing respirators for pre- Since 1994 over 8 million people have received free, high quality he- mature infants and newborns. Requirements of medicai devices in alth care by EMERGENCY. neonata! care are fundamentally different from those for adults; artificial respiration needs to be as gentle as possible and must take physiological differences into account. Recent development and integration of a module for automatic contro! of oxygen saturation in respirators, thus improving treatment of premature infants, is just one recent example how Stephan innovations result in advanced lifesaving technology. Foundation Acta Paediatrica GE Healthcare Address: Tomtebodavägen 9, 171 65 Solna, Sweden Website: www.gehealthcare.com Website: www.actapaediatrica.com Booth N°. : 21/22 Email:
[email protected] Telephone number: +46 730 202 44 47 GE Healthcare provides transformational medical technologies Booth N°. : 25 and services to meet the demand for increased access, enhan- ced quality and more affordable healthcare around the world. GE Acta Paediatrica is a monthly peer-reviewed journal at the forefront (NYSE: GE) works on things that matter - great people and techno- of international paediatric research. Our latest impact factor rose logies taking on tough challenges. From medical imaging, software by 25% this year, making us one of the top three general paediatric & IT, patient monitoring and diagnostics to drug discovery, biophar- journals in Europe. Editor-in-chief Professor Hugo Lagercrantz welco- maceutical manufacturing technologies and performance impro- mes original clinical and experimental research papers, reviews and vement solutions, GE Healthcare helps medical professionals deli- commentaries on a wide range of established and emerging pae- ver great healthcare to their patients. For more information about diatric subjects. Our particular areas of interest include non-invasive GE Healthcare, visit our website at www.gehealthcare.com. neonatology, such as CPAP, breastfeeding and Kangaroo care, and sudden infant death syndrome. We also focus on lifestyles and health, including how modern technology affects childhood development and the growing paediatric obesity crisis. 136 136 137 137 GINEVRI srl Injeq Oy (Ltd) Address: Via Cancelliera 25/B – 00041 Address: Hermiankatu 22, FI-33720 Tampere, Finland Albano Laziale (RM), Italy Website: www.injeq.com Website: www.ginevri.com Email:
[email protected] Email:
[email protected] Telephone number: +358 50 528 70 12 Telephone number: +39 0693459330 Booth N°. : 15 Booth N°. : 32 Injeq Ltd is a medical device company based in Tampere, Finland. GINEVRI srl is a “State of the Art” leading Italian manufacturer of ad- The company is devoted to developing real time bioimpedance vanced electromedical solutions regarding the neonatal/paediatric guided tissue identification technologies. The technologies can be field since 1953. applied for multiple clinical applications, for example regional ane- Being internationally recognized the Company strives for perfection in sthesia, lumbar punctures, and more. reliability, quality and innovation. Injeq IQ-Needle™ knows where its tip is during the lumbar puncture. A comprehensive range is available on the following website: www. Bioimpedance guidance functionality was developed to avoid too ginevri.com deep punctures and unnecessary tissue damage to improve the Each step of the production process is entirely monitored with our pro- success rate of lumbar punctures. The Injeq IQ-Needle™ products ducts being 100% MADE IN ITALY and fully customizable to meet the are expected to benefit the patients by improving diagnosis, redu- most demanding international medical standards. cing complications and enabling new type of treatments. Hamamatsu Photonics Deutschland GmbH Inspiration Healthcare Group plc Address: Arzbergerstraße 10, D-82211, Herrsching, Address: 2 Satellite Business Village, Fleming Way, Germany Crawley, West Sussex, RH10 9NE, UK Website: www.hamamatsu.de Website: www.inspiration-healthcare.com Email:
[email protected] Email:
[email protected] Telephone number: +49 8152-375-200 Telephone number: +44 (0) 1455 840555 Booth N°. : 34 Hamamatsu Photonics is a world leader in the manufacture of op- toelectronic devices, including many for the medical market. The Inspiration Healthcare Group plc is a global supplier of medical te- new NIRO-200NX Monitor enables the monitoring of the cerebral or chnology for critical care, operating theatre and home healthcare systemic oxygenation. As it provides not only the oxygenation data applications. Our mission is to provide high quality innovative pro- but also can detect the haemodynamic functions in the tissue it is a ducts to patients and caregivers around the world that help to im- perfect tool for monitoring and improvement of the patient manage- prove patient outcomes and efficiencies of healthcare organisa- ment during cardiac surgery. Our NIRO monitors are routinely used in tions with patient focused customer service and technical support. many hospitals. Our own brand of critical care solutions span non-invasive respi- ratory management, thermoregulation and patient warming for newborns through to adults in intensive care and the operating theatre, whilst our distribution business in the UK and Ireland sup- plies solutions to support specialised surgical procedures and infu- sion therapies. Inspiration Healthcare products are available in over 50 countries worldwide, our success has been built on continuous innovation, excellent customer service and an inherent commitment to impro- ving the quality of life of patients. 138 138 139 139 Masimo Corporation Medtronic Website: www.masimo.co.uk Website: www.medtronic.eu Booth N°. : 2 Email:
[email protected] Telephone number: +420 739 249 515 Masimo Corporation is one of the world’s most admired medical te- Booth N°. : 13 chnology companies credited with revolutionizing pulse oximetry and noninvasive patient monitoring. A global medical technology innova- As a global leader in medical technology, services and solutions, tor, Masimo has been on the forefront of patient safety and a beacon Medtronic improves the lives and health of millions of people each of innovation in healthcare for more than 25 years. As the inventor of year. We use our deep clinical, therapeutic and economic experti- Measure-Through Motion and Low Perfusion Masimo SET® pulse oxi- se to address the complex challenges faced by healthcare systems metry—the market-leading pulse oximetry technology solution—and today. Let’s take healthcare Further, Together. Masimo rainbow® Pulse CO-Oximetry™—a breakthrough noninvasi- ve blood-constituent monitoring platform, Masimo has a portfolio of clinically proven products that lead the way in innovation, perfor- mance and patient safety by giving health care providers the infor- mation they need to optimize clinical decision-making. In addition, with technology license and OEM agreements with leading patient monitoring manufacturers spanning the globe, Masimo’s advanced oximetry technologies can be found inside of today’s top multipa- rameter brands, such as Atom, Datascope, GE Medical, Medtronic, Philips, Spacelabs and Zoll, among others. Medela Monivent AB Website: www.medela.com Address: Arvid Wallgrens backe 20, 413 46 Booth N°. : 8 Gothenburg, Sweden Website: www.monivent.se Founded in 1961 by Olle Larsson and headquartered in Switzerland, Email:
[email protected] Medela today is led by his son Michael Larsson. Medela concentrates Telephone number: +46 73 800 43 55 on two business units: “Human Milk”, which is leading in the develop- Booth N°. : 18 ment and production of breastfeeding products and solutions, and “Healthcare”, which engineers and manufactures highly innovative Monivent is dedicated to improving the care of newborn babies medical vacuum technology solutions. Medela conducts basic rese- in need of respiratory support at birth. About 3-6 % of all newborns arch in partnership with leading scientists, medical professionals and end up in this situation, and the caregiver needs to provide ma- universities, and uses the research results in the development of its nual ventilation to the baby. Insufficient or excessive volumes of air breastfeeding products and solutions. Medela has 19 subsidiaries in given may contribute to severe injury to the lungs and other or- Europe, North America and Asia, and together with independent gans. Healthcare personnel are lacking good tools to determine partners distributes its products in more than 100 countries. The com- how effective the treatment really is. Monivent Neo is a user-friendly pany employs over 1,600 staff worldwide, 400 of whom are located in tool, measuring the airflow to the baby and providing continuous the Canton of Zug, Switzerland. feedback on several parameters, helping the caregiver achieve a gentle and effective treatment. 140 140 141 141 Natus Medical Nestlé Website: www.natus.com Address: Avenue Nestlé 55, 1800 Vevey, Switzerland Booth N°. : 6 Website: www.nestle.com Telephone number: +41 219241111 Natus Newborn Care products address the critical areas of asses- Booth N°. : 3/5 sment and treatment of newborns, and are designed for use by clinicians as they provide care in the critical minutes & hours after Nestlé Nutrition helps the next generation of children to develop delivery and prior to discharge from the hospital. By allowing for ear- their full potential and live healthier lives by providing high quality, ly detection and treatment, we believe our products can improve innovative, science-proven nutrition solutions and education for clinical outcomes, help reduce costs, and minimize the duration of mothers and infants in the crucial first 1000 Days’ of life. Together, treatment, unnecessary retesting, or hospital readmission. The Natus nurturing a healthier generation. Newborn Care product portfolio is offering a wide range of devices The Nestlé Nutrition Institute (NNI), shares leading science based dedicated to Hearing Screening, Thermoregulation, Newborn Brain information and education with health professionals, scientists, nu- Injury and Jaundice Management just to name the major applica- trition communities and stakeholders in an interactive way. NNI is tions. the world’s largest private publisher of nutritional information with more than 3000 publications. All our nutrition resources are avai- lable on the NNI website for free to registered members at http:// www.nestlenutrition-institute.org Neotech Products Peak Medical Ltd Address: 28430 Witherspoon Pkwy, Valencia, Address: Giborey Israel !0, Netanya, Israel CA 91355 USA Website: www.peakmedic.com Website: www.neotechproducts.com Email:
[email protected] Email:
[email protected] Telephone number: +972 522946755 Telephone number: +1 661-775-7466 Booth N°.: 11 Booth N°. : 14 Peak Medical Ltd is a provider of unique airway management, Neotech Products, based in the USA, have been leaders in the field of emergency and critical care devices that do beyond what tradi- neonatal care for 30 years. We create products that are developed tional devices would normally supply. by clinicians for clinicians. Our focus is on disposable, skin care frien- Our mission is to develop a steady stream of novel, patentable me- dly products that are gentle for neonatal and pediatric patients, and dical devices for Global Market. now home care. Some of our most popular products are the Neotech Among the products that Peak Medical has developed and is RAM Cannula, NeoShades Phototherapy Eye Shields, NeoBar ET Tube manufacturing are: - Video Laryngoscope for neonates, especial- Holder, NeoPulse Pulse Oximeter Wrap and the EZ-Hold Tubing and ly for very low weight preemies, with range of disposable blades Cannula Holder. and special attachments for surfactant application and oxygen insufflation. - Range of disposable and reusable laryngoscope for neonates, especially for very low weight preemies, with range of disposable blades and special attachments for surfactant applica- tion and oxygen insufflation. -Disposable Neonatal Transilluminator -Portable Neonatal Resuscitator -Ventilator - Portable Mobile Moni- tor of resuscitation process (under development) All the products based on 7 company’s patents and patents applications 142 142 143 143 PeerVoice SenTec AG Address: 3rd Floor, 75 Davies Street, London W1K 5JN Address: Ringstrasse 39, 4106 Therwil, Switzerland Website: www.peervoice.com Website: www.sentec.com Email:
[email protected] Email:
[email protected] Telephone number: +44 (0)20 7665 9200 Telephone number: +41 61 726 97 60 Booth N°. : 17 PeerVoice understands that today’s healthcare professionals are expected to stay up to date with the latest medical information and SenTec is leading the way to a new standard of care for nonin- to demonstrate continual improvements in patient care, but are vasive, continuous monitoring of neonates’ ventilation and oxyge- often challenged to find the time. We facilitate excellence in clinical nation. Doctors and nurses receive the information they need to practice through live and online education designed to positively im- safely adjust neonate’s respiration therapies and to reduce com- pact patient care. You can trust us to provide: plications in neonatal care. SenTec OxiVenT™ Sensors feature inno- • Education designed to eliminate specific knowledge and/or practi- vative technologies overcoming the limitations of current sensors, ce gaps such as drift of tcPO2 and risk of burns. The SenTec Digital Monito- • Objective discussion of the best-available evidence and treatment ring System is safe, accurate and easy to use. SenTec is already the guidelines standard of care in many leading Children Hospitals world-wide. • Practical clinical perspectives from internationally-renowned facul- ty • An easy-to-use online educational platform that allows you to con- trol how, when and where you learn Prolacta Bioscience Inc. SIMCharacters GmbH Address: 1800 Highland Avenue Duarte, CA 91010, USA Address: Rüdigergasse 10, 1050 Vienna, Austria Website: www.prolacta.com Website: www.simcharacters.com Email:
[email protected] Email:
[email protected] Telephone number: +1 626-599-9260 Telephone number: +43 1-5812094 Booth N°. : 16 Booth N°. : 33 Prolacta Bioscience, Inc. is a privately-held life sciences company SIMCharacters develops paediatric simulators to improve the me- dedicated to Advancing the Science of Human Milk®. The com- dical care of critically ill children. His work as a NICU specialist has pany pioneered the development of human milk-based nutritional taught founder Jens Schwindt that a highly professional interdisci- products to meet the needs of critically ill, premature infants in the plinary team is an indispensable prerequisite for effective medical NICU and leads the industry in the quality and safety of nutritional care. SIMCharacters´ High Emotion Preterm Simulator Paul enables products made from breast milk. Prolacta operates the first and only medical teams to train how to handle critical neonatal emergen- pharmaceutical-grade manufacturing facility for the processing of cies under highly realistic conditions. human breast milk. 144 144 145 145 SLE Ltd. Wisepress Medical Bookshop Address: Twin Bridges Business Park, 232 Selsdon Road, Address: 25 High Path, Merton Abbey, London SW19 2JL, UK Croydon, CR2 6PL, UK Website: www.wisepress.com Website: www.sle.co.uk Email:
[email protected] Email:
[email protected] Telephone number: +44 20 8715 1812 cc:
[email protected] Booth N°. : 4 Telephone number: +44 (0)208 681 1414 Booth N° : 19 Wisepress.com, Europe’s leading conference bookseller, has a ran- ge of books and journals relevant to the themes of the meeting. In SLE Ltd is a leading developer and manufacturer of infant life support addition to attending 200 conferences per year, Wisepress has a devices based in the UK. Our products provide respiratory support to comprehensive medical and scientific bookshop online with great infants in Neonatal Intensive Care Units globally, providing a range of offers. Follow us on Twitter for the latest news @WisepressBooks. invasive and noninvasive respiratory support modes. At this meeting we will be showing our new SLE6000 ventilator with its easy-to-use Lunar™ interface and additional non-invasive modes (Including nHFOV). The new SLE6000 uses SLE’s well-known technologies such as valveless ventilation and High Frequency Oscillation to give more controllable, responsive and powerful ventilation, and its compact design makes it ideal for the busy neonatal unit. Vygon Website: www.vygon.com Booth N°. : 24 Vygon is a world leader in the creation of high technology single-use medical devices, distributed throughout the world by our dedicated network of 27 subsidiaries and 331 integrated distribution partners. Vygon offers an extensive range of products suitable for use in the following clinical departments: • Neonatology, nutrition & obstetrics • Intensive care • Anaesthesia & Emergency • Intravascular Therapies • Cardiovascular & Surgery 146 146 Supporters Supporters 147 147 GENERAL INFORMATION CONGRESS SITE VENICE CONVENTION CENTER - veniceconvention.com Address: Lungomare Guglielmo Marconi - Lido di Venezia, VE, Italy Plenary room (Darsena) is located in Palazzo del Cinema Parallel sessions and Exhibition/F&B area are located in Palazzo del Casinò CONGRESS DATE 31st October - 4th November 2017 PRE CONGRESS COURSES DATE 30th October 2017 ESN COURSE 1 ESN COURSE 1 - Neonatal Infections 31st October 2017 ESN ESN COURSE 2 - Neonatal PCC 3 - Unmet needs: improving the COURSE PCC 3 2 Haemodynamics quality of neonatal care - approaches and strategies PCC 1 - Ventilatory support- PCC 4 - Controversity in PCC 1 PCC 4 matching physiology? pharmacology PCC 2 - Multimodal neuro-imaging PCC 5 - Neonatal gastroenterology, PCC 2 PCC 5 and neuro-monitoring in neonates surgery and nutrition 2nd November 2017 Neonatologist performed echocar- NPE diography (NPE) Abstract Book All abstracts submitted within the deadline are published on Journal of Pediatrics and Neonatal Individualized Medicine (JPNIM). Late breaker abstracts (the ones submit- ted after the deadline) will only be published in the abstract book. Both documents will be available on the congress website www.jens2017.eu 148 148 149 149 INTERNATIONAL ACCREDITATION (UEMS) Certificate of Attendance The Certificate of Attendance will be available for download at the end of the The 2nd Congress of Joint European Neonatal Societies has been accredited by the congress from the congress website. Participants will be notified by email. European Accreditation Council for Continuing Medical Education (EACCME) – as following: ORGANISING SECRETARIAT n. LEE17-00673 with 31 European CME credits (ECMEC) for the entire Congress. All attendees have to finalise their registration at the registration desk starting from EACCME credits are recognized Europe-wide and in North America. 31st October from 07:30. They can be converted into their national equivalent by contacting your National FROM TO CME authority. EACCME credits are recognized by the American Medical Associa- tion (AMA) by the Physicians Recognition Award (PRA). 31st OCTOBER 07:30 19:30 1st NOVEMBER 07:30 19:30 2nd NOVEMBER 07:30 19:30 ITALIAN ACCEDITATION (ECM - EDUCAZIONE CONTINUA IN MEDICINA) 3rd NOVEMBER 07:30 19:30 Congresso - 2nd Congress of joint European Neonatal Societies 4th NOVEMBER 07:30 13:00 N° evento: 202261 Crediti assegnati: 6 crediti OFFICIAL LANGUAGE CORSO ESN COURSE - Infectious Diseases English is the official language of the Congress. No simultaneous translation will be N° evento: 202050 provided. Crediti assegnati: 7 crediti COMMERCIAL EXHIBITS CORSO ESN - Circulation Course The Trade Show Exhibition, located on the third floor of Palazzo del Casino will be N° evento: 202072 held from 1st to 4th November 2017. It will feature pharmaceutical and biotech- Crediti assegnati: 5 crediti nology companies, medical publishers and scientific societies. Please refer to the “exhibition area” map in order to check all the companies that are present in the CORSO - Neonatologist performed echocardiography (NPE) exhibition area. N° evento: 202232 Crediti assegnati: 2 crediti SOCIAL EVENTS Il congresso e i corsi sono stati accreditati per le seguenti Welcome cocktail categorie: The welcome cocktail will be held in the Exhibition area anex (located on the 3rd floor of Palazzo del Casinò) Tuesday, 31st October at 18:30. MEDICO CHIRURGO - discipline di: FARMACISTA Neonatologia (farmacia ospedaliera/farmacia ospedaliera) Networking dinner Pediatria Infermiere Pediatrico The Networking dinner will be held on Friday, 3rd November 2017 close to the con- Pediatria (pediatri di libera scelta) Infermiere gress venue at Palazzo del Cinema Foyer. Ticket cost: €50,00* (per person) Per acquisire i crediti ECM, i partecipanti dovranno: Available for purchase at the new registrations desk. • aver partecipato al 90% dell’evento • aver compilato on line la scheda di partecipazione, la scheda di valutazione per *The price includes light dinner and welcome drinks. il congresso e il questionario per i corsi. This version of the programme has been printed on 20th October, 2017 • aver risposto correttamente ad almeno l’80% delle domande incluse nel questio- All the modifications sent after this date have not been taken into consideration nario ECM del congresso 150 150 151 151 152 152 153 153 Amadei F. 36 A Ambjörnsson T. 66 Ameliana E. 85 Abduvalieva S. 85 Amess P. 22 Abed Y.E.L. 112 Amirouche A. 88 Abogunrin S. 102 Amodeo I. 28, 49, 63 Abraham V. 37 Amoedo Blanco R. 116 Abroug S. 77 Amunts L. 47 Abrudan G. 115 Anastasovska V. 24 Achille C. 94 Anblagan D. 86 Achiron A. 76 Andelius T.C. 78 Achiron R. 76 Andersen G. 103 Acosta L. 17 Anderson C. 39 Adamczak A. 37 Anderson P. 103 Adam-Darque A. 118 Andersson M.X. 32, 45 Adams M. 58, 79, 93, 95, 103 Andersson O. 29, 33, 94 Adamsson M. 56, 86, 94, 103 Andersson S. 118 Aden U. 68, 77, 103, 104 Andorka C.S. 63 Åden U. 67, 103, 109 Andrada M.G. 94 Afset J. 103 Andraka B. 65 Agbeko R. 68 Andreicuţ D. 25 Ågren J. 111 Andresen J. 69 Ahearne C. 53 Andreu A. 114 Ahlqvist-Björkroth S. 90 Andriessen P. 31, 49, 88 Ahlsson F. 111 Angelico R. 75 Ahmad S. 50 Angelini F. 116 AI Evensen K. 78, 118 Annink K. 72 Aikey C. 97 Antari V. 44 Ai-Rhan Kim E. 62 Anthony M. 115 Aita M. 39, 82, 83 Antognoli L. 61 Aiton N. 22 Apsey C. 111 Ajmi H. 42, 77 Aquilano G. 117 Akanbi S. 40 Aquino G. 36 Akira O. 76 Aragon D.C. 61, 110, 20, 22, 25 Akuma A. 85 Arca G. 76 Al Masri D.A. 90 Arifoglu I. 83 Al Samnan M. 96 Arısoy A.E. 98 Aladangady N. 42, 43, 64 Arjona D. 78 Alarcon A. 101 Arlettaz R. 76, 26 Albachiara R. 21 Arman D. 113 Aldecoa-Bilbao V. 83 Armengaud J.B. 116, 121 Alfani R. 66 Arnold C. 37 Algra S.O. 53 Arques L. 83 Al-Hosni M. 99 Arriada Redondo M. 41 Ali A. 50, 53, 112 Arruza L. 36 Ali Mamuri G. 20 Arslanoglu S. 108, 24 Aliefendioglu D. 43 Arun Ozer E. 66, 78 Alisik M. 83 Arunoday 81 Alkan Ozdemir S. 79 Asaro J. 97 Alkhoraidly A. 32, 112 Asay G. 99 Allegaert K. 9, 15, 41 Ashina M. 110, 21 Allendorf A. 76 Ashton J. 43 Almeida A. 19, 116 Asner S. 101 Alonso-Clemente S. 112 Aspevall O. 66 Alonso-Moya M. 112 Assaf Z. 97 Alsina M. 20, 76 Ateş Beşirik S. 81 Alsweiler J.M. 61 Atikah S. 30 Altman M. 92, 95 Augurio M.R. 66 Alvarelhão J.J. 94 Aunal R. 115 Alves Sá de Almeida 68 Austin T. 48, 91 Alyamac E.D. 53 Avdic-Belltheus A. 54, 119 Alyamac Dizdar E. 23, 85, 98 Avenarius S. 120 154 154 155 155 Avian A. 64 Baydemir C. 98 Bidho M. 121 Branco M. 116, 115, 19 Axelin A. 30, 39, 90, 122 Bearer C.F. 43, 44 Binder C. 43, 44, 61, 87 Brandstetter S. 36 Ayache H. 108, 116, 25 Beaulieu J-F. 70 Binder J. 61, 62 Branvik-Ingelsson C. 83 Ayachi E. 81 Beauport L. 45 Binder-Heschl C. 61 Brasseler M. 49 Aydemir O. 39 Bech B.H. 58 Bjellmo S. 103 Bravo M.C. 19, 48, 64 Ayech H. 108, 109 Bech Jensen J.-E. 121 Björklund L.J. 97 Breatnach C. 14, 33, 64, 89 Ayyagari R. 31, 55 Beck I. 29 Bjuland K.J. 78 Breatnach C.R. 33, 41, 65, 89 Behrsin J. 85 Blackwell S.J. 47 Brégère C. 93 Beke A. 17 Blackwood B. 99 Breindahl M. 16, 62 B Belfort M. 82 Blaga L. 62, 115 Brenda E. 84 Belik J. 19, 42 Blake K. 71 Brennan C. 89 Babakissa C. 70 Bellalah M. 25, 108, 116 Blake R. 18, 116 Bresesti I. 27 Bach C.C. 29, 94, 103 Bellaleh M. 108, 109 Blanco C. 87 Breur J.H.M.P.J. 80 Bäckman M. 56, 94 Bellallah M. 77, 107 Blanco D. 72, 93 Breur J.M.P. 29, 109 Backman Johansson C. 44 Beller E. 79 Blaz W. 65, 83 Brightman L. 48 Bae J.G. 111 Bellini C. 79, 80 Blennow M. 36, 62, 120 Brignole D. 72 Baerts W. 47 Bellis S. 41, 107 Blibech S. 18, 19, 117 Brini I. 115 Bagcı O. 44, 66 Belteki G. 48 Blom H. 100 Brisigotti M.P. 72 Bahonjic A. 50 Beltempo M. 95 Bloor I. 119 Brodin P. 59 Baibarina E. 48 Belzer C. 43 Bluhme E. 57 Brohet R.M. 84 Baik-Schneditz N. 61, 62, 64 Bemgard C. 44 Boantă O. 25, 85 Brom M.K. 24 Bakalli I. 20 Ben Ahmed A. 112 Boardman J. 86 Brookle M.E.L. 79 Bakar F. 75 Ben Ameur K. 24, 25, 42, 77, 112 Bocu E. 24 Bröring T. 78 Balaam M-C. 123 Ben Ammou S. 77 Bodeau-Livinec F. 53 Broström L. 109 Balasch M. 114 Ben Amor S. 77 Boeri L. 68, 80 Brown A. 62 Balashova E. 75 Ben Hamida H. 24, 25, 42, 112 Bøgh N. 78 Brown S. 30 Balcells C. 45, 83, 113 Ben Salah N. 77, 112 Bogossian F. 79 Brubakk A. 78 Balestriere L. 38 Ben Salem A. 24, 25, 42 Bohlin K. 20, 51, 59, 82, 97, 120, 122 Brubakk A.M. 78 Balink S.J.A. 61 Ben Salem H. 18, 19, 117 Bohnhorst B. 120 Brugman A. 78 Ballantyne M. 81 Ben Singor C. 112 Boix H. 36, 72, 93 Brunet S. 81 Ballard P. 51 Ben Slamia L. 77 Bol B. 99 Bruno L. 109 Ballard R. 120 Benavente-Fernández I. 72, 93 Boldrini R. 75 Brunton A. 27 Baltane Z. 17 Benders M.J.N.L. 12, 29, 39, 47, 53, 68, 72 Bolger T. 18 Bruschettini M. 30, 77 Banerjee J. 42, 43, 64, 71 73, 80, 87, 118 Bolk J. 77 Brussé I.A. 57 Bansal S.C. 23 Bendix I. 87, 119 Bölte S. 67,104 Bruzzese D. 66 Baquedano I. 36 Bendor-Samuel O.M. 96 Bomont R. 22 Bucci L. 66 Baraldi E. 120 Bennedsgaard K. 64 Bonafiglia E. 110 Buchan S. 115 Barbaria W. 18 Berber M. 75 Bonefeld-Jørgensen E.C. 58 Bucher H. 57 Barbouch H. 109 Bercovitz R. 76 Bonsante F. 110 Bucher H.U. 42 Barbouche H. 25, 108, 116 Berger A. 36, 43, 44, 80, 81, 87, 103 Borena W. 115 Buffat C. 64 Barczyk-Kahlert K. 66 Berglund S.K. 93 Borges A. 25 Buhrer C. 9, 59, 65 Bariamis S.E. 113 Bergonzelli Degonda G. 118 Boria A. 62 Bujari D. 37 Baritussio A. 65 Bernet V. 29 Börjesson L. 39 Bujorescu D. 85 Barone C. 38 Bernhard J. 19 Borradori C. 67 Bullimore G. 39, 70 Baros A. 117 Berretim-Felix G. 113 Borradori Tolsa C. 79, 93, 103 Buonocore G. 79, 92 Barrett M. 18 Bertoldi M. 20, 22, 25 Borrego R. 78 Burger D. 41, 49, 88 Barrington K. 58 Bettolli M. 70 Borrelli A.C. 21 Burgess L. 45, 111 Barro C. 92 Betzelos N. 82 Borysiuk O. 37, 44 Burghardt K.M. 69 Barry J. 99 Bezirganoglu H. 53, 85, 96, 98 Böttger R. 120 Burgmann J. 66 Barta H. 67 Bezrukov L. 117 Bouaicha E.D. 19 Burkhardt T. 26 Bartnicka A. 113 Bhat N. 22 Boubred F. 64 Bussmann N. 19 Bartocci M. 42 Bhat P. 39, 70 Boukadida J. 115 Butticè S. 84 Barton N. 84 Bhatia A. 33, 50 Bourika V. 115 Buxmann H. 120 Bassi E. 120 Bhatt J. 27 Bouwmeester R. 27 Buyukkayhan D. 24 Bassler D. 19, 42, 58, 76, 85, 95, 103 Bhayat S. 26, 61 Bouza H. 59 Buyuktiryaki M. 23, 41, 53, 59, 82, 85 Basso O. 58 Bhisikar S. 30 Bowden A. 81 96, 98 Bastanie M. 100 Bialas A. 83 Boylan G. 12 Byrne J. 53 Bastin M. 86 Bianco F. 36 Boylan G.B. 72, 80 Byrne M. 81 Batra D. 24, 98, 109 Bianconi T. 98 Boyle E.M. 53, 86 Bystrykh O. 75 Battersby C. 95 97 Biban P. 110 Boyle M. 31, 65 Baud O. 75, 76, 101 Bickes M.S. 67 Bragatti J.A. 47 Baumann-Holzle R. 57 Bickle-Graz M. 79, 93, 103 Branagan A. 108 156 156 157 157 Cavallaro G. 28, 49, 63 Cirulli F. 86 C Cavanagh P. 69 Civelli M. 36 D Cebeci B. 22 Claessens N. 29 Caballero S. 122 Celaj E. 20 Claessens N.H.P. 29, 53, 118 D’Aló F. 36 Caballero-Villarraso J. 110 Cenni S. 66 Clark R. 99 D’Aronco S. 33 Cabañas F. 72, 93, 101 Cernada M. 72, 93 Clarke G. 72 D’Haens E. 43 Cacchioli A. 36 Ceroni F. 77, 123 Clarke P. 20 D’Haens E.J. 31 Cadete A. 94 Cerritelli F. 27 Claure N. 68 Däbritz J. 96 Caiazzo M.A. 21 Céspedes M.C. 114 Clayton A. 54 Daley A.J. 66 Cainelli E. 48 Cetinkaya M. 22 Clayton S. 56 Damhuis G. 122 Cakır U. 59 Ceyte H. 78 Cloet E. 53 Dammann O. 118 Calado E. 94 Chaaya S.B. 114 Cnattingius S. 102 Danhaive O. 80 Calderisi M. 79 Chae S.A. 78 Cobas J. 24 Dani C. 98 Calevo M.G. 30, 47, 72, 77, 80 Chaffanel M. 72, 93 Cobas Pazos M.J. 115 Dargaville P. 46, 68, 73 Calik Saglik A. 39 Chakhunashvili A. 83 Cobo T. 116 Darlow B. 58 Calixto C. 20, 22, 25, 61, 107 Chakravarty M. 45 Codru M. 85 Darlow B.A. 95 Callaghan F. 111 Chang J. 65 Coffey D. 97 Darque A. 68, 118 Callea F. 75 Chang M. 65 Coffrey Z. 97 D’Ascenzo R. 67 Calthorpe R. 84 Chang Y.S. 28, 95 Cogo P. 33, 48, 65, 120 Dassios T. 55 Cama A. 26, 79, 82 Chang Y-S. 28 Colby C. 99 Datta A.N. 118 Camblos A. 99 Chao K.Y. 23, 37, 107 Collins J. 33 Davies A. 27, 109 Campbell-Yeo M. 13, 30 Chappell F. 86 Colnaghi M. 63 Davis J. 22 Camporeale A. 66 Charlton M. 85 Comito V. 109 Davis J.W. 95 Campos A.C. 19, 76 Chartrand C. 81 Concheiro-Guisan A. 112 Davis P. 29, 37, 38, 46 Canabarro N.T. 96 Chasapi S.A. 113 Conti G. 38 Davis P.G. 30, 68, 84 Candace R. 79 Chatzidimitriou K. 79 Conti R. 44 De Angelis L. 65 Candotti F. 116 Chatzitoliou E. 44 Conway J. 80 De Bisschop B. 97 Caner I. 40 Chaudhry S. 107 Cools F. 97 De Boer J. 40, 57 Cañete M.D. 110 Chebsey A. 79 Cooper E. 86 de Boode W. 40, 48, 54, 89, 14 Canizci P. 108 Chen C.Y. 98 Corcoran D. 19 De Boode W.P. 48, 108 Cañizo D. 113 Chen H.K. 120 Cordero-Llana O. 54 De Booij E. 57 Canpolat F.E. 23, 41, 53, 85, 96, 98 Chen M. 121 Cornacchione S. 79 De Cássia Pinheiro Da Motta G. 83 Cao B. 96 Chen W.M. 108 Cornet M.-C. 32, 80 De Clifford-Faugère G. 39, 82 Cao Y. 40 Chen Y.L. 23, 37, 107 Correani A. 33, 50, 120 De Coppi P. 34 Caoci S. 23 Chen Y-T. 98 Corrias M. 82 De Dassel T. 79 Capasso L. 21, 66, 98, 120 Cheong J.L.Y. 47 Corsi C. 76 De Graaff J.C. 118 Capdevila E. 123 Chernausek S.D. 121 Corsini I. 98 De Grandis E. 68, 80 Capone E. 66 Chessell L. 50 Corso A.L. 65 De Groot R. 49, 88 Caram-Deelder C. 31 Chetcuti Ganado C. 115 Cortes D. 121 De Haan M. 53 Cardoso W.V. 120 Chiang C.E. 23, 37, 107 Coscia T. 32 de Halleux V. 96 Carey W.A. 99 Chien Y.H. 23, 37, 107 Cosmi E. 33 De Jonge R.C.J. 23, 61 Carfagna M. 50 Chimenti-Camacho P. 26, 82 Costeloe K. 95 De Jongh F.H.C. 36 Carlsson S. 43 Chiofalo B. 84 Coutts J. 115 De Klerk J. 41 Carmona F. 107 Chioukh F. 77 Coviello C. 98 De Kort E. 100 Carnielli V.P. 33, 48, 50, 51, 55, 61, 62 65, Chioukh F.Z. 24, 25, 42, 77, 112 Cowan F.M. 47 De la Torre M.J. 110 70, 102, 104, 120 Chisholm C. 99 Cozinov A. 67 De Luca D. 11, 20, 38, 55, 63, 69, 70 Carolan S. 53 Chisholm P. 64 Cragg L. 56 98, 101, 102 Carpenter J. 61 Chitty H. 68 Crasmöller M. 87 De Martino D. 66 Carpenter M. 114 Chmielarz B. 65 Croon A. 57 De Martino L. 102 Carr P. 30 Chmielewska A. 32 Crossley K.J. 84 De Meulemeester J. 97 Carter B. 22 Choi B.M. 42 Crothers E. 108 De Mol A.C. 100 Carvalho C. 19, 116 Choi Y.J. 62 Crott G.C. 19 De Rooy L. 111 Casale M. 44 Chojnacka K. 109 Cseko A. 64 De Tersant M. 38 Casale Aragon D. 22 Chollopetz Da Cunha M.L. 83 Cucerea M. 17, 107 De Villepin B. 88 Cassidy M. 81 Chou H-C. 98 Cucerea M.C. 108 De Vries L. 67, 87, 101 Castoldi F. 27 Christopoulou I. 113 Culliney L. 97 De Vries L.S. 29, 53 Castro Conde J.R. 47 Chu S.H. 21 Cuttini M. 53 De Vries W.B. 109 Catinella S. 36 Chu S.M. 59 Cuzino I. 67 De Waal C.G. 36 Catozzi C. 36 Chuang C.Y. 77 Cuzzilla R. 24, 47, 66 Dean F. 17 Catroon K. 90 Chung S.H. 110 Cyr P. 47 Dear P. 38 Caudron S. 78 Cilio M.-R. 32, 80 Cyranowicz B. 64 Degraeuwe P. 49 Caulfield F. 97 Ciralli F. 63 Degtyarev D. 48, 75 158 158 159 159 Degtyareva M. 98 Dudink J. 72 Escribano E. 114 Fitting C. 55, 102 Del Campo R. 114 Duerden E. 45 Eskola V. 81 Fitzgerald E. 65 Del Pozo S. 114 Dumitra R. 25, 85 Espinosa M.G. 24, 111 Fitzgerald M.P. 76 Del Rey Hurtado De Mendoza B. 26, 45, 113 Dunlop A. 40 Essers J. 38 Fitzpatrick C. 26 Dell’Orto V. 38, 55, 69, 102 Durmush R. 114 Evans D. 58 Fitzsimons J.J. 81, 82 Demeulemeester V. 100 Dzietko M. 119 Evans N. 54, 89 Fjalstad J. 114 Demirel N. 83, 113 Evensen K.A.I. 78, 118 Flacking R. 39 Dempsey E. 15, 49, 88 Evers K.S. 92 Fleiss B. 54, 71, 119 Dempsey E.M. 23 E Ewald U. 29, 122 Flemmer A.W. 19, 21, 111 Deneva S. 20 Ewer A. 35 Flint R. 34, 41, 49 Deoni S. 33 Ebbesen F. 46 Flint R.B. 88 Depoorter A. 92, 118 Ebela I. 17 F Flood E. 84 Derhaschnig U. 43 Edqvist I. 83 Florez I.D. 40 Dermitzakis M. 93 Edstedt Bonamy A-K. 53, 109, 111, 121 Faas D. 120 Flunt A. 36 Derriks F. 97 Edwards D.M. 78 Faiella A. 38 Folha T. 94 Descloux C. 119 Efstathiou A. 59 Fairchild K. 99 Folkmanis V. 17 Deshpande G. 42 Efstathiou P. 59 Falasco G. 48, 65 Fonollá Joya J. 116 Dewhurst C. 66, 92 Eggink A. 57 Falcão I. 19, 116 Foong J. 45 Dewitt K. 18 Egyepong J. 23, 82, 95 Fang A. 32 Förster K.M. 21 Dewitz R. 76 Ehman G.L. 41 Fang J. 99 Fowler S. 99 Di Costanzo P. 66 Eijsermans M.J.C. 39, 53 Fang L.C. 21 Fox C. 115 Di Cunto F. 100 Ejder Apay S. 114 Fantinato M. 120 Frame A. 70, 39 Di Fabio S. 109 Ejder Tekgündüz S. 114 Farombi I. 81 Francalanci P. 75 Di Guardo V. 98 Eklöf E. 67, 104 Farooqi A. 32, 56, 58, 77, 86, 94, 103 Frange P. 114 Di Lallo V. 36 El Doory S. 75 Farré J.M. 123 Franklin O. 33, 41, 65, 89 Díaz R. 78 El Halik M. 75 Farré-Sender B. 123 Franta J. 81 Díaz-Castro J. 66 El Helou S. 50 Fasth A. 33 Franz A.R. 109 Diaz-Redondo A. 82 Eldaw S.M. 82 Fauchère J. 57 Frauenfelder O. 122 Dima M. 117 El-Dib M. 47 Fedorova N. 75 Fredriksson Kaul Y. 78 Dinerstein A. 44 Eleanor M. 116 Fedorova T. 75 Freitas A. 116 Dinsdale S. 30 Eleuteri A. 48 Feeley N. 82, 83 Freitas L. 118 Dionne K. 30 Elfvin A. 43 Fehlhaber B. 65, 66 Frick M.A. 114 Doagi M. 19, 117 El-Khuffash A. 14, 19, 33, 40, 41, 48, 54 Felderhoff-Müser U. 87, 119 Friesenhagen J. 66 Doberschuetz N. 76 65, 89 Fellman V. 39, 88, 118 Frøisland D. 46 Dobryanskyy D. 21, 37, 44 Elliott M. 16 Feng W.W. 96 Fromonot J. 64 Dobush O. 44 Ellis E. 41, 57, 107 Fenton T.R. 53 Frusca T. 104 Doerr A. 39, 94 Ellsworth K. 99 Ferkol T. 41 Fuchs H. 29, 37, 97, 120 Dogan P. 44, 66 Ellsworth M. 99 Fernandes G.M. 113 Fuentes T. 75 Doglioni N. 120 El-Naggar W. 63 Fernandez P. 36 Fuiko R. 36 Doherty A. 41 Elorza M.D. 26, 33 Fernandez R. 22, 80 Fujioka K. 21, 67, 110 Doherty D. 80, 55 Elsaadany L. 109 Fernández C. 36 Fukushima S. 21 Doherty R. 75 Emery F. 39, 68 Fernandez Oviedo A.N. 82 Fulcheri E. 72 Doll H. 84 Emond A. 58 Fernández-Colomer B. 93 Fullarton J. 115 Domellöf M. 32, 43, 45, 93, 111, 121 Enes C. 19 Fernandez-Lorenzo J.R. 93, 112 Furness J. 18 Donaldson B. 114 Engström E. 32, 45 Fernando I. 24 Fusch C. 32, 50, 53, 82, 112 Donnikov A. 48 Er I. 98 Ferradal S.L. 47 Fusch G. 50, 53, 82, 112 Doolan A. 97 Erçin S. 112 Ferrara T. 66 Fustolo-Gunnink S.F. 31 Doré-Bergeron M.-J. 81 Ercoli G. 49 Ferreira C.H. 19, 42 Dorling J. 15, 18, 42, 69 Erdem Dursun Z.E. 43 Ferreira E. 36 Doros G. 108 Erdil A. 113 Ferretti E. 69 G Dorsi M. 114 Erel O. 83, 113 Festival J. 82 Douagi M. 18 Ereno I. 76 Ficial B. 110 Gadzinowski J. 17, 37, 53, 92 Downe L. 42 Erickson-Owens D. 33 Field D. 86 Gafencu M. 108 Doyle L. 46, 101 Eriksson J.G. 118 Fields D.A. 121 Gaia T. 94 Dozier M. 80 Eriksson M. 30 Fijnvandraat K. 31 Gale C. 90 Draper E.S. 86 Erokhina A. 98 Filip V. 75 Gałęcka M. 113 Drenchev N. 22 Erol S. 83, 113 Finer N. 30 Gáll Z.S. 108, 17 Drevin G. 61 Eros F.R. 17 Firmino I.C.L. 113 Gamulescu D. 13 Drews K. 92 Ertekin O. 23, 53 Fisch U. 92, 93 Gancheva S. 83 Dreyhaupt J. 120 Esaiassen E. 69, 114 Fischer Fumeaux C. 45 Gangaram-Panday N.H. 23 Drugan T. 190 Escobar A. 24, 78 Fischer-Riepe L. 66 Gantseva-Patsoura S. 101 Dubois J. 12 EscobarIzquierdo A.B. 115 Fischler B. 57 Gao F. 55 160 160 161 161 Gao W. 31, 55 González Pacheco N. 25, 26, 38, 41, 94, 112 Guzman R. 93 Hazbahta G. 23 Gao X. 90 González González N.L. 47 Guzoglu N. 43 He M. 43, 44 García-Alix A. 76, 101 González-Valcárcel M. 24, 75 Heathcote A. 20 García-Fragoso L. 113, 116 Goos T.G. 23, 61 H Heckmann M. 120 García-García I. 113, 116 Göpel W. 32, 73, 90 Hedin M. 100 Garcia-Rodenas C.L. 118 Gorbunov A. 98 Heep A. 79, 54 García-Sánchez A. 63, 102 Gordon E. 115 H’mida D. 77, 107 Heijnen C. 87 Garg S. 77, 84 Gorman T. 99 H’mida-Ben Brahim D. 77, 112 Heinemann A.S. 66 Garland C. 22, 39, 70 Goudoever J.B.V. 50 Ha C.G. 47 Heinonen K. 118 Gatti M.G. 92 Gounaris A. 101 Hachem T. 114 Heiring C. 120 Gatti S. 49 Gouvea A.B. 61 Haddaji Mastouri M. 77 Helder O.K. 99 Gavare I. 17 Gouveia R. 94 Hadj-Abdallah H. 107 Helenius K. 95 Gebauer C. 97 Gouyon J.B. 110 Haeberlin A. 99 Hellgren G. 32, 45, 87, 112 General F. 44 Govaert P. 92 Hafström M. 77, 103 Helliwell E. 68 Gennissen L. 57 Gowda H. 22, 25, 26, 61 Hagberg H. 54, 119 Hellström A. 32, 45, 60, 62, 87, 112 Gentilino V. 28 Gozen D. 112 Hägglöf B. 56, 86, 94 Hellström W. 112 Genzel-Boroviczeny O. 120 Gözen D. 81 Hagman C. 97 Hellström-Westas L. 78, 118 Georgakopoulou I. 113 Gozzini E. 98 Hagmann P. 45 Hemels M. 43 Georgieva R. 20 Gragnaniello D. 120 Haiden N. 36, 43, 44, 81, 87 Hemmatpour S. 81 Geraci D.M. 94 Gramignoli R. 57 Haiek L. 83 Hemse Nojd K. 44 Gerbaulet L. 117 Grandvuillemin I. 64 Hair A. 82 Henckel E. 57, 59 Geurtzen R. 27 Grant P.E. 47 Hakannson S. 95 Hending M. 57 Ghazal K. 77 Grathwohl D. 121 Hakeem M.A. 62 Hendriks M. 47, 57 Ghith A. 25, 108, 116 Gratopp A. 40 Halamek L. 27 Hendriksen A. 47 Giacalone M. 98 Gray J. 117 Halil H. 59 Henriksen T.B. 29, 31, 46, 58, 64, Giampietri M. 98 Gray P.H. 78 Hallab Y. 112 71, 78, 86 102, 103 Giampietro S. 94 Grayson N. 30 Hallak A.C. 22, 25 Henry C. 61, 95 Giannakopoulos I. 113 Green G. 118 Hallberg B. 34, 45, 57, 72, 83, 87, 88 Hentschel R. 34, 61, 96, 120 Giannattasio A. 66 Greenough A. 55 90, 94, 111 Héon M. 82, 83 Giannì M.L. 110 Gregersen N. 64 Halleb Y. 77, 107 Herber-Jonat S. 19, 21 Gibbins S. 30 Gregorio-Hernández R. 26, 82 Halonen S. 81 Herdt A. 97 Gibbons D. 53 Greisen G. 48, 50, 100, 103 Hamazaki T. 76 Herlenius E. 61, 117 Gil Fenoy A.M. 24 Gressens P. 34, 54, 72, 100, 119, 123 Hamdi S. 42 Hernandez-Chirlaque C. 19 Gil-Campos M. 19 Gribaa M. 77 Hamilton R. 86 Herranz Barbero A. 116 Gill A.W. 55 Griesmaier E. 92 Hammami S. 77 Herz J. 87, 119 Gilmore C. 56 Griffin I. 97 Hamolko K. 36 Hetzer B. 115 Ginet V. 119 Griggio A. 49 Hamvas A. 41, 89 Hiatt C. 18 Giordano V. 80, 87 Grill A. 36 Hannachi N. 115 Hidar S. 77 Giretti I. 120 Grimaldi C. 75 Hansen B.M. 103 Higginson J. 84 Giske C.G. 66 Grinfelde I. 17 Hansen G. 120 Higman W. 71 Giuseppi A. 81, 110 Grira M. 77 Hansen Pupp I. 45, 84, 97, 112 Hitendu D. 29 Gizzi C. 11 Groenendaal F. 29, 47, 53, 67, 72, 80, 87, Hansson V. 100 Hjerde E. 69 Gjeta I. 20 118 Hantzi E. 115 Hjortdal V. 29, 103 Gladstone M. 92 Gromann J. 26 32 Hård A–L. 45, 93 Hjortdal V.E. 31, 78 Glander S. 66 Grönqvist H. 78 Harding J.E. 28, 114 Höck M. 77 Glass H.C. 32 Grouiller F. 118 Harris D.L. 28, 114 Hoehn T. 17, 49 Gliga C. 17, 107, 108 Grunt S. 79, 93, 103 Harris L. 67, 80 Hofer M. 116 Glover A. 39 Grynspan D. 69 Härtel C. 65 Hoffmann C. 76 Goel S. 30 Gudmundsdottir A. 83, 109 Hartley C. 118 Hogeveen M. 27 Goeral K. 80 Guedich N. 77 Haschke F. 121 Högström J. 82 Gojnovci X. 114 Guerrero A. 115 Hascoet J-M. 78, 82 Hokuto I. 75 Gökalp A.S. 98 Gui L. 67 Hăsmăsanu M. 62, 109, 115 Holland M. 89 Golosovsky E. 83 Guimarães H. 26, 85, 116 Haumont D. 31 Holland M.R. 41 Golovchenko O. 83 Gulati N. 85 Ha-Vinh Leuchter R. 118 Höller N. 64 Gomez-Solaetxe M. 36 Gulczyńska E. 64 Hawksley J. 68 Hollis C. 104 Gonçalves A.B. 22, 25 Gulden S. 28, 49, 63 Hayakawa M. 76 Holsti A. 86 Gonçalves-Ferri W.A. 20, 22, 25, 61, 107, 110 Günlemez A. 98 Hayde M. 36 Holsti L. 31 Gonzalez J.J. 114 Guo T. 45 Haydon H. 79 Holt A. 23 Gonzalez R. 36 Gürol A. 114 Hayes B. 76 Hongjie G. 41 Gonzalez S. 114 Gursoy T. 112 Hayes-Gill B. 61 Honore A. 117 González Barrios D. 47 Gustafsson A. 59 Haynes M. 99 Hooper S. 29 González Campo C. 47 Gutierrez E. 63, 102 Hays N.P. 121 Hooper S.B. 84 162 162 163 163 Horgan E. 30 Isayama T. 95 Jost K. 55, 97, 99 Kendall G. 27, 59 Horoshkeeva O. 75 Išgum I. 53 Jourdain G. 38 Kennedy G. 70 Hosang N. 84 Isidoro-García M. 63, 102 Juhl S.M. 50 Kennedy S. 120 Hovhannisyan C. 114 Isik S. 82 Jung E. 79, 112 Kenner C. 105, 122 Hovi P. 56, 96, 118, 121 Iskander R. 112 Juul S. 87 Kent E. 41, 65 Howarth C. 42 Isler H. 19, 42 Juvet L. 114 Keogh C. 30 Hristova E. 63 Ismaili H. 23 Jynge Ö. 57 Kerinova E. 20 Hristova M. 54, 119 Israelsson C. 82 Kermorvant E. 32, 50, 75 Hsieh W.S. 98 Ivanova J. 20 Kernan R. 108 Hsieh W-S. 98 Ivanova V. 20 K Kerrn-Jespersen S. 64 Hsin A. 77 Iversen A. 66 Keshavjee B. 121 Hsu J.F. 59 Ives K. 37 Kacem I. 25, 107, 109, 116 Keskin H. 40 Hsu S. 108 Iyore E.O. 50 Kadioglu Simsek G. 23, 41, 82, 96 Kettle R. 99 Hu X.J. 40 Izquierdo M. 113 Kaila K. 63 Khammari Nystroem F. 95 Huang C.C. 95 Izquierdo-Renau M. 45, 113, 116 Kairamkonda V. 32 Khan R.A. 115 Huang E. 80 Kajantie E. 118 Khemis T. 24, 25, 46, 112 Huang R. 90 Kajtazi F. 23 Khoo P.C. 23 Huber E. 44, 92 J Kalaydzhieva M. 20 Kidszun A. 37 Huescar M. 24, 111 Kallel F. 77 Kiechl-Kohlendorfer U. 92 Huescar M. 24, 111 Jackson A. 27 Källén K. 58, 109 Kiely M. 45 Huh J. 96 Jacobs S.E. 24, 66 Kaltsogianni O. 55 Kierkegaard H. 64 Huhn E.A. 118 Jaekel J. 56, 58, 94 Kamath-Rayne B. 99 Kilchevski A. 36 Huhtala M. 90 James A.T. 33, 89 Kampmann B. 114 Kilic D. 22 Hulzebos C.V. 31 James E. 76 Kan Onturk Z. 112 Killalea A. 112 Humaun Kabir M. 66 Jansen N.J.G. 29, 53, 80 Kang S.J. 111 Kim A.R. 62, 79, 112 Hummler H. 38, 120 Jansen S. 97 KanijoMøller B. 121 Kim C.S. 111 Hundscheid T. 40 Jaraba M.P. 107 Kanmaz H.G. 23, 41, 96 Kim C.Y. 62 Hung C.C. 77 Jarosz-Lesz A. 19 Kanmaz Kutman H.G. 85 Kim E.J. 110 Hunt T. 22 Järvelin M.-R. 118 Kao Y.H. 21 Kim E.K. 77 Huotilainen M. 39 Jarvis H. 17 Kapadia V. 30 Kim H. 62 Hüppi P. 12, 34, 68, 86, 104 Jashari H. 114 Kapfhammer J. 79, 93 Kim H.R. 96 Hüppi P.S. 67 Jayasinghe D. 84 Kappeler J. 21 Kim H.S. 77 Hurley M. 27 Jazexhiu–Postoli E. 37 Kara M. 40 Kim K.S. 62, 112 Hurley T. 26 Jebali S. 81 Karadag A. 78 Kim K.-S. 79 Hurtado Suazo J.A. 24, 66, 112, 116 Jenken F. 39 Karadagi A. 57 Kim S. 62, 111 Hussain J. 84 Jenkinson A. 31 Karageorgou K. 23 Kim W.H. 18, 62 Hutten G.J. 36 Jensen C.F. 46 Karagianni P. 44 King M. 76 Huttner W. 91 Jensen E. 121 Karam M. 100 Kioumi A. 44 Hwang J.H. 24, 62, 79, 11 Jermendy A. 6, 64, 67 Karen T. 19, 42 Kirkham J.J. 49 Jesacher B. 99 Karetnikova N. 75 Kirpalani H. 46 Jeter J.M. 121 Kari J. 81 Kirtbaya A. 75 I Jiang M. 96 Karkani A. 83 Kirupakaran K. 27 Jiang P. 50 Karpinski L. 37 Kistler K. 94 Iacob D. 117 Jiang S.Y. 40 Kasdallah N. 18, 19, 117 Kjeldsen M. 64 Iacob E.R. 117 Jilma B. 43 Kasprian G. 80 Kjellin T. 57 Iacobelli S. 44, 69, 110 Jimenez-Espinoza C. 68 Kasraoui I. 18, 19, 117 Kjellson K. 44 Ibrahim C.P.H. 114 Jin X. 96 Kasser S. 32, 118 Klarer N. 118 Ibrahim H. 90 Joels M. 86 Kassirer M.Y. 57 Klebermass-Schrehof K. 36, 80, 87 Ichiba H. 76 Johansson E. 59 Katayama Y. 67 Klein N. 54, 119 Iglesias I. 113 Johansson S. 86, 95, 104 Kattwinkel J. 99 Klein S. 57 Iglesias-Platas I. 45, 83, 113 Johnson K. 111 Kavalloor N. 23 Kleinlein B. 120 Iijima K. 21, 110 Johnson M. 15, 69, 110 Kawase A. 107 Kleiser S. 19, 42 Ikuta T. 21, 67 Johnson S. 56 Kayyali R. 65 Klemme M. 21 Ilieva I. 20 Johnston C. 30 Kazeem O. 116 Kleshchenko E. 102 Imbulana D. 38 Johnston L. 79 Kbaier H. 18 Klevebro S. 45, 87, 111 Inarejos E. 83 Jones J. 20 KC A. 29 Klingenberg C. 29, 68, 84, 114 Indredavik M.S. 78 Jones J.G. 55 Keenan W. 99 Klishch O. 38 Ingman A-S. 83 Jones R. 111 Kelly J. 112 Klotz D. 37, 62, 97 Inomata K. 107 Jongmans M.J. 39 Kelly L. 80, 101 Kneyber M.K. 70 Inoue T. 76, 107 Jonsson B. 66 Kelly L.A. 101 Knibbe C. 15, 41, 49, 88 Ionov O. 48, 75 Jordanova A. 63 Kemp J. 41 Knibbe C.A.J. 88 Ioroi T. 67 Jorns C. 57 Kempley S. 64 Knirsch W. 29 164 164 165 165 Knol J. 43 Leon M. 76 Lundgren P. 43, 87, 93 Kobas M. 101 L Leonardi V. 98 Luu T.M. 81 Koch B. 114 Leong V. 47 Lydersen S. 78, 103 Kocova M. 24 Laarman A.R.C. 45 Lequin M. 72 Lynne K. 116 Koehne P. 40 Lager M. 92 Leucuta D. 62 Kokkori F. 101 Lærum A.M.W. 78 Leung T. 42, 43 Koksal N. 44, 66 Lafeber H. 78 Leva E. 63 M Kola E. 20 Lafeber H.N. 45 Levasseur K. 83 Kolossvary M. 67 Laforgia N. 37 Levy E. 69 Macchini F. 28 Koltunov I. 98 Laganà A.S. 84 Levy P. 89 Machidani N. 36 Komoriyama A. 92 Lagercrantz H. 67, 81, 88, 103, 104 Levy P.T. 41, 65 Mactier H. 86 Kondo Y. 107 Lahiff M. 84 Lewis J. 94 Mader S. 16, 51, 70, 90, 105, 122 König K. 122 Lakatos A. 67 Ley D. 45, 93, 112 Madero R. 26 Königs M. 78 Lakshminrusimha S. 71 Li C. 55 Maderuelo-Rodriguez E. 26 Konstantinova V. 20 Lalchev Z. 63 Li N. 121 Maeyama K. 67 Kontilska S. 20 Lamouchi M.T. 18, 19, 117 Li Y. 50, 98, 120 Magalhaes L.V. 47 Koopman-Esseboom C. 53 Lamur K.D. 80 Liamlahi R. 29 Magerl W. 118 Korja R. 90 Lamy E. 64 Lieftüchter V. 19 Magny J.F. 97, 114 Kornelisse R. 9 Landau-Crangle E. 32, 53 Liegl R. 87 Maguire F. 53 Kornsteiner-Krenn M. 43 Lange S. 59, 105 Liem D. 49, 88 Mahdhaoui N. 25, 77, 107, 108, 109, 116 Korstanje J.P. 100 Lano A. 118 Lien R. 106 Mahieu L. 100 Kortsalioudaki C. 27, 59 Lapaire O. 32, 92 Liew Z. 58 Mahoney L. 22 Kositamongkol S. 96 Lapillonne A. 15, 45, 50, 69, 97, 114 Likeman M. 79 Mai V. 65 Kosova R. 120 Laroche S. 100 Lilliesköld S. 82 Maida C.M. 94 Köster C. 87, 119 LaroneJuneau A. 83 Lima B.B. 25, 110 Maier R.F. 53 Kostilainen K. 39 Larsen S.H. 29 Lin C-H. 28, 95 Maingay-de Groof F. 100 Kostovski A. 24 Lasheras G. 123 Lin Y.C. 95 Majcherczyk M. 19 Kostukov K. 75 Latal B. 29, 76 Lin Y.J. 95 Malavolti A.M. 76 Kotidis C. 48 Latour J. 13, 36, 57, 90 Linde M.A. 114 Malchau Carlsen E. 121 Kousholt B.S. 64 Lattuada D. 49 Ling T.Y. 120 Maldonado J. 112 Kouskouni E. 59 Lauenborg J. 121 Lingam I. 54, 119 Malic N. 113 Kovacs K. 63, 64 Lauridsen M.H. 31 Linklater A.K. 24 Mallardi D. 110 Kovacs S. 25 Lavallée A. 39, 82, 89 Linnér A. 38 Mallya P. 84 Kozak L.R. 67 Lavizzari A. 11, 36, 46 Linsell L. 56 Malniece I. 17 Kramer B. 54, 119 Law S. 71 Liotto N. 110 Malone F. 33, 41 Krasinski Z. 109 Lawn C. 22, 39 Lista G. 20, 27, 120 Malone F.D. 41 Krasniqi F. 23, 114 Lawrenson J. 48 Lithoxopoulou M. 44 Malova M. 47, 68, 72, 79, 80, 92 Krasniqi I. 114 Lazar C. 75 Little G. 99 Målqvist M. 29 Kreissl A. 44, 87 Lazeyras F. 67, 68, 118 Little R. 39 Mancino I. 32 Kristiansen M. 81 Leach C. 39, 70 Liu K. 53 Mandò C. 104 Kronström K. 81 Lebouedec A. 96 Liu S-Y. 98 Manerkar S. 30 Kroon A.A. 31 Lee B.S. 62, 79, 112 Liu Z-J. 87 Mangili A. 31, 55, 84, 95 Kryuchko D. 48, 102, 107 Lee E.H. 42, 96 Löfqvist C. 32, 45, 87, 93, 112 Manktelow B.N. 86 Ksia A. 25 Lee H.J. 78 Loftus E. 53 Manley B. 37, 38, 46 Kuehn T. 82 Lee K.H. 96 Logothetis M. 59 Mannheimer C. 87 Kuhle J. 92 Lee K.J. 47 Lombaard C.J. 48 Manolidou Z. 59 Kuhn P. 51, 84 Lee L.H. 96, 111 Longford N. 87, 97 Manou A. 81 Kujawa M. 19 Lee M. 96 Longini M. 79 Mansvelt P. 99 Kuligowski J. 72, 93 Lee N.H. 18 Loof T.G. 66 Marchini G. 44 Kumar A. 65 Lee N.M. 78 Looney A.M. 72 Marchionni P. 50, 61, 62 Kumar Bikkarolla S. 66 Lee S. 51, 58, 95 Lopes T. 19, 116 Marciano Alves Mousinho R. 97 Kunz N. 68 Lee S.J. 40 Lopez Lozano Y. 115 Mardare R. 82 Kurinczuk J. 56 Lee S.K. 40 López-de-Heredia J. 36 Margeli A. 115 Kuroda J. 21 Lee S.L. 18, 84, 111 Lopriore E. 31 Marginean O. 108 Kurzawińska G. 92 Lee W.M. 18 Lordier L. 68 Marian R. 17, 107, 108 Kusuda S. 58, 76, 98 Lee Y.M. 18 Loureiro B. 36, 93 Mario M. 94 Kvanta H. 68 Lefebvre F. 81 Lourenço M.M. 25, 107 Markasz L. 21 Kwan C. 82 Lehtonen L. 13, 31, 58, 90, 95, 122 Lozar Krivec J. 19 Marlow N. 53, 56, 86, 103, 104, 105 Kwinta P. 45, 110 Lei W.T. 21 Lu K. 30, 95 Marrin M.L. 53 Kwon J.Y. 96 Lemmers P. 29, 47 Ludeña D. 63, 102 Marroun H.E.L. 118 Kyng K.J. 64, 71, 78, 86 Lemmers P.M.A. 109 Lui K. 30, 58, 95 Maršál K. 58, 93 Lenderking W. 95 Luka R.L. 20 Marshall A. 115 166 166 167 167 Marsinyach-Ross I. 26, 38 Meder U. 63 Monk D. 20 Nadeem N. 17 Marsubrin P.M.T. 85 Meehan C. 54, 119 Monnelly V. 86 Nader P.J.H. 17, 96 Mårtensson G. 67 Meesters N. 31 Monteagudo-Sánchez A. 20 Nader S.S. 17, 96 Martin A. 26 Meeus M. 100 Monteith C. 41 Naef N. 29 Martin D. 16 Megaw K. 113 Montesano G. 38 Nagamura-Inoue T. 76 Martin T. 65 Mellinger L. 66 Montirosso R. 122 Naghib S. 57 Martín C.M. 24 Melorz A. 116 Moore C.M. 81, 82 Nagy Z. 12 Martin-Alvarez E. 24, 66, 112, 116 Mendoza N. 114 Morales A. 24, 84 Naicker K. 65 Martin-Ancel A. 76 Menis C. 110 Morales De Mata P. 84 Nair H. 76 Martin-Celini F. 107 Menshykova A. 21 Moral-Pumarega M.T. 72, 93 Najm S. 32, 45, 112 Martinello K. 54, 119 Mercer J. 33 Morana G. 47, 68, 72, 80, 92 Nakato A.M. 20 Martinez A. 19, 24, 75 Merchant N. 77, 100, 123 Morcelli-Tovar C. 22 111 Nakstad B. 69, 116 Martinez F.E. 19 Merglen A. 118 Moreno A. 116 Nallagonda S. 82 Martinez V. 36 Méritet J.F. 88, 114 Moreno Hernando J. 20, 26 Napolitano 38 Martinez Gimeno A. 115 Mestiri K. 77 Moretti C. 68, 123 Narayanan S. 77, 100, 123 Martinez-Biarge M. 101 Methlouthi J. 25, 108, 116 Morgan C. 32, 45, 50, 110, 111 Nardi V. 109 Martini S. 47 Michalec M. 19 Mori R. 76 Nardou K. 116 Martín-Peregrina F. 66 Miechowicz I. 37 Mori T. 75 Nassel D. 81 Martins C. 101 Mielgo V. 36 Morioka I. 21, 67, 110 Nasseri N. 42 Martins-Celini F.P. 20, 22, 107, 110 Mielnik K. 17, 113 Morisaki N. 95 Natalucci G. 76, 79, 85, 93, 103 Maruniak-Chudek I. 19 Migliaro F. 98, 120 Morisawa T. 67 Nath P. 18, 23, 39, 100, 114 Masaki H. 113 Mikhalenka E. 36 Morley C.J. 30, 68 Navarro N. 85 Masilungan C. 115 Mikkola K. 39 Morris C. 115 Navarro Patiño N. 25, 41, 85 Maslarska R. 20 Mildenberger E. 37 Morris J. 42, 56, 64 Navér L. 66 Mastouri Haddeji M. 112 Mileder L.P. 61, 62, 64 Morsing E. 93 Negro S. 92 Mateos M. 63, 102 Miletin J. 26, 42, 108, 109, 112 Mosca F. 28, 49, 63, 110 Negrón J. 113 Mathlouthi J. 112, 107, 109 Miller P. 108 Moshous D. 114 Nelle M. 82 Matic A. 77 Miller S. 29, 45, 100 Mosig D. 121 Nelson S.E. 121 Matinolli H-M. 118 Mills M. 67, 80 Mougou S. 77, 108 Nemeth A. 57 Matterberger C.H. 62 Milov V. 63 Moungsuwan K. 96 Neovius M. 102 Matthew A. 64 Minoo P. 55 Mowitz M. 31, 55 Neşelioglu S. 83, 113 Matthiesen N.B. 29, 31, 58, 103 Mirada Vives A. 84 Msalbi K. 112 Nestaas E. 14, 33, 40, 54 Matusiak G. 17 Mirahamdi S. 61 Mu S.C. 23, 37, 107 Neumann R. 92 Matyas M. 62, 109, 115 Miranda A.M. 113 Muche R. 120 New K. 105, 122 Maurina A. 17 Miranda L. 94 Mukai T. 76 Newell S. 38 Mayer B. 37, 38 Miranda Romera P. 24 Mukherjee A. 117 Nguyen A. 50 Mazaev A. 98 Mitra S. 40, 63 Mukherjee D. 117 Nguyen T.D. 85 Mazela J. 37, 109, 113 Mitsiakos G. 44 Mulder A. 100 Nichols T. 58 Mazur-Magoła M. 83 Mittal S. 85, 107 Mulder E.E.M. 84 Nicloux M. 114 Mbuagbaw L. 40 Miyazawa T. 110 Müller V. 66 Nicolau Manzano M. 84 Mc Coy R. 32 Mizobuchi M. 67 Mungan Akin I 24, 108 Niedbalski P. 37 McCallion N. 33, 41, 68 Moczko J. 37 Mupanemunda R.H. 27 Niederhauser T. 99 McCarthy E. 45 Modi N. 31, 58, 90, 95, 97, 121 Muppidi P. 32 Niermeyer S. 99 McCarthy L. 65 Moeskops P. 53 Muraca M.C. 92 Nieto R. 44 McCartney D. 61 Mohammadzadeh A. 20 Muresan D. 109 Nijboer C. 87 McCormack M. 82 Mohammed L. 82 Murillo C. 116 Nikitina I. 48 McCurmin D. 87 Mohanraj N. 81 Mürner-Lavanchy I. 79 Niklas V. 91, 96 McDermott H. 24, 39 Mohlkert L.A. 121 Murphy M. 65, 120 Nilas L. 121 McDonald K. 22 Moiron M. 44 Murphy R. 53 Nilsson A.K. 32, 45 Mc Eneaney V. 80, 101 Moja L. 30 Murray D.M. 53, 71, 72, 80 Nilsson J. 82 McFadden V. 18 Mok D. 108 Mussi M.M. 110 Nishimura N. 67 Mc Garvey C. 76 Mól N. 45, 110 Mustafa S. 23, 87 Nixon P. 121 McGillick E.V. 84 Moldovan E. 107 Mustafa Kamal A.M. 84 Nobile S. 50, 61, 62 McGregor C. 72 Moles L. 114 Muster M. 83 Noguchi A. 95 McGuire J. 80 Moll J. 64 Mynarek M. 103 Nogueira M. 85, 116 McMillan D. 63 Mollamahmutoglu L. 83 Nohr E.A. 58 McNair C. 30 Molloy E.J. 18, 30, 43, 53, 80, 101 Nolan O. 108 McNamara D. 61 Moloney G. 72 N Nolbrant S. 94 McNamara P. 14, 54, 89 Moltu S. 32, 44, 50, 69, 110 Noori S. 14, 54 McNulty A. 70 Monastiri K. 24, 25, 42, 77, 112 Naberezhnev Y. 83 Noorizadeh S. 20 McPherson B. 54 Mondello I. 109 Nabetani M. 76 Noorlag L. 29 McSweeney L. 41 Mondkar J. 30 Nabialek T. 97 Nordberg V. 66 168 168 169 169 Nørgaard K. 121 Oosterlaan J. 78 Pavlyshyn H. 38 Polat S. 114 Norman E. 88, 122 Oostrom K. 78 Pavon A. 72, 93 Polentarutti S. 29 Norman G. 76 Oral B. 66 Pavord S. 81 Polglase G.R. 84 Norman M. 58, 66, 82, 93, 109, 111 Ordoñez M.D. 107 Paynter J. 79 Pollien P. 118 121 O’Regan S. 30 Pedersen L.H. 71, 86 Polonara G. 67 Nosarti C. 56 O’Reilly H. 56 Pedersen M. 78 Polycarpou E. 40 Noureldein M. 23, 82, 95 Orlikowsky T. 35 Pedersen M.V. 78 Ponce J. 116 Nouri A. 77 Örtenstrand A. 100 Pedersen T. 69 Ponchia E. 33 Nouri S. 77, 107, 109, 112 Osborne L. 23, 40 Peinado H. 26 Ponnusamy V. 75 Nouri Merchaoui S. 25, 108, 115, 116 Orsini B. 38 Pejovic N.J. 61 Popoiu A. 108 Noventa M. 84 Oshalim M. 59 Pelligra G. 82 Poppe J. 88 Nowak G. 57 Østergaard J.R. 29, 31, 103 Pelling V. 67, 80 Porcarelli F. 62 Núñez-Ramiro A. 72, 93 Østerholt H.C.D. 116 Peña-Caballero M. 66, 112 Porta R. 123 Ostojic D. 19, 42 Peng X. 90 Porter R. 85 O Ouwehand T.L. Ovali F. 53 24 Peralta J. Pereira Martins-Celini F. 115 22 Posod A. Prager S. 77, 92 119 Owen L. 37, 38, 46 Peretti A. 67 Prasad R. 75, 108 Ó Catháin N. 112 Owsiańska Z. 17 Perez E. 76 Prayle A. 27 O’Connor D. 82 Özcan B. 83 Pérez I. 24 Pre-Curto F. 116 O’Connor N. 53 Ozdemir N. 78 Perez-Navero J.L. 110 Preusche A. 109 O’Dea M. 101, 116 Ozer Bekmez B. 85 Perez-Perez A. 26 Pritchard M. 78, 79, 105, 122 O’Dowd M. 39 Ozkan H. 44, 66 Perk Y. 81 Procianoy R.S. 47, 65 O’Leary J.J. 101 Perrone M. 110 Proença E. 19, 116 O’Riordan M. O’Sullivan M.P. 97 72 P Perrone S. Perrotta I. 79, 92 38 Proietti F. Provitera L. 79 28, 49 O’Brien O. 53 Pertile M. 36 Pryds O. 121 Ochoa J.J. 66, 112 Padalino M. 48, 65 Pescador Chamorro I. 25, 38, 94, 95 Psyllidou S. 117 O’Connor N. 53 Padbury J. 33 Peters J. 120 Puccini P. 36 Odd D. 58, 79, 94 Padilla N. 67, 68 Petersen O.B. 31 Pugni L. 63 Oddie S. 59, 65 Pagel J. 65 Peterson M. 102 Puigarnau Vallhonrat R. 84 O’Dea M. 101, 116 Paiva P. 22, 25 Petersson G. 92, 102 Pulzer F. 120 O’Donnell C. 65, 120 Paiva P.P. 61 Petrela E. 37 Pupp Hansen I. 112 O’Donnell C.P.F. 30 Paize F. 92 Petroni G. 99 Putter H. 31 Oei J. 30 Pakarinen S. 39 Petropoulou C.H. 59 Puyal J. 119 Ofoegbu B. 82, 90 Pal R. 22 Petrova D. 63 Ognean M.L. 25, 85 Palmkvist Kaijser K. 44 Petrukhina N. 102 Oguz S.S. 23, 41, 53, 59, 82, 85 Panickar A. 77 Petty J. 105 Q 96, 98 Panjwani D. 107 Peyter A.C. 64 Ohlund I. 32 Pansy J. 64 Pfeifer S. 66 Quero J. 101 Ohyama S. 21 Pantoja A. 24 Pfeiffer H. 32 Quigley A. 86 Okafor I. 18 Panza R. 37 Pfister M. 32 Quigley J. 44 O’Kelly R. 112 Papadopoulou M. 83, 101 Pfister R.E. 79 Quintana Rio E. 84 Okubo S. 21 Papamichael E. 40 Philpott A. 18 Quintero Fuentes I. 47 Okur N. 23, 41, 53 59, 82, 85, Papassotiriou I. 115 Pianesi A. 67 96, 98 Park J.H. 18, 111 Pichler G. 61, 62, 64 Olariu A. 23, 82, 95 Park S.H. 18 Pieltain C. 96 R Olariu E. 25 Park W.S. 34 Piemontese P. 110 Olariu G. 20, 27, 85 Parker A. 33 Pietrobelli A. 110 Raaymakers M.J.A. 108 Olariu L. 20 Parmar M. 77, 123 Pillow J.J. 55, 62 Raba G. 83 Olariu S. 20, 27 Parodi A. 47, 68, 72, 79, 80, 92 Piñeiro-Ramos J.D. 72 Rabe H. 22, 27, 33, 48, 49, 67, 80, Olbertz D. 96 Paro-Panjan D. 19, 79 Pinho L. 19 91, 109 Olin A. 59 Parra A. 72, 93 Pioselli B. 36 Rabi Y. 30 Olischar M. 80 Parraga M.J. 107 Pirr S. 65, 66 Raffa S. 47 Olsen J. 58 Parrella C. 21 Pissarra S. 26 Raffaeli G. 28, 49, 63 Olsen R.K. 64 Parri N. 98 Pittet M.P. 79 Ragab S. 54, 119 Olsson K.W. 43 Partanen E. 39 Poets C.F. 68, 101, 109 Rahim R. 114 Olsson Mägi C-A. 81 Parthasarathy P. 100 Poggi C. 98 Rai D. 86 Olteanu R.G. 67 Patel B. 27 Poggi G. 120 Räikkönen K. 118 Omann C. 78 Patel M. 89 Pogka M.M. 113 Raimondi F. 21, 66, 98, 120 Omer M. 116 Patel M.D. 41 Poindexter B. 82 Raiskila S. 122 Oncel M.Y. 59, 82 Pavel A.M. 97 Pokrzywinski R. 95 Rajadurai V. 23 Onland W. 31, 98 Paviglianiti E. 109 Polat I. 40 Ramanathan R. 55, 90 170 170 171 171 Ramaswamy R.C. 24 Rocha N.A.C.F. 76 Sadeghirad B. 40 Sauser J. 118 Ramenghi L.A. 12, 27, 47, 67, 68, 72, 79 Rochow N. 32, 50, 53, 82, 96, 112 Saeidi R. 20 Savani R.C. 21 80, 92, 104 Rodgers-Gray B. 115 Saenz De Pipaon M. 114 Sävman K. 32, 45, 112, 118 Ramos N. 24 Rodrigues M. 116 Saffioti M.C. 75 Saysanasongkham B. 17 Ramos-Navarro C. 18, 25, 26, 38, 41, 85 Rodriguez A. 95 Saghrouni F. 116 Sboui H. 77, 107, 115 Rana N. 29 Rodriguez M.V. 107 Saglam O. 22 Scacioli L. 22, 25 Rapisarda A.M.C. 84 Rodríguez J.M. 114 Sala D. 20 Scalise L. 61 Rapushi E. 37 Rodríguez J.R. 114 Salabay Z. 37, 44 Schaefer C. 29 Rascher W. 120 Rodriguez Fanjul J. 26, 98 Salas S. 113 Schappin R. 53 Raschetti R. 55 Rodriguez Guerineau L. 20 Saleh M.T. 75 Schelonka R. 99 Rasiah S. 24 Rodriguez Sánchez De la 18, 25, 38, 41, 82, 94, 95 Saleh S. 75 Schenk D. 19 Rasiah S.V. 18, 24, 75, 108 Blanca A. Salguero E. 24, 111 Schenk W. 120 Rasiah V. 117 Rodriguez-Benitez M.V. 19 Saliba A. 90 Schiefele L. 38 Ratiu A. 85 Roehr C.C. 18, 20, 23, 31, 37, 46, 62, Sallabanda S. 20 Schimmel M.S. 57 Ravanetti F. 36 81 91, 96, 115, 123 Sallemi M. 18 Schloesser R. 76 Ravegnani M. 79 Roesch L.F. 65 Sallmon H. 18, 40 Schlösser R. 120 Ravn M.J. 81 Rogerson S. 47 Salomone F. 36 Schmid A. 77 Raynero R.C. 24 Roggero P. 110 Salvagno M. 48, 65 Schmid M. 38, 120 Razai A. 117 Rogido M. 97 Samuelsson M. 86 Schmidt L. 80 Re M. 72 Rohde O. 120 San Feliciano L. 63, 102 Schmidt S. 17 Rechtman D. 96 Rohsiswatmo R. 85 Sanches E.F. 87 Schmolzer G. 99 Ree I.M. 31 Roldán R. 24 Sanchez A. 36 Schmölzer G.M. 62 Regnicolo L. 67 Rolle U. 76 Sanchez A.A. 41, 89 Schneider H. 37, 97 Reicherzer T. 111 Romantsik O. 77 Sanchez T. 111 Schneider J. 45, 47, 101 Reichman B. 58 95 Rombo K. 13 Sánchez-de-Toledo J. 26 Scholkmann F. 19, 42 Reinboth B.S. 119 Romero J. 87 Sánchez-Gómez De Orgaz M. 26 Schöning J. 66 Reis e Melo A. 26 85 Romeu Garbí J. 84 Sánchez-Illana Á 72, 93 Schreek S. 66 Reiss I.K.M. 9, 23, 31, 35, 49, 57, 88 Rook D. 30 Sánchez-Luna M. 16, 18, 26, 38, 41, 60, 68 Schultze J.L. 66 100 Rosander K. 78 82, 85, 94, 95 Schulze A. 21, 111 Reister F. 38 Rosário M. 26, 85 Sánchez-Martínez M.B. 66, 112 Schulzke S.M. 99 Reitan S.K. 78 Rosario Filho N. 20 Sánchez-Redondo M.D. 24, 78, 115 Schumann S. 37 Relton C.L. 71, 86 Rosenbaum J. 78 Sanchez-Torres A.M. 26 Schütze G. 111 Remesal A. 63, 102 Roseto B. 38 Sandegren L. 66 Schwaberger B. 61, 62, 64 Renes I. 43 Rossetti D. 84 Sangalli A. 17 Schwartz E. 84 Repa A. 43, 44, 81, 87 Rossi A. 47, 68, 72, 80, 92, 109 Sangaralingham L. 99 Schwarz C.E. 109 Resnick S. 95 Rossi R. 120 Sangild P.T. 50 Scopesi F. 27 Rettedal S. 69 Roth J. 65, 66 Sannia A. 47, 68, 72, 79, 80 Scott J.G. 79 Reulecke B. 22, 80 Rotta I. 38 Sanpietro G. 84 Scott M. 114 Reuner F. 66 Rousson V. 29 Sansone C. 120 Scrivens A. 37 Reyes Millán B. 47 Roviglione B. 27 Sánta R. 17, 108 Sdobnikovs M. 17 Reynolds A. 76 Rovira Zurriaga C. 20 Santhalingam T. 95 Seboui H. 25, 77, 108, 116 Reynolds P. 37 Roy R. 21, 116 Santos A.L. 116 Sedin G. 21 Rey-Santano C. 36 Rudas G. 67 Santos M.M. 76 See L.C. 108 Rheinländer C. 40 Rueda C. 116 Santos Silva J. 85 Segerer H. 120 Riccardi D. 38 Rueda R.L. 107 Sanz-Lopez E. 26, 82 Seidenberg J. 120 Ricci F. 36 Ruiz M.D. 107 Sapia F. 84 Sekarski T. 89 Rich W. 30 Ruiz-Gonzalez M.D. 19 Saporito L. 94 Sekarski T.J. 41 Richter A. 61 Rumba-Rozenfelde I. 17 Sapun O. 102 Sekili Z. 39 Richter M. 65 Rusconi F. 58 95 Sarapuk I. 38 Sekretar L. 37 Rickenbacher H. 118 Rusneac M. 17, 107, 108 Sarda S. 31, 55, 84, 94, 95, 102 Sellami M. 117 Rigby M. 65 Russo L. 101 Sari F.N. 85, 98 Sellwood M. 27, 59 Rigo J. 96 Russo S. 79 Sari R. 85 Semberova J. 26, 42, 108, 109, 112 Rigourd V. 81, 88, 97, 110, 114 Ryan E. 18 Sarmiento-Carrera N. 112 Semple S. 86 Rimensberger P. 70 Sarosa G. 114 Senterre T. 96 Rimol L.M. 78 Sarri G. 102 Senyuk T. 102 Rite S. 36 S Sartori S. 48 Seppänen A-V. 53 Rivera-Sánchez S. 116 Sartz L. 94 Seraissol P. 88 Roberts C. 37, 46 Saad A. 77, 107, 112 Saso A. 114 Serdar M. 87 Roberts E. 49 Saccani F. 36 Sato Y. 76 Seremak-Mrozikiewicz A. 92 Robertson N.J. 54, 87, 119 Sacramento E. 20, 22, 25, 61, 107 Satodia P. 17, 18, 23, 40, 114 Serenius F. 58, 77, 86, 103 Roch G. 83 Sadarangani M. 115 Saugstad O.D. 30, 31, 61, 62, 71, 92, 118 Seribeli G.H. 20 Rocha G. 26 Sadasivam I. 81 Saunders M. 116 Seribelli G.H. 25, 107 172 172 173 173 Serkant U. 59 Singh Y. 41, 89, 107 Stewart M. 37 Taki A. 76 Serrano I. 36 Singhal N. 99 Stiles S. 111 Takyi A. 27 Serrano López L. 24, 66, 112, 116 Sinha A. 64 Stjernqvist K. 103 Talar T. 64 Serreau R. 88 Sinha S. 68 Stocken D. 68 Talbot L. 83 Severino M. 47, 68, 72, 80, 92 Sipola-Leppänen M. 118 Stoecklin B. 55, 62 Talias M. 40 Sevuk Ozumut S. 24, 108 Sizonenko S. 51 Stoelhorst G.M.S.J. 100 Talman M. 121 Sgarbi E. 36 Sizonenko S.V. 87 Støen R. 69 Tamayo M.E. 40 Shah P. 58, 95 Sizun J. 51, 57 Stoiber H. 115 Tammela O. 81 Shah Farhat A. 20 Sjörs G. 95 Stoimenova E. 63 Tamura M. 76 Shanahan I. 65 Sjöström A. 94 Stokes S. 66 Tan J. 22, 64 Shankar-Aguilera S. 55, 63, 102 Skenderi Mustafa B. 23 Stoltz Sjöström E. 45, 111, 121 Tan K. 38 Shankle N. 18 Skiöld B. 38, 92, 109 Storring N. 75 Tandberg B. 122 Sharafutdinova D. 75 Skjaerven R. 102 Stoyanova V. 63 Tang N. 43, 44 Sharkey D. 61, 95, 119 Skranes J. 18 Stranak Z. 42, 109 Taniguchi S. 107 Sharp G. 71 Slater R. 118 Strand M. 99 Tann C. 54, 119 Sharp G.C. 86 Sminato M. 55 Strand Brodd K. 78 Tann C.J. 59 Sharp H. 27 Smith A. 39, 41, 65, 89 Streuli J. 57 Tarko A. 19 Shetty N. 59 Smith J. 48, 67 Stringer S. 95 Tarnow-Mordi W. 30, 88 Shibata A. 67 Smith L.E.H. 45, 87, 93 Stroescu R. 108 Tataranno M.L. 109, 118 Shimotake J. 80 Smyth J. 30 Strom S. 57 Tayman C. 59, 85 Shin J. 42 Snoek L. 98 Stucchi I. 120 Tchirikov M. 83 Shin J.S. 77 So H.Y. 53 Studzinski F. 96 Tedroff K. 102 Shin S.H. 77 Sodano A. 98 Su Y.N. 77 Teh W.Y. 76 Shin S.Y. 18, 111 Söderström M. 57 Suarez-Albo M. 112 Tei M. 92 Shing H. 25 Sol J. 57 Subhedar N. 14 Teig N. 120 Shintaku H. 76 Solana C. 44 Subhedar N.V. 99 Tekgündüz K.Ş 40, 114 Shipley L. 61, 119 Sola A. 35, 60 Suchojad A. 19 Tekgündüz S.E. 114 Shires P. 109 Sola-Visner M.C. 87 Suciu L. 17, 107 Tekin N. 39 Shishkina O. 102 Soler P. 114 Suciu L.M. 108 Teles Silva C. 85, 116 Shishko G. 36 Solevåg A.L. 116 Sukharava A. 36 ter Heine R. 41 Shoji H. 110 Soliz A. 21 Sun A. 96 Terki Hassaine R. 81 Shore H. 111 Soliz J. 21 Sun K.M. 22 Testoni D. 25 Shuttleworth B. 59 Soltirovska Salamon A. 79 Sun Y. 87 Tetruashvili N. 75 Shyur S.D. 21 Song I.G. 77 Sun Song W. 62 Thanhaeuser M. 43, 44, 81, 87 Siahanidou T. 115 Songstad N.T. 84 Sundberg B. 38 Theodoraki M. 83, 101 Siddiqui F. 85 Sørensen A.S. 46 Suppiej A. 48 Thibault M-P. 69 Sierra A. 100 Soubasi V. 44 Sutcliffe M. 18 Thiele N. 57, 105 Siffel C. 55, 94, 102 Souza T.S. 22 Suter L. 99 Thielen M. 99 Siljehav V. 117 Spaans E. 41 Suzuki K. 43, 113 Thio Lluch M. 62 Silva A. 87 Späth C. 111 Svedenkrans J. 55 Tho A. 95 Silva G. 85, 116 Spaull R. 54 Svensson J. 103 Thomas S. 99 Silva R.P.G.V.C. 20 Spencer S. 27 Sweetman D. 31, 43, 44, 80 Thomson G. 39, 123 Silveira R.C. 47, 65 Spittle A.J. 47 Syrimi E. 23 Thomson L. 50 Silverman A. 27 Spong R. 56 Szabo M. 63, 64, 67 Thorolfson F. 82 Simard J.M. 43 Spyroulias G.A. 113 Szadkowska A. 65 Thwaites R. 115 Simeoni U. 53, 64, 96, 116, 121 Staffler A. 21 Szakmar E. 63, 64 Tibboel D. 48, 49, 57, 88, 118 Simmen P. 99 Stanescu A. 97 Szczapa T. 17, 37 Tidrenczel Z.S. 17 Simms V. 56 Stanulla M. 66 Szczapa-Krenz H. 37 Tikanmäki M. 118 Simon M. 17, 107, 108 Stanzelova A. 112 Szepetowski P. 100 Timme K. 120 Simonato M. 33, 48, 65, 102, 120 Starnberg J. 93 Szpecht D. 92 Tin W. 68 Simons E.A. 100 Stas H.G. 100 Szymankiewicz M. 92 Tocoian A. 84 Simons S.H.P. 9, 15, 27, 31, 41, 49, 57, Staunstrup N.H. 86 Todorov T. 20 59 88, 100 Staves J. 81 Toet M. 29, 118 Sindelar R. 21, 43 Stefanovic S. 115 T Tofani L. 98 Singer B.B. 119 Stefanovic V. 115 Tofé I. 19, 72, 93, 107, 110 Singh A. 24, 85 Stegeman R. 80 Tabasso C. 110 Toivonen M. 90 Singh B. 63 Steinhorn R. 11, 55, 71 Taber M. 42 Toma A.I. 67 Singh G. 89 Stellari F.F. 36 Tachtsidis I. 54, 119 Tomasik P. 45, 110 Singh G.K. 41 Stellin G. 48 Taddio A. 30 Tomasini E.P. 61 Singh K. 32 Stendahl T. 39 Taguchi A. 76 Toome L. 53, 122 Singh M. 108 Stephansson O. 92, 95 Taher N.A. 80, 116 Topf H-G. 120 Singh N. 85 Stevens B. 30 Takatera A. 67 Tormey P. 44 174 174 175 175 Toro F. 38 Veneselli E. 68, 80 Wagner M. 80 Torres Torres M. 95 V Vento Torres M. 30, 31, 35, 58, 60, 71, 72, Waheed G. 86 Tortora D. 47, 68, 72, 80, 92 73, 93, 95 Walker A. 109 Totsu S. 110 Vääräsmäki M. 118 Verdoliva L. 120 Walker K. 105, 122 Touati A. 77, 107, 112 Vaiman D. 81 Vereshchak S. 37 Walker S. 118 Touqui L. 55, 102 Valenti G. 84 Vergely C. 121 Wallace L. 71 Towers H.M. 57 Valentsiukevich I. 36 Verhage C. 67 Wallendorff M. 41 Trabelsi S. 77 Valstar M. 95 Verhage C.H. 39 Walsh B. 47 Traggiai C. 80 Valverde E. 72, 93 Verhagen E. 55 Walsh B.H. 80 Tran P-A. 99 Van Beek F. 49 Verlato G. 120 Wang D.H. 96 Trancassini M. 94 van Beek R.H.T. 61 Vermeulen R. 100 Wang H.S. 96 Tremblay E. 69 van Bel F. 47, 87 Verstyuft C. 88 Wang J. 31 Tremlett C. 116 Van De Heuvel M. 12 Vervenioti A. 51 Wang J.Y. 21 Treston B. 108, 112 Van De Ville D. 118 Vestergaard E.M. 31 Wang L.X. 96 Trevisanuto D. 23, 62, 120 van Den Akker C.H.P. 43 Viberg M. 83, 100 Wang M. 33 Triantafyllidou P. 101 van Den Anker J. 114 Vidra C. 115 Wang S.M. 96 Trickett J. 104 van Den Anker J.N. 32 Vieira A.A. 22, 111 Ward C. 61, 95 Troiano D.C. 22 van Den Bosch G.E. 110, 118 Viemann D. 65, 66 Ward R. 84 Truttmann A. 45, 119 van Den Hoogen A. 9, 16, 38, 39, 70, 80, 105 Vieten D. 18 Warner B. 41 Truttmann A.C. 101 van Der Aa N. 67 Vijlbrief D. 72 Warren J. 99 Tsai L.Y. 23, 37, 107 van Der Bom J.G. 31 Vijlbrief D.C. 31, 109 Warwick H. 23 Tsai M.H. 59 van der Horst B. 88 Vik T. 103 Washburn L. 121 Tsai Y-S. 28 van Der Lugt A. 118 Villamor E. 28, 49, 102 Watabe S. 76 Tsakalidis C. 44 van Der Net J. 39 Villar-Castro S. 25 Watchko J.F. 43, 44 Tsanova A. 63 van Dijk M. 31, 40, 57, 118 Villarino R. 75 Watkins R. 22 Tsao P.-N. 77, 98, 120 van Dijk-Lokkart E. 78 Villetti G. 36 Watts L. 39, 70 Tsilika S. 24, 98 van Drongelen J. 108 Vinaixa Vergés A-A. 84 Wauer R.R. 18 Tsou K.I. 95, 98 van Essen T. 23 Virella D. 94 Webbe J.W.H. 90 Tsou K-I. 98 van Eyck J. 84 Virupachi S.F. 115 Weber S.C. 40 Tsuji M. 76 van Gasselt B. 67 Visentin S. 33 Wechselberger K. 77 Tubman R. 39 van Gennip A. 84 Vishna Rasiah S. 85 Weeke L. 12, 29 Tufvesson E. 97 van Haastert I.C. 53, 109 Visick M. 99 Weider S. 78 Tully E.C. 41 van Heijst A. 27 Vitagliano A. 84 Weindling M. 48 Tunescu M. 27, 85 van Kaam A.H.L.C. 36, 70, 73, 98, 101 Vitale S.G. 84 Weiss M.D. 79 Turner A. 71 van Kampen F.S. 100 Vitsa L. 113 Wellmann S. 26, 32, 79, 92, 93, 118 Turner M. 9, 31, 45, 47, 84, 105 Van Laere D. 100 Viuff A-C. 58, 71, 86, 94 Wells J. 123 Turner M.A. 47 van Lingen R. 43 Vlasova O. 69, 117 Wen Y.H. 98 Twomey D.M. 53 van Lingen R.A. 84 Voeten M. 100 Wertheim D. 65 Tzialla C. 94 van Marter L. 99 Vogeser M. 111 Wesolowska A. 82 van Meurs-Asseler L. 100 Vogl T. 65, 66 Westerlund F. 66 van Rosmalen J. 31 Voigt M. 96 Westin V. 45, 111 U van Straaten I. 101 Völler S. 88 Weston P.J. 28, 114 van Tuyl M. 98 Völlger L. 66 Westrup B. 38, 93, 122 Uccella S. 68, 80 van Weissenbruch M. 100 Volpe J.J. 92 Wheeler K.I. 68 Uclés G. 24, 75, 78 van Weissenbruch M.M. 45 von Hofsten C. 78 White T. 118 Uclés López G. 115 van Weteringen W. 23, 88 von Kaisenberg C.S. 66 Whybra-Trümpler C. 37 Ueda M. 67 Van Wyk L. 48, 107 von Köckritz-Blickwede M. 66 Wickström R. 92 Ulas T. 66 van Zanten H. 99 von Krusenstiern L. 31 Wielenga J. 99 Uldbjerg N. 31 van Zoeren-Grobben D. 43 Von Laer D. 115 Wigdel J.B. 81 Ulrich T.H. 120 van’t Verlaat E.P.G. 100 Vora S. 23 Wiingreen R. 103 Ulubas Isik D. 83, 113 Vanniyasingam T. 40 Vormoor J. 68 Wilbaux M. 32 Umphrey L. 62 Vanpée M. 45, 117 Vu K.P.T. 45 Wilde Å 93 Unal S. 83, 113 Vanya M. 84 Vucinovic A. 80 Willassen N.P. 69 Uney J. 54 Varal I. 44, 66 Vucinovic M. 80 William J. 17 Ungureanu M. 107 Varvarigou A. 113 Vyas R. 47 Williams K. 111 Uras N. 23, 41, 82, 85, 96, 98 Varxalama E. 101 Williams L.Z.J. 61 Urbanek M. 77 92 Vecchio D. 94 W Williams M. 57 Urilli D. 92 Vedovelli L. 33, 48, 65, 102 Williams T. 17, 76, 102 Urlesberger B. 61, 62, 64, 80, 82 Vedovili L. 55 Wackernagel D. 62 Wilson E. 83 Uygun M. 24 Vejnoska B. 92 Wada K. 110 Wilson P. 59 Veldhuis M.S. 109 Wagenaar N. 67, 87 Winckler M.I. 47 Velilla-Aparicio M. 38 Wagh D. 22 Winderbank-Scott D. 39 176 176 177 177 jENS 2017 Industry Satellite Symposium To register visit us online at www.peervoice.com/RSVLive Winter J. 37, 99 Zareen Z. 80, 101 Witoslaw B. Wittekindt B. Wittwer-Backofen U. 37 76 96 Zasada M. Zdraveska N. Zea A.M. 45, 110 24 40 Respiratory Syncytial Virus: Wolf M. Wolfs T. Wolke D. 19, 42, 109 54, 119 56, 58, 94, 103, 104, 118 Zeballos Sarrato G. Zeballos-Sarrato S. Zeitlin J. 26 25 53 Should We Identify Paediatric Patients at Risk for Severe Disease? Wood C. 76 Zenker S. 66 Wood H. 108 117 Zernickel M. 120 Woodgate L. 115 Zgârcea C. 25 Woods P. 62 Zhang L. 50 Wösten-van Asperen R.M. 98 Zhang R. 90 Wright B. 116 Zhang Y. 40, 96 Pre-registration Wright I. Wrigley C. 30 53 Zhao J. Zhou P. 31, 55 50 Wednesday, 1 November 2017 is preferred, but walk-ins welcome Wróblewska-Seniuk K. 109 Zhou Q. Zhu L. 40 90 13:30 – 15:00 Zhu X. 79, 93 X Ziegler E.E. 121 Venice Convention Centre Zile I. 17 Xiao J. 42 Zimmermann A. 120 Room: Lecce Zimmermann L. 16, 53, 62, 91 Zivanovic S. 20, 37, 96 Y Zoutkamp G.I. 43 Expert perspectives from: Zuanetti G. 28, 49, 63 Chair Bosco A. Paes, MBBS, FRCPI, Maarten O. Blanken, MD, PhD(c) Yacoubi M.T. 25 Zubkov V. 75 Paolo Manzoni, MD, PhD Utrecht University Medical Center FRCPC, FAAP Yagmur Bas A. 83, 113 Zwittink R. 43 Sant’Anna Hospital McMaster Children’s Hospital Utrecht, the Netherlands Yahya L. 90 Zych B. 65, 83 Torino, Italy McMaster University Yajamanyam P. 43 Hamilton, Ontario, Canada Yalnızoğlu Çaka S. 81 Yamada J. 30 Yamada N. 27 Yamana K. 21 Yamane M. 67 AGENDA Yan J. 79, 93 Yang H-I. 98 Severe RSV Disease: The Worldwide Burden Yao L.M. 96 - Paolo Manzoni, MD, PhD Yap T.L. 23 Yaprak Sul D. 113 Who Needs RSV Infection Prevention? A Closer Look at Children With Chronic Diseases Yaremchuk S. 37 Yasin F. 115 - Bosco A. Paes, MBBS, FRCPI, FRCPC, FAAP Ye X. 50 Yen T.A. 84, 98 Cases in Identifying Children at Risk of Severe RSV Disease Yi F. 47 - Panel Yılmaz Semerci S. 22 Yoon H.R. 77 The Acute and Long-Term Consequences of Severe RSV Disease Yoon Y.M. 77 - Maarten O. Blanken, MD, PhD(c) Yoshimoto S. 67 Yousef N. 63, 98 Yurdakul E. 113 “Ask the Faculty” and Concluding Remarks Yzydorczyk C. 64, 116, 121 Z Learning Objectives • Describe the current clinical burden of severe RSV disease in early childhood Zaharie G. 62, 115 • Identify paediatric patients, particularly those with chronic diseases, at risk for severe RSV disease Zaharie G.C. 109 • Describe the potential clinical and societal consequences associated with severe RSV disease Zamir I. 121 Zanetti B. 21 Zanin A. 75 This activity is supported by an educational grant from AbbVie. Zappettini S. 30 This independent medical education activity is organised by PeerVoice. PeerVoice activities are designed to fill the unmet needs of the medical community by reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. The preparation of PeerVoice activities is supported by Zardi S. 77 written agreements that clearly stipulate and enforce the editorial independence of PeerVoice and the faculty presenters. 178 178 Copyright © 2010-2017, PeerVoice CCHD Screening with Masimo SET ® Measure-through Motion and Low Perfusion Pulse Oximetry ™ ™ Please visit us at Masimo Stand #2 Studies found that Masimo SET® contributed to increased sensitivity and specificity of critical congenital heart disease screening compared to physical exam alone1-5 > In the largest CCHD screening study to date, with over 122,738 subjects, screening sensitivity increased from 77% using clinical assessment alone to 93% when clinical assessment was combined with Masimo SET® pulse oximetry.4 > Masimo SET® pulse oximeters and sensors were exclusively used in the two studies (59,876 subjects) that were the basis for the CCHD workgroup recommendation for CCHD screening protocols.1, 3, 6 Eve™ Newborn Screening Software Application* > Automates each of the screening steps with animated instruction, including sensor application, measurement selection, and screening result determination. www.masimo.co.uk/eve PLCO-001150/PLLT-10032C-0717 © 2017 Masimo. All rights reserved. 1 de-Wahl Granelli A et al. BMJ. 2009 Jan 8;338:a3037. 2 de-Wahl Granelli A et al. Acta Paediatr.2007 Oct;96(10):1455-9. 3 Ewer AK et al. Lancet. 2011 Aug 27;378(9793):785-94. 4 Zhao QM et al. Lancet. 2014 Aug 30;384(9945):747-54. 5 Meberg A et al. Acta Paediatr.2009 Apt;98(4):682-6. 6 Kemper AR et al. Pediatrics. 2011 Nov;128(5):e1259-67. * Referred to as “CCHD Mode” in Radical-7 Operator’s Manual. For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions. Masimo devices with Eve has obtained CE Marking. Not available in the U.S.